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SUMMARY
Summary
1. The reduced species of molecular oxygen, superoxide anion, rapidly destroys 
nitric oxide and thereby impairs the vital vasodilator role played by the 
endothelium. Therapeutic treatment with the endogenous scavenger of superoxide, 
superoxide dismutase (SOD) is of limited value since it cannot penetrate cell 
membranes to protect nitric oxide intracellularly.
2. In this study, a number of structurally distinct membrane-permeant SOD mimetics 
were examined both biochemically for their ability to inhibit superoxide-catalysed 
reactions and fimctionally for their ability to protect nitric oxide from destruction 
by oxidant stress in rabbit aorta.
3. The SOD mimetics investigated were the nitroxide spin traps PTIYO (4-phenyl- 
2,2,5,5-tetramethyl imidazolin-1 -yloxy-5-oxide) and tempo! (4-hydroxy 2,2,6,6- 
tetramethylpiperidine-1 -oxyl), the superoxide scavenger tiron (4,5-dihydroxy-1,3- 
benzene-disulfonic acid), the metal-based compounds CuDIPS (Cu [II]- 
[diisopropylsalicylate]2) and MnTMPyP (Mn [III] tetrakis [l-methyl-4-pyridyI] 
porphyrin), and the metal salts CUSO4 and MnCb-
4. These mimetics were investigated for their ability to inhibit the superoxide anion- 
catalysed reduction of cytochrome c and nitro blue tétrazolium. The ranlc order of 
potency in inhibiting the reduction of cytochrome c was C11SO4 > MnCb > 
CuDIPS > MnTMPyP > tiron > tempo! > PTIYO. The requirement of EDTA 
prevented the assessment of the activity of CUSO4, MnC^ and CuDIPS in the 
assay involving inhibition of reduction of nitro blue tétrazolium. However, the 
ranlc order of potency for those agents which could be examined (MnTMPyP > 
tiron > tempo! > PTIYO) was similar to that seen in the cytochrome c assay.
Summary
5. Novel models of oxidant stress were generated in rabbit isolated aortic rings by 
inactivating endogenous Cu/Zn SOD with diethyldithiocarbamate DETCA (60 
min) either alone at 3 mM or at 0.3 mM in combination with superoxide 
generation using xanthine oxidase (XO; 4.8 mu ml"') and hypoxanthine (HX; 0.1 
mM).
6 . Addition of XO/HX to DETCA (0.3 mM)-treated tissues powerfully impaired both 
basal and acetylcholine-induced relaxation and exogenous SOD (250 u ml"') fully 
reversed the blockade, suggesting the oxidant stress was extracellular. CuDIPS (0.1 
- 3 pM), CUSO4 (0.3 - 3 pM), M11CI2 (1 - 100 pM) and MnTMPyP (100 - 600 pM) 
also reversed the blockade powerfully. Tempol (30 pM -  1 mM) and tiron (0.3 -  10 
mM) reversed the blockade weakly and PTIYO (10 -  300 pM) enhanced the 
blockade.
7. ACh-induced relaxation was inhibited by DETCA (3 mM, 60 min) and was not 
restored by exogenous SOD (250 u ml"'), suggesting the oxidant stress was 
intracellular. MnTMPyP (600 pM and 1 mM) and MnCl2 (100 pM) were the only 
agents to reverse the blockade of ACh-induced relaxation.
8 . Thus, MnTMPyP was the only SOD mimetic to restore nitric oxide-dependent 
relaxation in conditions of both extracellular and intracellular oxidant stress. It 
was found, however, that MnTMPyP can paradoxically destroy basal nitric oxide 
through the generation of superoxide. This undoubtedly compromises its 
therapeutic potential in the treatment of vascular pathologies associated with 
oxidant stress.
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Introduction Chapter 1
1.1 VASCULAR NITRIC OXIDE
1.1.1 The vascular endothelium
The luminal surface of the entire cardiovascular system, from the heart to capillaries, 
is lined by a smooth, single layer of endothelial cells, forming an interface between 
the blood and underlying tissue. These cells, collectively known as the endothelium, 
play an important role both in short- and long-term regulation of vascular 
homeostasis.
The endothelium provides anti-thrombogenic activity via the release of prostacyclin 
and nitric oxide, both of which inhibit platelet activation (Moncada et aL, 1976; 
Radomski et al., 1987a). Additionally, nitric oxide inlnbits platelet adhesion to the 
vessel wall (Radomski et aL, 1987b). Also released is tissue plasminogen activator 
which initiates the dissolution of blood clots by plasmin (Loskutoff & Edington, 
1977). The endothelium also participates in haemostasis by releasing von 
Williebrand factor (Jaffe et at., 1973), a factor Vlll-related protein, which promotes 
adherence of platelets to a damaged vessel wall facilitating formation of a platelet 
plug. It also synthesises active hormones from inactive precursors such as in the 
conversion of angiotensin I to angiotensin II by the angiotensin converting enzyme 
(Caldwell et aL, 1976).
The endothelium can also modulate vascular tone by the production and release of 
the vasodilator mediators prostacyclin (Moncada et aL, 1976), endothelium-derived
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hyperpolarising factor (Taylor & Weston, 1988), and endothelium-derived relaxing 
factor (Furchgott & Zawadzki, 1980) later found to be nitric oxide (Palmer et al.,
1987), as well as the vasoconstrictor peptide endothelin-1 (Yanagisawa et aL, 1988).
1.1.2 Endothelium-derived relaxing factor
Acetylcholine (ACh) is a potent vasodilator in vivo but does not always produce 
relaxation in isolated blood vessel preparations. Furchgott & Zawadzki (1980) 
reconciled this by their discovery that endothelial cells play an obligatory role in the 
relaxation. The simple explanation was that the previously over looked endothelial 
cells were almost always inadvertently rubbed off during isolation of blood vessels 
for tension recording. Using a ‘sandwich’ preparation of a rabbit endothelium- 
containing aortic (donor) strip co-mounted with an endothelium-denuded (detector) 
strip, they further demonstrated that ACh stimulated the endothelial cells to release a 
humoral substance which in turn acted on the smooth muscle of the detector strip to 
produce vasorelaxation. They termed this substance ‘endothelium derived relaxing 
faetor’ (EDRF).
Endothelium-dependent relaxations involving EDRF were subsequently 
demonstrated in many vascular preparations from many species and in response to a 
variety of substances other than acetylcholine, such as bradykinin, substance P, 
calcium ionophore A23187, vasopressin, adenine nucleotides and histamine (see 
Moncada et aL, 1991).
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Further characterisation of the nature of EDRF came from isolated tissue studies and 
variants of the ‘sandwich’ bioassay type of preparation described above. It was 
reported that EDRF had a half-life of only a few seconds in oxygenated physiological 
Krebs solution (Griffith et aL, 1984; Cocks et aL, 1985). The reduced species of 
oxygen, superoxide anion, appeared to contribute to the instability of EDRF since its 
relaxant effects in cascade bioassay systems were potentiated and prolonged by the 
addition of the scavenger of superoxide, superoxide dismutase (SOD; Gryglewski et 
aL, 1986; Rubanyi & Vanhoutte, 1986b). SOD also prevented the action of other 
inhibitors of EDRF, such as pyrogallol and hydroquinone, suggesting that these act 
by generating superoxide (Moncada et aL, 1986). Another inhibitor of EDRF, 
haemoglobin, however, did not act via a superoxide related mechanism but was 
found to bind the EDRF molecule (Martin et aL, 1985b; Hutchinson et al., 1987). An 
important discovery came from Rapport & Murad (1983) who reported that the 
endothelium-dependent relaxation of smooth muscle was mediated via the 
stimulation of soluble guanylate cyclase, with concurrent elevation o f cyclic 3’,5’- 
guanosine monophosphate (cGMP) levels. Indeed, the inactivator of soluble 
guanylate cyclase, methylene blue (Gruetter et aL, 1981), blocked endothelium- 
dependent relaxation (Martin et aL, 1985a). Methylene blue, however, is now known 
to have the additional action of superoxide anion generation (Wolin et aL, 1990) and 
has been superseded as the drug of choice by the more selective inhibitor of soluble 
guanylate cyclase, ODQ (Garthwaite et aL, 1995). Schmidt et al. (1998) report, 
however, that ODQ possibly has the additional action of interfering with the 
synthesis of nitric oxide. The ability of selective inhibitors of cGMP 
phosphodiesterase, such as M&B 22948 (zaprinast), to potentiate endothelium-
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dependent relaxation further supported the role of cGMP in vascular relaxations 
(Martin et aL, 1986b). The most recently introduced inhibitor of cGMP 
phosphodiesterase 5, sildenafil (Viagra), has been shown to be some 100 -  240 fold 
more potent than zaprinast (Moreland et aL, 1998). This compound has great clinical 
utility in the treatment of male impotence (Goldstein et aL, 1998). This effect is 
derived from the involvement of nitric oxide in the relaxant responses that induce 
penile erection.
1.1.3 Chemical nature of endothelium-derived relaxing factor
In 1986, Furchgott and Ignarro both speculated, on the basis of almost identical 
pharmacological profiles and physical and chemical properties, that EDRF may be 
nitric oxide or a closely related species (see Furchgott 1988; Ignarro et aL, 1988). 
Conclusive evidence for this came from a series of compelling experiments 
conducted by Palmer et al. (1987). In these studies, nitric oxide was measured, by 
chemiluminesence, as the product of its reaction with ozone. It was reported that 
nitric oxide was released in a concentration-dependent manner from cultured 
endothelial cells in response to stimulation by bradykinin and that the levels of nitrie 
oxide released were sufficient to account for the relaxation of vascular detector 
strips. In addition, both EDRF and nitric oxide caused a relaxation of the vaseular 
strips that declined at the same rate during passage down a bioassay cascade. 
Furthermore, the relaxant actions of EDRF and nitric oxide were inhibited by 
haemoglobin and enhanced by SOD to a similar degree.
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The chemical properties of nitric oxide could readily explain many of the 
characteristics of EDRF. The inactivation of EDRF by haemoglobin could be 
explained conveniently by the avid binding of nitric oxide to the haem iron of this 
molecule (Gibson & Roughton, 1957; Martin et aL, 1985b). In addition, the ability of 
superoxide anion to inactivate EDRF could be readily explained as a consequence of 
its extremely rapid reaction with nitric oxide, rate constant 6.9 x lO^M'^s'^ (Huie & 
Padmaja, 1993). Furthermore, the vasorelaxant activity of nitrovasodilators, which is 
similar to that of EDRF, had long been suspected to be mediated by nitric oxide 
(Katsuki et aL, 1977; Arnold et aL, 1977).
1.1.4 Controversy over acceptance of nitric oxide as EDRF
For some, the finding that EDRF was nitric oxide seemed implausible. Many initial 
objections were founded on the basis that nitric oxide is a well Icnown noxious agent. 
It is an enviromnental pollutant, contributes to acid rain and is found in cigarette 
smoke (Gibaldi, 1993). Such a labile, toxic gas seemed an unlikely endogenous 
biological mediator. Many researchers questioned, and provided evidence against, 
the conclusion that nitric oxide could account for the activity EDRF.
It was reported that EDRF from cultured endothelial cells only relaxed vascular 
smooth muscle whereas authentic nitric oxide also relaxed guinea pig vascular, 
tracheal and taenia coli smooth muscle (Shikano et aL, 1987; Dusting et aL, 1988). 
These findings were explained, however, by the much lower sensitivity to nitrie
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oxide of respiratory and gastrointestinal smooth muscle than of vascular smooth 
muscle (Gillespie & Sheng, 1988).
Another report suggested that EDRF, but not nitric oxide, was stabilised by 
acidification (Murray et aL, 1986). This was explained, however, by the reaction of 
nitric oxide with oxygen in physiological solution to form nitrite, which can generate 
nitric oxide when acidified. Nitrite has the same chromatographic mobility as that 
reported for the acidified 'stable' form of EDRF (Moncada et aL, 1991).
It was also suggested that EDRF may be a nitric oxide-releasing molecule, such as an 
unstable nitroso compound, rather than nitric oxide per se (Myres et aL, 1990). 
Based on comparisons of the potency of S-nitrosocysteine with that of nitric oxide on 
vascular strips and measurements of nitric oxide release by chemiluminesence, they 
suggested that EDRF was much more likely to be a nitrosylated compound than 
authentic nitric oxide. Another group (Kukreja et aL, 1993) compared the effects of 
nitric oxide and S-nitrosocysteine on tissues in relation to the associated increment in 
nitrite concentration and concluded that S-nitrosocysteine resembled EDRF more 
closely than nitric oxide. In contrast, however, more recent studies by Feeliseh et aL 
(1994) propose that the actions of EDRF and nitric oxide, but the not S-nitrosothiols 
S-nitrosocysteine and S-nitrosocysteamine, were inactivated by L-cysteine, 
suggesting that EDRF and nitric oxide are identical.
It was recently suggested that nitric oxide, formed in neuronal tissue, is initially 
released as nitroxyl anion and that SOD plays an obligatory role in the conversion of
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this to nitric oxide (Schmidt et aL, 1996). This finding, however, has been disputed 
by Xia & Zweier (1997b) who report that electron paramagnetic resonance 
spectroscopy measures directly authentic nitric oxide but not nitroxyl anion produced 
from neuronal tissue. These authors speculated that the above findings by Schmidt et 
al,. (1996) derive from the additional presence superoxide in the experimental 
procedure which would explain the necessity of SOD to detect nitric oxide.
It appears, therefore, that most of the evidence suggesting that EDRF is not authentic 
nitric oxide has been disputed. Nevertheless, even if EDRF is initially released as a 
precursor molecule, it seems virtually certain that its biological effects are ultimately 
mediated by nitric oxide.
1.1.5 Relaxant mechanisms of nitric oxide
Vascular smooth muscle cell tone is controlled primarily by the intracellular level of 
calcium. Free intracellular calcium binds to calmodulin and this complex attaches to 
and activates myosin liglit-chain kinase (MLCK). This protein kinase then utilises 
ATP to phosphorylate myosin which can then interact with actin. This initiates 
crossbridge cycling and the generation of force resulting in cell contraction (see 
Berne & Levy, 1998). It seems reasonable that the mechanism of vascular smooth 
muscle relaxation induced by nitric oxide occurs either via the lowering of free 
intracellular calcium levels or by reducing sensitivity to calcium.
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Once produced, nitric oxide can readily pass through biological membranes where it 
can activate soluble guanylate cyclase in the smooth muscle cells. The endogenous 
receptor for nitric oxide on guanylate cyclase is the ferrous haem moiety (Ignarro et 
al., 1982). The nitric oxide-guanylate cyclase bond dislocates the haem iron, thereby 
inducing a conformational change of the enzyme, which in turn activates the catalytic 
site (Tsai, 1994). The subsequent increase in formation of cGMP from guanosine 
triphosphate produces smooth muscle relaxation. The primary mechanism by which 
cGMP induces smooth muscle relaxation is by lowering intracellular calcium levels 
and phoshorylating MLCK (Collins et aL, 1986). It is likely that cGMP exerts its 
actions via a cGMP-dependent protein kinase. This activated protein kinase lowers 
caleium levels by: (i) stimulating calcium-ATPase activity to sequester calcium into 
the sarcoplasmic reticulum (Amrani et aL, 1995) and out of the cell (Ficus, 1988); 
(ii) stimulating calcium-activated potassium channels leading to a hyperpolarisation- 
mediated inhibition of calcium entry through L-type voltage-gated calcium channels 
(Robertson et aL, 1993); (iii) phosphorylation of phospholipase C resulting in 
inhibition of 1,4,5-trisphosphate formation and consequent release of calcium from 
sarcoplasmic reticulum (Hirata et aL, 1990); and (iv) inhibition of receptor-operated 
calcium channels (Godfraind, 1986). The protein kinase also lowers sensitivity to 
calcium by increasing the dephosphorylation of myosin light chain (Welch & 
Loscalzo, 1994). It has also been suggested that nitric oxide can directly open 
potassium channels in smooth muscle (Koh et aL, 1995), which would cause 
hyperpolarisation, leading to relaxation (see Figure 1.1).
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1.1.6 Synthesis of nitrie oxide
Synthesis of nitric oxide requires oxygen and the amino acid, L-arginine, as 
substrates. Cofactors required include calcium, calmodulin, flavin adenine 
dinucleotide, flavin mononucleotide, NADPH and tetrahydrobiopterin (Palmer et al., 
1988; Palmer & Moncada, 1989; Mayer et aL, 1989; Mulsch et aL, 1989; Bredt & 
Snyder, 1990; Hevel et aL, 1991; Stuelrr et aL, 1991a; Leone et aL, 1991; Schmidt et 
aL, 1992b). See Figure 1.1.
The enzymatic generator of nitric oxide, nitric oxide synthase (NOS), appears to 
catalyse a five electron reduction of the terminal guanidino nitrogen atom of L- 
arginine to form nitric oxide. The formation of nitric oxide is likely to occur in at 
least a two step process. In the first step, L-arginine is converted to N^-hydroxy-L- 
arginine by means of reduced NADPH- and tetrahydrobiopterin-dependent mono­
oxygenation. In the second step, the oxidative cleavage of the C=N bond of N*^ - 
hydroxy-L-arginine leads to the formation of nitric oxide and the byproduct, L- 
citrulline (Leone et aL, 1991; Stuehr et aL, 1991a; Marietta, 1993; Korth et aL, 1994) 
(see Figure 1.1).
Cells that synthesise nitric oxide possess an active uptake mechanism for L-arginine. 
Uptake is mediated by an active transporter, y+, which is also used by other cationic 
amino acids (Kerwin et aL, 1995; Bogle et aL, 1996). Some inhibitors of NOS, such 
as N^-monomethyl-L-arginine, appear to exert an additional inhibitory action by 
competing with L-arginine for the cationic transporter (Kerwin et aL, 1995).
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FIGURE 1.1 Biosynthesis of endothelial nitric oxide (NO). NO is formed from the 
terminal guanidino group of the amino acid L-arginine, which is taken into the cell 
by an active transport mechanism (y+). The activation of receptors (R) by agonists 
such as acetylcholine (ACh) or bradykinin (BK) leads to increased intracellular Ca^  ^
levels which activate the NOS to form NO and L-citrulline through the intermediate 
compound N^-hydroxy-L-arginine (L-OHArg) and the use of cofactors. NOS is 
blocked by analogues of L-arginine, such as L-NMMA. In smooth muscle cells 
(SMC), NO activates soluble guanylate cyclase (SGC; which is blocked by ODQ), 
increasing cGMP levels. cGMP produces relaxation by several mechanisms 
including: inhibition of Ca^ "" entry through receptor operated channels (ROC); 
stimulation of membrane Ca^^-ATPases and inhibition of myosin light chain kinase 
(MLCK). See text for details. Co factor abbreviations: BH4 (tetrahydrobiopterin); 
FAD (Havin adenine dinucleotide); FMN (flavin mononucleotide). Taken From 
Marin & Rodriguez-Martinez, 1997.
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1.1.7 Isoforms of nitric oxide synthase
Many non-endothelial cells are able to synthesise nitric oxide. To date, thiee 
isoforms of NOS have been identified as being responsible for this synthesis. The 
isoforms are termed NOS I, II, and III (see Forstermann et aL, 1994).
NOS I was first purified in brain tissue (Bredt & Snyder, 1990) and is therefore 
sometimes referred to as bNOS (for brain) or nNOS (for neuronal). These 
classifications, however, are somewhat imprecise since NOS I has been localised in 
the epithelium of lung, uterus and stomach (Schmidt et aL, 1992a) and in skeletal 
muscle (Nakane et aL, 1993). This enzyme is constitutively expressed and is 
regulated not only by calcium/calmodulin but also by calcium/calmodulin-dependent 
protein kinase II (which inhibits activity) and protein kinase C (which enhances 
activity) (TMakane et aL, 1991).
NOS II is not usually expressed but is induced in cells by bacterial 
lipopolysacchaarides and/or certain cytokines (Stuehr et aL, 1991a; Hevel et aL, 
1991). This enzyme is sometimes referred to as iNOS (for inducible). NOS II 
expression is classically associated with macrophages but can be also be found in 
smooth muscle cells (Mitchell et aL, 1992), lymphocytes, neutrophils, Kupffer cells 
and endothelial cells (Bandaletova et aL, 1993). This enzyme is calcium- 
independent, and was originally believed also to be calmodulin-independent. It has 
been shown, however, to bind calmodulin so tightly that it is continuously activated 
by this cofactor even when calcium levels are low (Cho et aL, 1992). The regulation
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of its activity is therefore by the induction of transcription (Xie et al., 1992) and de 
novo synthesis of NOS II protein. This gives NOS II the characteristic of producing 
greater and longer lasting release of nitric oxide than the two constitutive isoforms.
In humans, NOS I, II and III are encoded by separate genes located on chromosomes, 
12 and 17, 7 respectively (Marsden et aL, 1993; Xu et aL, 1993). Despite this, the 
NOSs have many features in common and all show a high degree of amino acid 
sequence homology with NADH-cytochrome P450 reductase. Also, across species, 
the amino acid sequences for each isoform are well conserved (>90 % for NOS I and 
III and > 80 % for NOS II; see Forstermann et aL, 1994; Kerwin et aL, 1995). All
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NOS III is found in endothelial cells and is sometimes called eNOS (for endothelial). 
As with bNOS or nNOS, the term eNOS is largely an oversimplification since it has 
also been localised in platelets (Radomski et aL, 1990) and certain neuronal 
populations of the brain (Dinerman et aL, 1994). Unlike the other two soluble 
enzymes, it is more than 90 % particulate and anchored in the membrane 
(Forstermann et aL, 1991; Mitchell et aL, 1991a). Like NOS I, NOS III is 
constitutively expressed and is regulated by calcium/calmodulin. The pathway for the 
calcium increase in endothelial cells is unclear. It has been suggested, however, that 
entry may be through a receptor-operated ion channel (Johns et aL, 1987) and, to a 
lesser degree, calcium release from cyclopiazonic acid- and thapsigargin (calcium- 
ATPase inliibitors)-sensitive internal stores (Hutcheson & Griffith, 1997). It has been 
reported that the shear stress of flowing blood upregulates NOS III expression 
(Nishida et aL, 1992).
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isoforms can be inactivated by high concentrations of nitric oxide. Therefore nitric 
oxide may function as a negative feedback modulator of its own synthesis (Rogers & 
Ignarro, 1992; Assreuy et al., 1993). The mechanisms by which nitric oxide 
inactivates NOS is unknown but it may bind with the haem moiety of the enzyme or 
induce S-nitrosylation of a critical thiol.
1.1.8 Inhibitors of nitric oxide synthase
Considering the requirement for so many cofactors and the mechanisms by which it 
is regulated, inliibition of NOS can be realised in a variety of ways (see Fukuto & 
Chaudhuri, 1995). These can essentially be split into two groups, non-selective and 
isoform selective inhibitors.
Non-selective inhibitors operate by inactivating elements common to all isoforms. 
All NOS enzymes require flavin adenine dinucleotide and flavin mononucleotide. 
Therefore inhibitors of flavoproteins would be expected to inhibit NOS activity. 
Indeed, one such inliibitor, diphenyleneiodonium, has been shown to inhibit NOS I in 
nitrergic nerves (Rand & Li, 1993), NOS II in macrophages and NOS III in 
endothelial cells (Stuehi* et al., 1991b). In addition, inhibition of tetrahydrobiopterin 
biosynthesis, by 2,4-diamino-6-hydroxypyrimidine, also leads to a loss of NOS II 
activity in macrophages (Sakai et al., 1993) and NOS III in endothelial cells 
(Schmidt et al., 1992b). Furthermore, analogues of L-arginine represent another 
route to inhibit NOS activity. These include N^-methyl-L-arginine, N^-nitro-L- 
arginine and N^-nitro-L-arginine methyl ester which have been shown to be
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competitive inhibitors of NOS I, NOS II and NOS III (Gross et aL, 1990; Rees et aL, 
1990).
Isoform-specific inhibitors of NOS operate by inactivating elements unique to the 
isoenzyme. For example, inhibition of calmodulin would be expected to impair NOS 
I and III function but not NOS II since this enzyme is not regulated by this agent. 
Indeed, the calmodulin inhibitors, calmidazolium and fendiline, inhibit ACh-induced 
relaxation in rat aorta but have no effect on cytokine-induced NOS II expression and 
nitric oxide production (Schini & Vanlioutte, 1992). In addition, some L-arginine 
analogues inhibit certain NOS isoforms more than others. N^-nitro-L-arginine, 
inhibits NOS I more powerfully than NOS II (Furfine et aL, 1993). Moreover, N- 
amino-L-arginine and N-nitro-L-arginine analogues were about 100 fold more potent 
in inhibiting NOS III than the other isoenzymes (Gross et aL, 1991). Recently, 
however, much more selectively potent inhibitors have become available, such as the 
NADPH-dependent agent, N-(3-(aminomethyl)benzyl)acetamidine (1400W), which 
has been described as 1000-fold more potent against NOS II than NOS III (Garvey et 
aL, 1997). Amino guanidine (Misko et aL, 1993) and L-N6 -(l-iminoethyl)lysine 
(Moore et aL, 1994) have also has been described as a highly selective inhibitors of 
NOS II while 7-nitroindazole (Moore et al., 1993; Nanri et a/.,1998) and l-(2- 
trifluoromethylphenyl) imidazole (TRIM) (Flandy et aL, 1995; Handy et aL, 1996) 
selectively inhibit NOS 1.
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1.1.9 Physiological functions of nitric oxide synthase isoforms
Selective inliibition of the NOS isoforms has uncovered many of the physiological 
functions of these enzymes.
Nitric oxide produced from NOS I mediates neurotransmission both in the central 
and peripheral nervous systems. In the central system, nitric oxide has been 
associated with long-term potentiation, a process connected with the formation of 
memory (Shibuki & Okada, 1991; Izumi et aL, 1992). Indeed, inhibitors of NOS 
impair learning and can produce amnesia in chicks and rats (Holscher & Rose, 1992; 
Bolime et aL, 1993). In the periphery, nitric oxide appears to mediate 
neurotransmission in a particular set of non-adrenergic non-cholinergic nerves. These 
‘nitrergic’ nerves (Rand, 1992) innervate some smooth muscle of the gastrointestinal 
tract, pelvic viscera and airways and their stimulation results in muscle relaxation 
(see Gillespie et aL, 1990; Martin & Gillespie, 1991).
Induction of NOS II produces large amounts of nitric oxide in macrophages or other 
cells types. These high concentrations of nitric oxide play a primary role in the 
defence against micro-organisms, parasites or tumour cells. Nitric oxide can bind to 
iron in proteins of target cells which can inhibit key enzymes including 
ribonucleotide reductase (involved in DNA replication) and iron-sulphur cluster 
dependent enzymes involved in mitochondrial electron transport e.g. aconitase 
(Nathan & Hibbs, 1991). In addition, nitric oxide can have a direct effect on the 
DNA of target cells causing stand breaks and fragmentation (Wink et aL, 1991;
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Fehsel et a i,  1993). There is also clear evidence that superoxide anion generated 
from macrophages can react with co-released nitric oxide to from the potent oxidant, 
peroxynitrite (Xia & Zweier, 1997a). Peroxynitrite can cause nitration of proteins 
leading to altered protein function, increased protein turnover and alteration of 
tyrosine phosphorylation (Crow & Beckman, 1995). A combination of these effects 
probably explains the cytotoxic effects of nitric oxide. Why macrophages are more 
resistant to nitric oxide than their target cells is not yet known.
NOS III is constitutively active and nitric oxide is, therefore, constantly produced 
from the endothelium. This results in a tonic dilatory influence on the vascular 
smooth muscle (Eglème et al., 1984; Griffith et al., 1984; Rubanyi et al., 1985; 
Martin et al., 1986a). Nitric oxide production can be further stimulated by a number 
of agonists (see section 1.1.2) and physical stimuli such as the shearing of flowing 
blood (Pohl et al., 1986; Rubanyi et aL, 1986; Busse & Fleming, 1998) or hypoxia 
(Pohl & Busse, 1989; Igari et aL, 1998). The importance of endothelial NOS III in 
the control of vascular tone is clearly demonstrated when the L-arginine/nitric oxide 
pathway is disrupted by infusion of inliibitors of NOS. This leads to peripheral 
vasoconstriction and increased blood pressure (Rees et aL, 1989; Gardiner et aL, 
1990; Tresham et aL, 1991). Nitric oxide produced from NOS III in the endothelium 
can also inhibit platelet adhesion to the vascular wall (Radomski et aL, 1987b).
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1.1.10 Vascular disorders associated with nitric oxide
':;;WM
Inappropriate or over production of nitric oxide can disrupt normal vascular tone and, 
in severe cases, can result in major pathology. For example, nitric oxide is thought to 
play a key role in migraine. It is proposed that 5-hydroxytryptamine induces 
endothelial cells of the cerebral vasculature to release nitric oxide. The nitric oxide 
can then activate directly sensory fibres to release their transmitters e.g. substance P 
and calcitonin gene-related peptide, causing oedema formation and inducing pain. 
Overall, nitric oxide seems to induce a ‘sterile’ inflammatory response (see Fozard, 
1995). This proposal is supported by the finding that some nitric oxide donors, such 
as amyl nitrite, cause a migraine-like headache (Olesen et al., 1994).
Another condition associated with overproduction of nitric oxide is septic shock. 
This is a clinical syndrome of excessive hypotension and associated cardiovascular 
failure. Bacterial endotoxins are likely to induce an over expression of NOS 11 which 
causes over production of nitric oxide. This excess of nitric oxide may cause 
cytotoxicity and extensive vasodilation resulting in myocardial depression and 
circulatory failure (see Moncada et al., 1991; Fôrstermann et al., 1994). In animal 
models of septic shock, the nitric oxide overproduction caused by NOS 11 induction 
can be blocked by inhibitors of NOS, thus restoring blood pressure and vascular 
responses to normal levels (Kilbourne et al., 1994). Such treatment, however, must 
be used with caution since a general inhibitor of NOS will inactivate NOS 1 and 111 
as well as isoform 11. Such treatment could result in additional complications for the 
patient. Therefore, development of a highly selective inhibitor of NOS 11, such as
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1400W (Garvey et a l ,  1997; Hamilton & Warner, 1998) or amino guanidine (Misko 
et al., 1993) offer great therapeutic potential.
Under production and/or activity of nitric oxide may also contribute to vascular' 
pathologies. Indeed, many pathologies are associated with reduced endothelium- 
dependent relaxation. For example, endothelium-dependent relaxation to 
acetylcholine is reduced in spontaneously hypertensive rats (Dohi et al., 1990; 
Grunfield et al., 1995). Human hypertensive subjects also have impaired 
vasorelaxation to acetylcholine (Linder et al., 1990) and reduced vasoconstriction to 
inhibitors of NOS, suggesting reduced influence of basal nitric oxide activity as 
compared to normotensives (Fanza et al., 1993). Hypercholesterolaemia and 
atherosclerosis are also associated with reduced endothelium-dependent 
vasorelaxation (Shimokawa & Vanhoutte, 1989; Wennmaln, 1994; Ohara et al., 
1995). Moreover, reduced endothelium-dependent relaxation has been reported for 
human and animal diabetic (Calver et al., 1992; Heygate et a l ,  1995; Kamata & 
Kobayashi, 1996) and heart failure subjects (Kubo et al., 1991; Lindsay et a i ,  1992; 
Hirooka et al., 1994). Recent findings suggest that a defect in the nitric oxide 
pathway can promote abnormal vascular remodelling and may facilitate pathological 
changes in vessel wall morphology associated with diseases such as hypertension and 
atherosclerosis (Taddei et al., 1998).
Consideration of the source(s) of the nitric oxide dysfunction in the above diseases 
could perhaps open up novel therapeutic possibilities. As already mentioned, nitric 
oxide is rapidly destroyed by the reduced species of molecular oxygen, superoxide 
anion (Gryglewski et ai, 1986). The loss of vasodilator function following the
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interaction of nitric oxide with superoxide anion (Kaustic & Vanhoutte, 1989; 
Ohlstein & Nichols, 1989, Mian & Martin, 1995a) had led to the suggestion that this 
process may be involved in many pathological process. Consideration of this 
possibility requires an understanding of reactive oxygen species and endogenous 
antioxidant mechanisms.
1.2 REACTIVE OXGEN SPECIES
1.2.1 Oxygen
All aerobic organisms are vulnerable to damaging assault by oxygen. This toxicity is 
largely due to reactive intermediates of oxygen reduction. These reactive oxygen 
species include the free radicals, superoxide anion and hydroxyl radical, as well as 
hydrogen peroxide. By definition this last species is not a free radical but is 
nonetheless an important damaging oxidant. Free radicals can be defined as ‘any 
species capable of independent existence that contain one or more unpaired 
electrons’ (Halliwell & Gutteridge, 1989). The presence of unpaired electrons 
usually causes radicals to be unstable and highly reactive species. Molecular oxygen, 
containing two unpaired electrons, certainly qualifies as a free radical. Due to its 
outer electron configuration, however, it tends to accept electrons one at a time 
making it react rather sluggishly with many non-radicals (see Fridovich, 1983; 
Halliwell & Gutteridge, 1989; Fridovich, 1989; Warner, 1994; Yu et al., 1994; Marin 
& Rodriguez-Martinez, 1995; Crow & Beckman, 1995; Kerr et al., 1996).
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1.2.2 Superoxide anion
Superoxide anion (0% ) is formed by a one step reduction (addition of an electron; e') 
of molecular oxygen (O2).
O2 + e —> O2
The term ‘superoxide’ does not relate to its activity but was coined to describe its 
electron configuration (Pauling, 1979). In fact, with only one unpaired electron, 
superoxide is actually less of a radical than oxygen itself. Indeed, many of its 
deleterious effects are thought to be due to its conversion to more reactive oxygen 
species such as hydrogen peroxide or hydroxyl radical (see below). Superoxide has 
been shown, however, to directly cause the oxidation of catecholamines as well as 
initiating the peroxidation of unsaturated lipids. Importantly, superoxide destroys the 
vasorelaxant actions of nitric oxide (Gryglewski et al, 1986; Kaustic & Vanhoutte, 
1989; Ohlstein & Nichols, 1989, Mian & Martin, 1995a).
Spontaneous dismutation of superoxide to hydrogen peroxide is a very rapid process, 
with a rate constant 5 x 10  ^ M"‘ s"^  at pH 7.8 in aqueous solution, and this is 
dramatically increased (10,000-fold) by the endogenous enzyme, superoxide 
dismutase (SOD). This gives superoxide a very short half life, 1 x 10'^ s at 37 °C, and 
a steady state cellular concentration of approximately 1 x 10"'' M (see Fridovich, 
1983; Halliwell & Gutteridge, 1989; Yu et al., 1994; Marin & Rodriguez-Martinez, 
1995).
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Superoxide anion is produced biologically from a number of sources: membrane 
bound NADH/NADPH oxidase (Pagano et al., 1995; Rajagopalan et al, 1996), 
xanthine oxidase (M'^Cord & Fridovich, 1968), cyclo-oxygenase (Kontos et al., 1985; 
Cosentino et al., 1994), lipoxygenase (Kukreja et al., 1986), nitric oxide synthase 
(Pou et al., 1992; Xia et al., 1996; Xia & Zweier, 1997a), and electron spillage 
during electron transport chain from mitochondria (Boveris, 1977). In addition, 
autoxidation of compounds such as haemoglobin (Misra & Fridovich, 1972a), 
catecholamine (Misra & Fridovich, 1972b), thiols (Misra, 1974), sulfhydryl 
compounds (Jia & Furchgott, 1993) and guanidino containing compounds (Aoyagi et 
al., 1989) result in formation of superoxide anion.
1.2.3 Hydrogen peroxide
Addition of an electron to superoxide anion gives the peroxide ion (O^ ). The 
oxygen-oxygen bond in this ion is relatively weak, and in biological systems, is 
usually stabilised by a couple of hydrogen ions (H^) forming hydrogen peroxide 
(H2O2).
O2 + O2 + 2i f  —> FI2O2 + O2
Flydrogen peroxide is formed mainly from the dismutation of superoxide but can also 
be generated directly from such enzymes as glycollate oxidase, D-aminoacid 
oxidase, and urate oxidase. Flydrogen peroxide is not a free radical (it does not
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contain unpaired electrons) but is a weak oxidant. It is more stable than superoxide 
and can easily diffuse through cell membranes. It is, however, potentially more 
cytotoxic than superoxide due to its ability to inactivate many enzymes directly via
the oxidation of thiols. Moreover, it directly causes increased permeability of I
:endothelial monolayers (Berman & Martin, 1993) and impairs contraction and "
I
endothelium-dependent relaxation in rabbit aorta (Dowell et aL, 1993). Its major 
route of damage, however, is thought to be via the generation of hydroxyl anion, 
either by spontaneous decomposition or by reaction with transition metals (see below 
and for review see Halliwell & Gutteridge, 1989; Yu et a l ,  1994; Marin & 
Rodriguez-Martinez, 1995; Kqxv et a l ,  1996).
In addition to its actions as a oxidant, hydrogen peroxide can also induce vascular 
relaxation by endothelium-dependent and -independent mechanisms (Furchgott,
1991; Zembowicz et a l,  1993; Mian & Martin, 1995a; Mian & Martin, 1995b).
1.2.4 Hydroxy! radical 
Addition of an electron to hydrogen peroxide can generate hydroxyl radical. This
, |reaction is, however, slow but can be catalysed in vivo by the combined presence of 
superoxide anion and trace amounts of transition metals, specifically iron or copper.
This is loiown as the superoxide-assisted Fenton reaction or the transition metal- 
catalysed Haber-Weiss reaction. Here, free ferric iron (Fe^^) or cupric copper (Cf'^‘) 
is reduced by superoxide anion to ferrous iron (Fe^^) or cuprous copper (C f )  (Step 
1 ). The reduced iron or copper is then oxidised by hydrogen peroxide (H2O2) to form
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hydroxyl radical (OH") and the inert hydroxide anion (OH”) (Step 2). (Halliwell & 
Gutteridge, 1989).
Step 1 : + O2' -> Fe^* / Cu* + O2
Step 2: Fe^+ / + H2O2 ^  Fe^+ / + OH' + OH'
Net: O2 + H2O2 —> OH" + OH + O2
Hydroxyl radical is considered to be potentially the most potent oxidant encountered 
in biological systems and can react with virtually all classes of biological molecule. 
Some authors argue that its effective diffusion radius of only a few angstroms, along 
with its half life of approximately IxlO'^s at 37 °C, make it too reactive to elicit any 
specific damage. During its brief life, however, it may initiate a propagating chain of 
reactions that can lead to lipid peroxidation, DNA alteration and damage to other 
vital materials such as proteins.
The hydroxyl radical-mediated cytotoxicity of superoxide and hydrogen peroxide is 
influenced, therefore, by the distribution of free metal ions. Consequently, tightly 
controlled sequestration of metal ions in ‘safe’ forms could prevent formation of this 
damaging radical. Generation of hydroxyl radical by hydrogen peroxide can be 
catalysed, however, by iron-containing proteins such as haemoglobin. In addition, 
superoxide anion can cause ferritin, an iron storage molecule, to release iron which 
can then participate in the Haber-Weiss reaction. Most copper complexes present in 
vivo, however, are not able to contribute to the generation of hydroxyl radical and 
free copper levels are kept low by binding proteins such as caeruloplasmin and 
albumin. Nevertheless, the Cu/Zn isoform of SOD is inactivated by prolonged
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exposure to hydrogen peroxide perhaps due to the generation of hydroxyl radical 
which could destroy the histidine residues essential for the catalytic mechanism (for 
review see Fridovich, 1983; Halliwell & Gutteridge, 1989; Fridovich, 1989; Warner, 
1994; Yu et a l,  1994; Marin & Rodriguez-Martinez, 1995; Crow & Beckman, 1995; 
Kerr et aL, 1996). Hydroxyl radical can also be formed by a metal-independent 
means, via the decomposition of peroxynitrite (see below).
Hydroxyl radical has been reported to play a role in endothelium-dependent 
acetylcholine (ACh)-induced relaxation (Rubanyi & Vanhoutte, 1986b). This 
conclusion is derived from the ability of the hydroxyl radical scavenger, mamiitol, to 
impair relaxation. Prasad & Bharadwaj (1996) also report that hydroxyl radical is 
involved in ACh-induced relaxation and propose that it is formed via breakdown of 
peroxynitrite, generated from the interaction of superoxide anion with ACh- 
stimulated release of nitric oxide (see below). The inability, however, of exogenously 
applied SOD to affect ACh-induced relaxation (Ohlstein et a l ,  1989; Abrahamsson 
et al., 1991 ; Mian & Martin, 1995a) would suggest that superoxide (and hence 
peroxynitrite and hydroxyl radical) play no role in the endothelium-dependent 
relaxation. Indeed, the evidence that ACh-induced relaxation is mediated by nitric 
oxide and not some other agent is overwhelming.
1.2.5 Peroxynitrite
The reaction of nitric oxide with superoxide anion forms peroxynitrite (ONOO )
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NO + O2 ONOO
Peroxynitrite is stable (for weeks) in alkaline solutions but at physiological pH has a 
half-life of 1 -  2 s. It also has properties identical to hydroxyl radical (Beckman et f
ai,  1990). These authors proposed that the protonated form of peroxynitrite can 
decompose to form hydroxyl radical and nitrogen dioxide (NO2).
ONOO' + H^ ONOOH 
ONOOH OH* +N O 2
Decomposition of peroxynitrite, therefore, forms an alternative pathway to the 
Fenton or Haber-Weiss reaction (section 1.2.4) for formation of hydroxyl radical.
In addition, peroxynitrite is a powerful cytotoxic oxidant. It can cause oxidation and 
nitration of tyrosine residues in proteins (it is thought to inactivate Mn-based 
superoxide dismutase (SOD) in this manner; MacMillan-Crow et al., 1998) and 
alcohols in sugars. Moreover, it directly attacks sulfhydryl groups of molecules and 
proteins and initiates lipid peroxidation (see Marin & Rodriguez-Martinez, 1995;
Crow & Beckman, 1995).
Even under physiological conditions, peroxynitrite is stable enough to diffuse several 
cell diameters and cross lipid membranes to damage critical cellular machinery either 
directly or by decomposing to form hydroxyl radical. Clearly, this agent is highly
Page 25
Introduction Chapter 1
toxic but its activity can be controlled by impairing the ability of superoxide anion to 
react with nitric oxide.
In vivo, macrophages may utilise peroxynitrite, formed from co-released nitric oxide 
and superoxide, to attack invading organisms or other pathogens (Xia & Zweier, 
1997a). In addition, peroxynitrite is also a powerful vasorelaxant. Dowell et al. 
(1997; 1998) report that this is due to peroxynitrite reacting with an alcohol 
functional group or thiol to form novel relaxant species. The physiological relevance 
of this action, if any, remains to be resolved.
1.2.6 O ther reactions involving nitric oxide
Nitric oxide is itself a free radical and in addition to its reaction with superoxide to 
form peroxynitrite, it also reacts with other oxygen-derived species.
Nitric oxide can react with molecular oxygen to from nitrogen dioxide (NO2)
2N 0 + O2 2NO2
In the gas phase, this reaction occurs rapidly resulting in the characteristic brown 
fmnes of nitrogen dioxide. Indeed, one of the objections to nitric oxide accounting 
for the actions of EDRF was that it would be immediately converted to nitrogen 
dioxide. In the aqueous phase, however, this reaction is slow with a half-life of
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hours. The short physiological half-life of nitric oxide is not, therefore, likely to be 
due to destruction by molecular oxygen (Butler et al., 1995).
Nitric oxide can also react with ozone (O 3) leading to the production of activated 
(high energy state) nitrogen dioxide.
NO + O 3 -> N O 2 (excited) + O 2 
NO2 (excited) -> NO2 + light
This generation of light can be easily detected by chemiluminesence. Indeed, this 
reaction formed the basis by which the original experiments were conducted to 
identify endothelium-derived relaxing factor as nitric oxide in biological systems 
(Palmer et a l ,  1987; see section 1.1.3).
1.3 D E F E N C E S  A G A IN S T  R E A C T IV E  O X Y G E N  S P E C IE S
Agents which act to counteract the risks induced by reactive oxygen species are 
laiown generally as antioxidants. These can be defined as ‘any substance that, when 
present in low concentrations compared to those of an oxidizable substrate, 
significantly delays or inhibits oxidation of that substrate’ (Halliwell & Gutteridge,
1989). These include a diverse range of agents that work by quite varied chemical 
process, but essentially can be divided into two groups: first, those which prevent the 
generation of reactive species, such as inhibitors of enzymes that generate radicals or 
agents which tightly bind metals which could act as catalysts in the formation of
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reactive species. The second group act to scavenge the radicals once they are formed. 
These include specific enzymes such as superoxide dismutase which scavenges 
superoxide, and catalase and glutathione peroxidase both of which act to scavenge 
hydrogen peroxide. Removal of superoxide anion and hydrogen peroxide prevents 
the formation of hydroxyl radical.
1.3.1 Superoxide dismutase
The major endogenous antioxidant mechanism against superoxide anion is the 
enzyme superoxide dismutase (SOD). This enzyme catalyses the oxidation of one 
molecule of superoxide to form molecular oxygen, and reduction of another 
molecule of superoxide (with the additional involvement of hydrogen ions) to form 
hydrogen peroxide. The rate constant for the reaction is about 2 x 1 0 ^  M'* s'  ^ and is 
insensitive to pH over a wide range (Fridovich, 1983). It is also proposed that SOD 
has a cluster of positive charges surrounded by a broad distribution of negative 
charges elsewhere on the protein which attracts the negatively charged superoxide 
anion to its active site (Getzoff et al., 1983).
Three isoforms of SOD have been identified and located in mammalian organisms 
and each is encoded by a separate gene: intracellular Cu/Zn SOD (Heckl et a l,
1988); extracellular Cu/Zn SOD (Hjalmarsson et a l ,  1987); and Mn SOD located 
mainly in the mitochondria (Ho & Crapo, 1988). A fourth Fe-containing isoform is 
found only in bacteria. All isoforms of SOD catalyse the same reaction with 
comparable efficiency (Fridovich, 1989). For the mammalian types of SOD, the
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copper and manganese metals are the active sites of these enzymes. Both metals 
undergo redox cycling to catalyse the reaction described above, i.e.
SOD-Cu^VMn^* + O2 -» SOD-CuVMn^* + O2 
SOD-Cr/Mn^"^ + O2 + 2H* SOD-Cu^^/Mn^* +H2O2
Net: 2 O2 + 2H'‘ -> H2O2 + O2
Intracellular Cu/Zn SOD is found in, and synthesised by, virtually every cell type in 
the body. Each enzyme is composed of two identical subunits with an overall 
moleculai- weight of 32,000 dal tons. Each subunit contains one copper and one zinc 
molecule.
The extracellular Cu/Zn SOD enzyme is a tetrametric glycoprotein with a molecular 
weight of 135,000 daltons and is found in plasma, lymph and synovial fluid. This 
enzyme is secreted by only a few cell types, such as fibroblasts and glia cells, to 
diffuse around and reversibly bind to heparin on the surface of most tissue types and 
in the interstitial matrix (Marklund, 1990).
Both intracellular and extracellular isoforms of Cu/Zn SOD are inactivated by the 
copper chelator diethyldithiocarbamate. This irreversibly binds copper at the active 
site and removes the metal from the enzyme (Heikkila el aL, 1976; Cocco et al., 
1981; Kelner et al., 1989). The zinc appears to stabilise the enzyme.
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Mn SOD is a tetramer of molecular weight 88,000 daltons and is located strictly in 
the inner membrane of mitochondria. This enzyme acts to scavenge superoxide 
overflowing from the electron transport chain. In contrast to Cu/Zn SOD, Mn SOD is 
not inliibited by diethyldithiocarbamate but is destroyed by chloroform and ethanol 
(Halliwell & Gutteridge, 1989).
The importance of the antioxidant action of SOD to cells is clearly demonstrated in 
mutant organisms in which this enzyme is omitted. Such organisms are highly 
susceptible to damage by superoxide anion and this injury is prevented following the 
réintroduction of the SOD gene (Warner, 1994). Altered genetic expression of SOD 
is linked to two known diseases in humans. The first is familial amyotrophic lateral 
sclerosis (ALS) which is an age-dependent degenerative disorder of motor neurones 
in the cortex and spinal cord. This disorder is linked to mutated gene expression on 
chromosome 21. It results in SOD levels being less than 50 % of normal (Rosen et 
aL, 1993). The pathology associated with ALS may therefore be due to accumulation 
of superoxide anion in motor neurones. The second disorder is Down’s syndrome 
which is associated with 3 copies of chromosome 21 in cells. In contrast to ALS, this 
leads to a 50 % elevation in levels of Cu/Zn SOD (Garber et aL, 1979). With no 
similar concurrent increase in catalase activity, this could lead to overproduction of 
hydrogen peroxide (Warner, 1994). Indeed this condition, perhaps as an adaptive 
response, is associated with elevated levels of glutathione peroxidase. Cells from 
individuals with Down’s syndrome have increased lipid peroxidation, perhaps due to 
elevated hydrogen peroxide, which can lead to premature cell death especially in the 
brain (Ceballos et (%/.,1988).
Page 30
Introduction Chapter 1
Findings following the use of the use of, diethyldithiocarbamate, which inactivates 
both extracellular and intracellular isoforms of Cu/Zn SOD suggests that this enzyme 
exerts a vital role in protecting nitric oxide produced by the vascular endothelium 
(Omar et aL, 1991; Miigge et aL, 1991a; Abrahamsson et al., 1992; Mian & Martin, 
1995a) and nitrergic nerves (Martin et aL, 1994; Lilley & Gibson, 1995) from 
destruction by superoxide anion. Deficiency in Cu/Zn SOD activity thus provides a 
mechanism by which inactivation of nitric oxide by superoxide anion could occur. 
Indeed, decreased expression of Cu/Zn SOD mRNA has been correlated with 
impaired endothelium-dependent relaxation on diabetic rats (Kamata & Kobayashi,
1996).
Levels of Cu/Zn SOD associated with ALS and Down’s syndrome suggest that the 
expression of this enzyme is constitutive and directly related to copy number. 
However, cells and organisms, exposed to reactive oxygen species can display 
increased expression of either Cu/Zn SOD or Mn SOD. For example, exposure to 
elevated levels of superoxide induces greater expression of Mn SOD in neonatal rat 
lungs (Stevens & Autor, 1977). In addition, the superoxide-generator, paraquat, 
induces enhanced Cu/Zn SOD expression in leukocytes (Niwa et aL, 1990). The 
factors controlling expression of antioxidant enzymes are poorly understood but may 
be related to levels of cytokines such as interleukin- 1 and tumour necrosis factor 
(Fridovich, 1983; Warner, 1994).
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1.3.2 Catalase
Catalase is a tetrameric protein having a molecular weight of 60,000 daltons. Each
catalase-Fe^^ + H2O2 -> compound I
compound I + H2O2 —> catalase-Fe^^ + FI2O + O2
net: 2H2O2 —> 2H2O + O2
The exact structure of compound I is uncertain but it is perhaps a two electron 
oxidation product of catalase-Fe^^, i.e. catalase-Fe^^.
The endogenous enzyme catalase acts to remove hydrogen peroxide. This enzyme is 
present in all major organs of the body and is especially concentrated in liver and 
erythrocytes. It is largely located in peroxisomes (subcellular organisms bounded by 
a single membrane) which contain hydrogen peroxide-generating enzymes, such as 
glycollate oxidase.
protein subunits contains a haem (Fe^^-protoporphyrin) group at its active site and a Imolecule of NADH which stabilises the enzyme. It catalyses the reduction of 
hydrogen peroxide, via an intermediate compound (compound I), by converting it to 
water (H2O) and molecular oxygen at a rate constant of 2 x 10  ^ M'* s'* (see 
Fridovich, 1983; Halliwell & Gutteridge, 1989; Fridovich, 1989; Warner, 1994; Yu
era/., 1994)
■|
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Catalase can be inhibited by sodium azide or cyanide but a more specific inhibitor is 
aminotriazole (Mian & Martin, 1995b; Mian & Martin, 1997). This agent exerts its 
actions by binding to and irreversibly inhibiting compound I. Therefore, it will only 
inhibit catalase if hydrogen peroxide is available to allow generation of this 
intermediate.
As with SOD, catalase activity can be upregulated in cells exposed to reactive 
oxygen species. For example, it was reported that there was a 20-fold increase in 
catalase activity in Chinese hamster fibroblasts exposed to high concentrations of 
hydrogen peroxide (Spitz et aL, 1992).
1.3.3 G lutathione peroxidase
Glutathione peroxidase is an endogenous selenium-containing enzyme which offers 
an alternative pathway of hydrogen peroxide removal. It is a tetrameric protein with 
a molecular weight of about 76,000 daltons. It is fairly ubiquitous but found in high 
concentrations in heart, lung and brain. The enzyme catalyses the oxidation of the 
thiol, glutathione, at the expense of hydrogen peroxide at a rate constant of 5 x 10  ^
M‘* s''.
In its reduced state, glutathione (GSH), is a low molecular weight tripeptide 
(glutamic acid-cysteine-glycine). Glutathione peroxidase catalyses the oxidation of 
two molecules of GSH. This liberates two hydrogen ions from the -SH  groups of 
cysteine which then reduce hydrogen peroxide to water. In the process, the two GSH
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molecules join together by forming the disulphide bridge of oxidised glutathione 
(GSSG).
H2O2 + 2GSH GSSG + 2H2O
Most free glutathione in vivo is present in the reduced GSH form rather than oxidised 
GSSG. This is due to the presence of the enzyme glutathione reductase which 
catalyses the reduction of GSSG to GSH at the expense of NADPH. Glutathione 
reductase is a dimeric protein with each subunit containing a flavin adenine 
dinucleotide (FAD) at its active site. The NADPH reduces the FAD which then 
passes the electrons onto the disulphide bridge between the two cysteine residues in 
GSSG. This breaks the bridge, reforming the -SH groups and the reduced GSFL
GSSG + NADPH + H^ 2GSH + NADP^
Both catalase and glutathione peroxidase function to remove hydrogen peroxide. In 
addition to differences in their catalytic action, these two enzymes have different 
substrate affinities. Catalase has a high capacity for the reduction of hydrogen 
peroxide but a low affinity for its substrate. Whereas, glutathione peroxidase has a 
low capacity but a high affinity for hydrogen peroxide. It is thought, therefore, that 
low levels of hydrogen peroxide are removed preferentially by glutathione 
peroxidase while high levels are reduced by catalase (see Halliwell & Gutteridge, 
1989; Fridovich, 1989; Warner, 1994; Yu et aL, 1994; Marin & Rodriguez-Martinez, 
1995)
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1.3.4 Other antioxidants
In addition to the enzymes described above that deal with specific substrates, other 
antioxidants exist that are known to protect against reactive oxygen species.
In addition to its actions as a vitamin, ascorbate (vitamin C) is a powerful water 
soluble reducing agent. This provides ascorbate with the ability to neutralise many 
reactive species. For example, ascorbate is known to reduce superoxide anion and 
hydroxyl radical forming the semidehydroascorbate radical (oxidised ascorbate) in 
the process. Ascorbate may play an important physiological antioxidant role in the 
lens of the human eye where its levels are high and expression of SOD is low 
(Halliwell & Gutteridge, 1989).
Glutathione, in addition to its role as the substrate for the hydrogen peroxide- 
removing enzyme glutathione peroxidase (section 1.3.3), also directly scavenges 
hydroxyl radical itself. Furthermore, the end product of purine metabolism, uric acid, 
is also known to be a powerful scavenger of hydroxyl radical (Halliwell & 
Gutteridge, 1989). Vitamin E is also reported to have antioxidant actions. Indeed, 
vascular relaxations to ACh were impaired in Vitamin E deprived rats and normal 
relaxation was restored following vitamin E supplementation (Rubino & Burnstock, 
1994). Furthermore, the lipid soluble vitamins A and E are thought to play a vital 
role in preventing reactive oxygen species-induced lipid peroxidation and low 
density lipoprotein oxidation (Halliwell & Gutteridge, 1989).
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Interestingly, it has been hypothesised that basal release o f nitric oxide may act to 
scavenge superoxide anion thereby providing antioxidant protection to stimulated 
release of nitric oxide (Laight et aL, 1998). Any antioxidant actions of nitric oxide by 
this method would, however, produce the damaging species peroxynitrite.
1.4 REACTIVE OXYGEN SPECIES IN PATHOLOGY
1.4.1 Oxidant stress and impaired endothelium-dependent relaxation
The fragile equilibrium that exists between production of reactive oxygen species 
and endogenous antioxidant activity may be altered toward oxidative stress in 
pathology. Oxidant stress can be defined as ‘an imbalance between oxidants and 
antioxidants in favour of the oxidants, leading to damage’ (Sies, 1996). As 
determined by plasma markers of radical damage such as malondialedehyde, many 
diseases (see below) are associated with oxidant stress. It is likely that the enhanced 
generation of superoxide anion in these diseases will destroy greater amounts of 
nitric oxide. The attraction between these two radicals is enormous. Indeed, the rate 
constant for this reaction (6.9 x 10  ^ M”' s''; Huie & Padmaja, 1993) exceeds even 
that for the reaction of superoxide with its endogenous scavenger, superoxide 
dismutase (2 x 10  ^M"' s''; Fridovich, 1983).
It is not surprising therefore that enhanced destruction of endothelium-derived nitric 
oxide by superoxide anion forms a common defect in a number of conditions. 
Indeed, hypertension (Nakazono et al, 1991; Grunfeld et al, 1995; Bouloumie et al,
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1997), atherosclerosis (Sharma et al, 1992; Ohara et al, 1993), ischaemia- 
reperfiision injury (Downey, 1990), diabetes (Hattori et al, 1991; Kamata & 
Kobayashi, 1996) and heart failure (McMurray et al, 1990; Katz et al, 1993) are ail 
associated with increased free radical production and reduced nitric oxide-dependent 
relaxation. The source of the superoxide in each case may be different, endothelial 
and smooth muscle NADPH/NADH oxidase in angiotensin Il-induced hypertension 
(Rajagopalan et aL, 1996), endothelial xanthine/xanthine oxidase and neutrophil 
NADPH oxidase in ischaemia-reperfusion injury (Downey, 1990), advanced 
glycosylation productions in diabetes (Bucala et aL, 1991), and mitochondrial 
respiration and NADH oxidoreductase in heart failure (Mohazzab et aL, 1995).
1.4.2 Therapeutic intervention
As detailed in section 1.3.1, the integrity of endogenous Cu/Zn SOD is of vital 
importance in protecting endothelium-derived nitric oxide from destruction by 
superoxide anion. Endogenous levels of this enzyme may therefore be critical in the 
aetiology of vascular pathologies associated with oxidant stress. Consequently, stable 
elevation of the activity of SOD might form the basis of a rational strategy for 
therapeutic intervention in these cardiovascular pathologies. It is likely, however, 
that therapeutic treatment with Cu/Zn SOD itself will be of limited effectiveness. 
This is because SOD is not orally active, is rapidly cleared from the circulation and, 
in view of its large size, is unable to penetrate cell membranes to protect nitric oxide 
from an intracellular oxidant stress (Gardner et aL, 1996). Greater therapeutic
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potential may lie, however, with low molecular weight, membrane-permeant, 
compounds that exhibit SOD-like activity.
1.4.3 Membrane-permeant superoxide dismutase mimetics
A diverse range of membrane-permeant superoxide dismutase mimetics has been 
described. These include superoxide scavengers, nitroxide spin traps and metal-based 
compounds.
The superoxide anion scavenging agent tiron (4,5-dihydroxy-1,3-benzene-disulfonic 
acid; Ledenev et al, 1986) has been shown to inhibit superoxide-induced damage in 
neutrophils (Gyllenhammer, 1987) and lymphocytes (Devlin et aL, 1981). Tiron 
(TH2) is thought to scavenge superoxide by reducing it to hydrogen peroxide leaving 
the tiron radical (T») (Ledenev et aL, 1986).
TH2
Nitroxide spin traps are agents used in electron spin resonance (ESR) studies. They 
react with highly reactive radicals to produce another long-lived radical that can be 
detected by ESR. Nitroxides, such as PTIYO (4-phenyl-2,2,5,5-tetramethyl 
imidazolin-1 -yloxy-5-oxide) and tempo 1 (4-hydroxy 2,2,6,6 -tetramethylpiperidine-1 - 
oxyl), have been reported to have superoxide anion-scavenging ability in
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biochemical and cultured cell studies (Mitchell et al, 1990; Ewing & Janero, 1995). 
Nitroxides (RN-O; where R denotes the rest of the molecule) are thought to oxidise 
superoxide to molecular oxygen. The reduced nitroxide can then be reoxidised back 
to the parent nitroxide (Samuni, 1991).
RN-0  + O2 + —> RN-OH + O2
The metal “based agents CuDIPS (Cu [II]-[diisopropylsalicylate]2 ; Huber et al, 1987; 
Sorenson, 1995) and MnTMPyP (Mn [III] tetrakis [l-methyl-d-pyridyl] porphyrin; 
Faulkner et al, 1994; Gardner et al, 1996) as well as the simple metal salts of Cu 
and Mn (Fluber et al, 1987; Beyer & Fridovich, 1990) also possess SOD-like 
activity in biochemical and isolated cell studies. Their modes of action are thought to 
mimic the catalytic sites of Cu/Zn SOD and Mn SOD, respectively (see section 
1.3.1).
Before commencement of this study, none of the above putative SOD mimetics had 
been investigated for their potential ability to protect endothelium-derived nitric 
oxide from destruction by superoxide anion.
1.5 AIM
The aim of this study was to determine whether SOD mimetics were potentially 
useful in protecting vascular nitric oxide from destruction in conditions of oxidant 
stress.
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2.1 INTRODUCTION
Endothelium-derived nitric oxide is of vital importance in the regulation of vascular 
tone and blood pressure (see Moncada et al, 1991). Nitric oxide is destroyed, 
however, by the reduced species of molecular oxygen, superoxide anion (Gryglewski 
et al, 1986). In eukaryotic cells, three isoforms of superoxide dismutase (SOD) have 
evolved to cope with the stress induced by the oxygen-rich enviromnent: an 
intracellular Cu/Zn-containing form, an extracellular Cu/Zn-containiiig form, and a 
Mn-containing form found in the mitochondria, and all dismutate superoxide at 
equivalent rates (Fridovich, 1989). Endogenous levels of Cu/Zn SOD have been 
shown to be critically important in protecting nitric oxide from destruction by 
superoxide in a number of isolated blood vessels including the aorta of the rabbit 
(Miigge et al, 1991a) and rat (Mian & Martin, 1995a) and the bovine pulmonary 
(Cherry et al, 1990) and coronary arteries (Omar et al, 1991).
The loss of vasodilator function following the interaction of nitric oxide with 
superoxide has led to the suggestion that this process is involved in a number of 
cardiovascular pathologies. For example, hypertension (Nakazono et al, 1991; 
Grunfeld et al, 1995; Bouloumie et al, 1997), atherosclerosis (Sharma et al., 1992; 
Ohara et al, 1993), ischaemia-reperfusion injury (Downey, 1990), diabetes (Hattori 
et al, 1991; Kamata & Kobayashi, 1996) and heart failure (McMurray et al, 1990; 
Katz et al, 1993) are ail associated with increased free radical production and 
reduced nitric oxide-dependent relaxation. Endogenous levels of SOD may therefore
be of critical importance in the aetiology of vascular pathologies associated with
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oxidant stress. Stable elevation of the activity of SOD might, therefore, form the 
basis of a rational strategy for therapeutic intervention in these cardiovascular 
pathologies. Therapeutic treatment with Cu/Zn SOD itself, however, is of limited 
effectiveness. This is because SOD is not orally active, is rapidly cleared from the 
circulation and, in view of its large size, is unable to penetrate cell membranes to 
protect nitric oxide from an intracellular oxidant stress (Gardner et aL, 1996). Greater 
therapeutic potential may lie, however, with low molecular weight, membrane- 
permeant, compounds that exhibit SOD-like activity.
A diverse range of these compounds has been described but before the putative SOD 
mimetics can be assessed for their ability to protect endothelium-derived nitric oxide, 
conditions must be created where nitric oxide-dependent relaxation is impaired by 
oxidant stress. These models of oxidant stress should hopefully mimic the 
pathological process associated with vascular dysfunction. Oxidant stress can be 
defined as ‘an imbalance between oxidants and antioxidants in favour of the 
oxidants, leading to damage’ (Sies, 1996). In this particular study, the roles of the 
oxidant, superoxide anion, and the antioxidant, SOD, were the subject of 
investigation. There are two potential strategies, therefore, which can be adopted to 
develop oxidant stress: the first, to decrease the activity of the antioxidant enzyme 
SOD. This could be achieved by use of a copper chelator such as 
diethyldithiocarbamate (DETCA). DETCA irreversibly inactivates Cu/Zn SOD both 
in the intracellular and extracellular space by chelating the copper from the enzyme, 
but has no effect on Mn SOD (Heikkila et al., 1976; Cocco et al., 1981; Halliwell & 
Gutteridge, 1989). Inactivation of endogenous SOD leads to increased levels of
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superoxide in the vasculature, as determined by chemiluminesesce (Cherry et al., 
1990; Omar et al., 1991; Pagano et al., 1993). The second strategy is to elevate levels 
of superoxide anion by its exogenous generation. Many superoxide anion-generators 
are available but some of the better characterised include: the xanthine 
oxidase/hypoxanthine (XO/HX) system in which XO oxidises HX to form xanthine 
and superoxide anion and xanthine is then further oxidized by XO to produce uric 
acid and another superoxide anion (Halliwell & Gutteridge, 1989). Also available are 
LY 83583 and pyrogallol, both are quinones and can create oxidative stress by 
undergoing redox cycling, i.e. the quinone autoxidises to its semiquinone which then 
reacts reversibly with oxygen to form quinone and superoxide anion (Halliwell & 
Gutteridge, 1989). Together, these strategies can be employed in an attempt to 
recreate the pathological processes associated with impaired nitric oxide-dependent 
relaxation and oxidant stress.
This chapter is concerned, therefore, with characterisation of the effects of oxidant 
stress on the activity of basal and agonist-stimulated endothelium-derived nitric 
oxide in rabbit aorta. Once established, these models will serve as a basis with which 
to assay the efficacy of the putative SOD mimetics in protecting endothelium-derived 
nitric oxide in oxidant stress.
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2.2 METHODS
2.2.1 Preparation of Tissues
Male New Zealand White rabbits (2.5 - 3.5 kg) were killed with an injection of 
sodium pentobarbitone (200 mg kg ') into the marginal ear vein. The thoracic aorta 
was then carefully removed and immersed in Krebs bicarbonate buffer solution 
consisting of (mM): NaCl 118, KCl 4.8, CaCl] 2.5, MgSO^ 1.2, KH2PO4 1.2, 
NaHCO] 24, glucose 11, and pre-gassed with 95% O2 and 5% CO2. The aorta was 
then cleaned of fat and connective tissue and care was taken not to damage 
inadvertently the intimai surface of the aorta where the endothelium is located. Some 
tissues were used that day while others were stored in oxygenated ICrebs solution 
overnight at 4 °C for use the following day. The aorta was then cut into transverse 
rings (2.5 mm wide) using a razor blade slicing device. In some experiments, the 
endothelium was removed to abolish the influence of endothelium-derived nitric 
oxide. This was achieved by locating the aortic ring between two stainless steel 
hooks, with the base hook weighted with a 2 g weight, and gently rubbing the initial 
surface with a matchstick moistened with Krebs solution. Removal of the 
endothelium was deemed successful if, following development of phenylephrine- 
induced tone, no relaxation took place in response to the endothelium-dependent 
relaxant, acetylcholine (10 nM - 3 pM).
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2.2.2 Tension recording
The aortic rings were then mounted under 2 g resting tension on stainless steel hooks 
within 10 ml tissue baths containing Krebs solution gassed with 95% 0% and 5%
CO2. The Krebs solution was maintained at 37 °C by a water jacket heated by a 
thermostatically controlled pump (Techne water circulator model C-85D). Tension 
was recorded isometrically with Grass FT03C transducers and responses displayed 
and recorded on a MacLab (E Series, AD Instruments) or on a Grass polygraph 
model 7D. Tissues were allowed to equilibrate for 60 min before experiments were 
carried out, during which time the resting tension was re-adjusted to 2 g, as required. 1
2.2.3 Induction of tone
Following the 60 min equilibration period, aoitic rings were contracted with the 
stable a  1-adrenoceptor agonist, phenylephrine (PE). Once induction of submaximal 
(40 - 50% of maximal) PE (30 - 300 nM)-induced tone had stabilised, relaxant 
responses could be obtained. Relaxant responses are expressed as a percentage (%) 
relaxation of the PE-induced tone existing immediately prior to addition of the 
relaxant. A number of the experimental procedures employed affected the level of 
tone induced by PE. For example, endothelial removal or treatment with the inhibitor 
of nitric oxide synthase, N^-nitro-L-arginine methyl ester (L-NAME; Rees et ctL,
1990), both lead to an increase in sensitivity to PE due to the loss of the 
vasodepressor influence of basal nitric oxide. In order to take account for these 
changes in sensitivity, the concentration of PE employed in each individual
Page 44
Generation o f Oxidant Stress... Chapter 2
experiment was adjusted to ensure that the level of tone achieved was 40 - 50 % of 
the maximum observed on control, endothelium-containing rings. This procedure 
ensured that physiological antagonism, resulting from differences in levels of tone, 
did not contribute to the results obtained. Following completion of each 
concentration-response curve, the baths were repeatedly washed out and the tissues 
allowed to re-equilibrate for at least 30 min before further experimentation.
2.2.4 Assessment of basal activity of nitric oxide
Basal activity of nitric oxide was assessed indirectly by measuring the endothelium- 
dependent depression of PE-induced vasoconstriction on rabbit aortic rings. The 
rationale for these experiments is that basal nitric oxide produced by the endothelium 
results in a tonic vasodepressor effect opposing the actions of vasoconstrictor agents 
(Elglème et al., 1984; Martin et al., 1986a). Consequently, this endothelium- 
dependent depression of vasoconstriction would be expected to be blocked or 
enhanced by agents which block or enhance the activity of nitric oxide, respectively. 
Specifically, submaximal tone was generated using PE (0.1 pM) in endothelium- 
containing rings and basal nitric oxide activity was assessed by the augmentation of 
tone seen following addition of the inhibitor of nitric oxide synthase, L-NAME (100 
pM).
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2.2.5 Assessment of agonist-stimulated release of nitric oxide
Agonist-stimulated activity of endothelial-derived nitric oxide was determined by 
assessing acetylcholine (ACh)-induced relaxation. Specifically, cumulative 
concentration-response curves to ACh (10 nM - 3 pM; in increments of 0.5 log units) 
were constructed on endothelium-containing rings following induction of sub- 
maximal PE (30 -  300 nM)-induced tone.
2.2.6 Generation of oxidant stress by inhibition of endogenous Cu/Zn 
superoxide dismutase
In certain experiments the effects were examined of inactivation of the endogenous 
SOD on basal and agonist-induced activity of nitric oxide. There are two major 
forms of this enzyme, a Cu/Zn containing form which is located both extracellularly 
and intraceilularly and a Mn-containing form which mainly resides in the 
mitochondria (Fridovich, 1989). Cu/Zn SOD can be selectively inactivated by use of 
a copper chelator such as diethyldithiocarbamate (DETCA; Cocco et al., 1981; 
Halliwell & Gutteridge, 1989; Mian & Martin, 1995a). Since DETCA is a specific 
copper chelator it will have no effect on Mn SOD. DETCA (0.3 - 10 mM) was added 
to the Krebs solution bathing the aortic rings for a period of 60 min to allow time for 
this agent to permeate the tissue and penetrate cells.
Since DETCA inhibits Cu/Zn SOD irreversibly, there is no need for this agent to be 
present in the tissue bath once it has produced its effects. Consequently, following
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the 60 min incubation period, the tissues were extensively washed with fresh Kiebs 
solution to remove DETCA. This procedure ensured that in experiments in which 
exogenous Cu/Zn SOD was added in an attempt to reverse the actions of DETCA, 
there was no risk of this added enzyme being inactivated by DETCA.
Following the 60 min incubation period and washout of DETCA, the tissues were 
submaximally contracted with PE (0.1 pM). The effects of DETCA on basal activity 
of nitric oxide were assessed by measuring the augmentation of tone seen following 
addition of the inliibitor of nitric oxide synthase, L-NAME (100 pM).
The effects of DETCA on agonist-stimulated activity of nitric oxide were assessed 
by cumulative concentration-response curves to ACh (10 nM - 3 pM) constructed on 
endothelium-containing rings following induction of submaximal PE (30 -  300 nM)- 
induced tone.
2.2.7 Generation of oxidant stress by superoxide anion production
Tissues were exposed to tliree well characterised superoxide anion generating 
systems: xanthine oxidase (XO)/hypoxanthine (HX), LY 83583 and pyrogallol.
XO/HX is a commonly used enzymatic system (McCord & Fridovich, 1968; 
Halliwell & Gutteridge, 1989; Mian & Martin, 1995a) in which XO oxidises HX to 
form xanthine and superoxide anion. Xanthine is then further oxidized by XO to 
produce uric acid and another superoxide anion (Halliwell & Gutteridge, 1989). In
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.experiments involving XO/HX, XO was added either to precontracted tissues or to 
the tissues prior to contraction with PE and tone was then induced. In either case XO 
was in contact with the tissue for at least 20 min to allow time for this enzyme to 
permeate the interstitial space of the tissues before addition of its substrate, HX.
Both LY 83583 and pyrogallol are quinones and can generate superoxide anion by 
undergoing redox cycling (Halliwell & Gutteridge, 1989)
The effects of superoxide anion generation on basal nitric oxide activity were 
assessed differently to the protocols detailed in section 2.2.4. In these experiments, 
aortic rings were submaximally contracted with PE (0.1 pM) and when the 
contraction had stabilised the effects of applied XO (4.8 mu ml"')/HX (0.1 mM), LY 
83583 (0.3 pM) or pyrogallol (0.1 mM) were examined on tone. Since superoxide 
destroys nitric oxide and therefore its vasorelaxant activity, any augmentation of tone 
observed upon the addition of these agents gives an indirect measurement of the 
activity of basal nitric oxide.
The effects of superoxide anion generation on agonist-stimulated activity of nitric 
oxide were also assessed. Immediately after stabilisation of submaximal PE (30 - 300 
nM)-induced tone and following the addition of either XO (4.8 mu mP')/HX (0.1 
mM), LY 83583 (0.3 pM) or pyrogallol (0.1 mM), cumulative concentration- 
response curves to ACh (10 nM - 3 pM) were constructed and relaxation compared 
with that seen on control rings.
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2.2.8 Generation of oxidant stress by inactivation of endogenous Cu/Zn 
superoxide dismutase and superoxide anion production
In certain experiments we wished to examine the effects of superoxide anion 
generation in tissues in which endogenous Cu/Zn SOD was inhibited. Here Cu/Zn 
SOD was inactivated by treatment with a low concentration of DETCA (0.3 mM). 
This concentration produced only slight inhibition (<20 % inliibition of maximal 
relaxation, see Results section) of ACh-induced relaxation by itself.
Following induction of submaximal PE (30 - 300 nM)-induced tone in tissues 
pretreated with DETCA (0.3 mM, 60 min, washout), XO (4.8 mu m f')/HX (0.1 
mM), LY 83583 (0.3 pM) or pyrogallol (0.1 mM) were added. The augmentation of 
tone observed was used as an indirect measure of basal nitric oxide activity. 
Following addition of superoxide anion generators and immediately after 
stabilisation of tone, cumulative concentration-response curves to ACh (10 nM -  3 p 
M) were constructed and relaxation compared with that seen in control rings.
2.2.9 T reatm ent with exogenous superoxide dismutase
The effects of exogenously applied Cu/Zn SOD were assessed on basal and ACh- 
stimulated activity of nitric oxide. In these experiments, SOD (250 u m f')  was added 
to submaximally PE-contracted rings at least 20 min before the assessment of basal 
or ACh-stimulated activity of nitric oxide. Basal nitric oxide activity was assessed by 
the augmentation of tone observed following the addition of L-NAME (100 pM).
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Agonist-induced activity of nitric oxide was assessed by the construction of 
cumulative concentration-response curves to ACh (10 nM - 3 pM).
In some experiments, an examination was made of the ability of exogenously applied 
Cu/Zn SOD to reverse the inhibition of basal or ACh-stimulated activity o f nitric 
oxide induced by treatment with DETCA (3 mM, 60 min, washout) alone; with the 
superoxide anion generators XO (4.8 mu m f')/HX (0.1 mM), LY 83583 (0.3 pM) or 
pyrogallol (0.1 mM) alone; or with the superoxide generators in combination with 
treatment with DETCA (0.3 mM; 60 min; washout). In these experiments, SOD (250 
u m f')  was added to the tissue after incubation and washout of DETCA but 20 min 
before the addition of the superoxide generators. Basal nitric oxide activity was 
assessed by the augmentation of tone seen following addition of superoxide anion 
generators. ACh-induced activity of nitric oxide was assessed by construction of 
cumulative concentration-response curves to ACh (10 nM - 3 pM).
All experiments involving DETCA, XO/HX, LY 83583 or pyrogallol were 
conducted in the presence of catalase (1000 u ml"'), given as a pretreatment to 
prevent accumulation of hydrogen peroxide.
2.2.10 Drugs and solvents
Acetylcholine chloride (ACh), catalase (bovine liver), diethyldithiocarbamate 
(DETCA), N'^-nitro-L-arginine methyl ester (L-NAME), phenylephrine 
hydrochloride (PE), hypoxanthine (HX), superoxide dismutase (SOD, Cu/Zn-
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containing enzyme from bovine erythrocytes) and xanthine oxidase (XO, buttermilk) 
were obtained from Sigma (Poole, UK). 6-anilino-5,8-quinolinedione (LY 83583) 
was obtained from Calbiochem (Nottingham, U.K.). Pyrogallol was obtained from 
BDH Ltd. (Poole, U.K.).
All drugs were dissolved in normal saline (0.9 %), except for hypoxanthine (50 mM 
stock) and LY 83583 (20 mM stock) which were dissolved in 0.1% sodium 
hydroxide and ethanol, respectively. Control experiments demonstrated that the 
solvents, sodium hydroxide and ethanol, did not account for the effects observed 
with hypoxanthine and LY 83583, respectively. All dilutions were made in saline 
(0.9 %). Concentrations of drugs are expressed as the final molar concentration in the 
tissue bath.
2.2.11 Statistical analysis of data
Results are expressed as the mean ± s.e. mean of n separate experiments. Statistical 
comparisons were made by one-way analysis of variance followed by the Bonferroni 
post-test. A value of P<0.05 was considered significant. Concentration-response 
curve fitting and statistical analyses were performed using a computer-based 
programme (Graph Pad, Prism).
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2.3 RESULTS
2.3.1 Basal activity of nitric oxide in the rabbit aorta
Basal release of nitric oxide in rabbit aortic rings can be assessed indirectly by 
measuring the endothelium-dependent depression of phenyleplirine (PE)-induced 
tone (Martin et al., 1986a). This is clearly observed in Figure 2.1 where endothelium- 
denuded rings are considerably more sensitive to PE than endothelium-containing 
rings. Consequently, addition of PE (0.1 pM) generated 2.02 ± 0.23 g of tension (n = 
30) on endothelium-containing rings but induced substantially greater levels of tone 
on denuded rings: 3.54 ± 0.15 g; n = 29 (Figure 2.3). Furthermore, treatment of 
submaximally contracted aortic rings with the inhibitor of nitric oxide synthase, N*^ - 
nitro-L-arginine methyl ester (L-NAME; 100 pM) significantly enhanced tone in 
endothelium-containing but not endothelium-denuded rings (Figure 2.2 and 2.3).
2.3.2 Effect of diethyldithiocarbam ate and superoxide dismutase on basal 
activity of nitric oxide
Treatment for 60 min (followed by washout) with diethyldithiocarbamate (DETCA; 
0.3, 1 and 3 mM) to inhibit endogenous Cu/Zn superoxide dismutase (SOD) did not 
affect the enhancement of tone induced by treatment with L-NAME (100 pM) on PE 
(0.1 pM)-contracted endothelium-containing aortic rings (Figure 2.4).
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FIGURE 2.1 Concentration-response curves showing the contractile effect of 
phenylephrine (PE) on endothelium-containing (□ ) and endothelium-denuded (A) 
rings of rabbit aorta. Each point is the mean ± s.e. mean of 29-30 observations. 
*P<0.05, **P<0.01 and **=^P<0.001 indicate significant difference from the level of 
tone induced by PE in endothelium-containing rings.
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FIGURE 2.2 Individual experimental traces showing the ability of the inhibitor of 
nitric oxide synthase, N^-nitro-L-arginine methyl ester (L-NAME; 100 pM), to 
enhance phenylephrine (PE)-induced tone on an endothelium-containing ring of 
rabbit aorta (a) but not an endothelium-denuded ring (b). Drug concentrations are 
expressed in log molar units.
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FIGURE 2.3 The inhibitor of nitric oxide synthase, N^-nitro-L-arginine methyl ester 
(L-N; 100 pM), enhanced phenylephrine (PE; 0.1 pM)-induced tone on endothelimn- 
intact (open columns) but not endothelium-denuded (filled columns) rings of rabbit 
aorta. Data are expressed as mean ± s.e. mean of 28 observations. ***P<0.001 
indicates a significant difference from PE-induced tone in endothelium-intact rings.
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FIGURE 2.4 The change in phenylephrine (0.1 pM)-induced tone (A tension) 
resulting from addition of N^-nitro-L-arginine methyl ester (100 pM) to 
endothelium-intact rings of rabbit aorta was unaffected by treatment with 
diethyldithiocarbamate at 0.3, 1 and 3 niM (60 min; washout; filled columns). 
Experiments were conducted in the presence of catalase (1000 u m f') to prevent 
accumulation of hydrogen peroxide. Data are expressed as mean ± s.e. mean 8-12 
observations.
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FIGURE 2.5 (a) Pretreatment for 20 min with exogenously applied superoxide 
dismutase (SOD; 250 u mf^) did not change the ability of N'^-nitro-L-arginine 
methyl ester (L-N; 100 pM) to enhance phenylephrine (PE; 0.1 pM)-induced tone (A 
tension) in endothelium-intact rings of rabbit aorta, (b) The relaxation induced by 
treatment with SOD in PE-contracted endothelium containing (+EC) rings was 
unaffected by treatment with L-N or endothelial removal (-EC). Data are expressed 
as mean ± s.e. mean 8 observations.
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These findings suggest that basal action of nitric oxide was not impaired by treatment 
with DETCA.
Pretreatment for 20 min with exogenously applied SOD (250 u m f *) did not affect 
the L-NAME-induced enhancement of tone (Figure 2.5a). The addition of SOD (250 
u m f’) to submaximally PE-contracted aortic rings resulted in a small relaxation (less 
than 10 %; Figure 2.5b). This relaxation was unaffected by treatment with L-NAME 
(100 pM) or by endothelial removal, however, there was a tendency for the SOD- 
induced relaxation to be reduced in both conditions. These findings suggests that in 
rabbit aorta, SOD-induced relaxation does not involve nitric oxide.
2.3.3 Effects of superoxide anion generation by xanthine oxidase/hypoxanthine
on basai activity of nitric oxide
Following submaximal PE-induced tone, addition of xanthine oxidase (XO; 4.8 mu 
mf*) resulted in a substantial, but transient, relaxation of tone in endothelium- 
containing aortic rings (Figure 2.6). This fall in tone was reduced in tissues treated 
with L-NAME (100 pM) and absent following endothelial removal. Furthermore, 
this relaxation was present only upon the first addition of the enzyme to the tissue. 
This relaxation is known to be due to contamination of XO with a trace amount of 
trypsin, which itself produces endothelium-dependent relaxation (Thomas & 
Ram well, 1987).
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FIGURE 2.6 Individual experimental traces showing that a transient relaxation was 
seen following addition of xanthine oxidase (4.8 mu m f')  to PE-contracted 
endothelium-containing rings of rabbit aorta. Subsequent addition of hypoxanthine 
(0.1 mM) led to transient enhancement of a phenylephrine (PE)-induced tone. The 
transient relaxation to XO and the enhancement of tone by HX were inliibited by 
treatment for 20 min with N^-nitro-L-arginine methyl ester (L-NAME, 100 pM) (b) 
or by endothelial removal (d). Treatment with SOD (250 u ml"*) for 20 min had no 
effect on the transient relaxation to XO but abolished the enhancement of tone to HX 
(c). All experiments were conducted in the presence of catalase (CAT; 1000 u ml" )^ 
to prevent accumulation of hydrogen peroxide. Drug concentrations are expressed in 
log molar units.
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Addition of hypoxanthine (HX; 0.1 mM) to precontracted endothelium-containing 
aortic rings already treated with XO (4.8 mu ml"^) resulted in a transient 
enhancement of tone (Figures 2.6). This enhancement was reduced in tissues treated 
for 20 min with L-NAME (100 pM) and absent in tissues treated with SOD (250 u 
ml'^) or following endothelial removal. The enliancement of tone was, therefore, 
likely to be due to destruction of basal nitric oxide by superoxide anion.
2.3.4 Effects of the combination of diethyldithiocarbamate and snperoxide 
anion generation on basal activity of nitric oxide
Treatment with DETCA did not impair the enhancement of PE contraction induced 
by L-NAME (100 pM; see section 2.3.2 and Figure 2.4). This suggests that 
inactivation of endogenous Cu/Zn SOD did not lead to destruction of basal nitric 
oxide activity in rings of rabbit aorta. From the results of section 2.3.3 it would 
appear, however, that superoxide anion generation leads to inactivation of basal nitric 
oxide activity. If endogenous Cu/Zn SOD is important in protecting basal nitric oxide 
activity then its inactivation by DETCA would be expected to potentiate the 
inliibitory effects of the superoxide generating systems. Consequently, this 
possibility was investigated by examining the actions of the superoxide anion 
generators XO/HX, LY 83583 and pyrogallol on PE-induced tone in aortic rings 
previously treated with DETCA.
Following treatment of rabbit aortic rings with DETCA (0.3 mM; 60 min; washout) 
and XO (4.8 mu mb'), the enhancement of PE (0.1 pM)-induced tone seen upon
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addition of HX (0.1 mM) was greatly augmented (Figure 2.7). Treatment with SOD 
(250 u mb') for 20 min abolished the enhancement of PE-induced tone seen with 
XO/HX in control tissues and tissues treated with DETCA. Treatment with LY 
83583 (0.3 pM) or pyrogallol (0.1 mM) also led to enhancement of PE (0.1 pM)- 
induced tone on endothelium-containing rings of rabbit aorta (Figure 2.8). As with 
XO/HX, the enliancement of tone induced by LY 83583 or pyrogallol was 
augmented in tissues treated with DETCA (0.3 mM; 60 min; washout). The 
enhancement of tone induced by these agents in control tissues and in tissues treated 
with DETCA was abolished following pretreatment with SOD (250 u mb^).
These results suggest that basal nitric oxide is inactivated by superoxide and that 
endogenous Cu/Zn SOD plays a role in protecting it.
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FIGURE 2.7 The enhancement of phenylephrine (0.1 pM)-induced tone (A tension) 
seen following treatment with xanthine oxidase (X; 4.8 mu ml’Vhypoxanthine (H; 
0.1 mM) was greater in tissues treated with diethyldithiocarbamate (D; 0.3 mM; 60 
min; washout) than in control tissues. Pretreatment for 20 min with superoxide 
dismutase (S, 250 u ml"') abolishes the enhancement of tone seen upon addition of 
xanthine oxidase/ hypoxanthine to control tissues and tissues treated with DETCA. 
Experiments were conducted in the presence of catalase (1000 u ml"') to prevent 
accumulation of hydrogen peroxide. Data are expressed as mean ± s.e. mean of 8 
observations. ***P<0.001 indicates significant differences from the change in tone 
induced by xanthine oxidase/ hypoxanthine alone. ###P<0.001 indicates a significant 
blockade by superoxide dismutase.
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FIGURE 2.8 The enhancement of phenylephi'ine (0.1 pM)-induced tone (A tension) 
seen following treatment with LY 83583 (LY; 0.3 pM; a) or pyrogallol (PY; 0.1 
mM; b) was greater in tissues treated with diethyldithiocarbamate (D; 0.3 mM; 60 
min; washout) than in control tissues. Pretreatment for 20 min with superoxide 
dismutase (S, 250 u ml"') abolishes the enliancement of tone seen upon addition of 
LY 83583 or pyrogallol to control tissues and tissues treated with DETCA. 
Experiments were conducted in the presence of catalase (1000 u ml"') to prevent 
accumulation of hydrogen peroxide. Data are expressed as mean ± s.e. mean of 6-8 
observations. *P<0.05 and ***P<0.001 indicate significant differences from the 
change in tone induced by treatment with LY 83583 or pyrogallol alone. #P<0.05 
and ###P<0.001 indicate a significant blockade by superoxide dismutase.
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2.3.5 Agonist-induced activity of nitric oxide in rabbit aorta
Submaximal tone (40 - 50 % of maximum; 2.5 - 3.0 g tension) was induced by PE 
(30 - 300 nM) in endothelium-containing rings of rabbit aorta. When this tone had 
stabilised, acetylcholine (ACh; 10 nM - 3 pM) was added, and produced powerful 
concentration-dependent relaxations (Figures 2.9a and 2.10): the maximum 
relaxation was 96.2 ± 2.1 %; n = 10. Following a 20 min treatment with the inhibitor 
of nitric oxide synthase, L-NAME (100 pM), the ability of ACh to induced 
relaxation was powerfully impaired, and after endothelial removal it was abolished 
(Figures 2.9 and 2.10).
These results show that in conditions where nitric oxide synthase activity is removed, 
the ability of ACh to induce relaxation is almost abolished.
2.3.6 Effects of diethyldithiocarbamate and superoxide dismutase on 
acetylcholine-induced activity of nitric oxide
The ability of ACh to induce relaxation was investigated in endothelium-containing 
aortic rings in which Cu/Zn SOD was inactivated following treatment with DETCA. 
Treatment with DETCA for 60 min at 0.3, 3 and 10 mM (followed by washout) 
resulted in a concentration-dependent impairment of the ability of ACh (10 nM - 3 p 
M) to induce relaxation (Figure 2.11). The blockade induced by treatment with a 
submaximal concentration of DETCA (3 mM) was sustained over time as determined 
by a subsequent concentration response curve obtained 60 min later (Figure 2.11).
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FIGURE 2.9 Individual experimental traces showing concentration-dependent 
relaxation to acetylcholine (ACh) on phenylephrine (PE)-contracted endothelium- 
containing rings of rabbit aorta (a) and the inhibition of this relaxation by treatment 
with the inhibitor of nitric oxide synthase, N'^-nitro-L-arginine methyl ester (L- 
NAME; 100 pM; b) or endothelial removal (c). Drug concentrations are expressed in 
log molar units.
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FIGURE 2.10 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ ) on phenylephrine-contracted endothelium-containing rings of rabbit aorta. 
Treatment with the inliibitor of nitric oxide synthase, N^-nitro-L-arginine methyl 
ester (100 pM; A), powerfully impaired the relaxation while endothelial removal (T) 
abolished it. Each point is the mean ± s.e. mean of 10-18 observations. ***P<0.001 
indicates a significant difference from the relaxation induced by the maximal 
concentration of ACh in untreated rings.
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In an attempt to replenish lost stores of endogenous Cu/Zn SOD, exogenously 
applied SOD was given as a 20 min treatment to tissues already exposed to a 
submaximal concentration of DETCA (3 niM; 60 min; washout). Exogenous SOD 
(250 or 750 u m f ‘) did not restore ACh-induced relaxation to any degree (Figure 
2.12). Consequently, since exogenously applied SOD cannot penetrate cells, these 
findings suggest that treatment with DETCA results in destruction of nitric oxide 
mainly in the intracellular space. Control experiments showed that exogenously 
applied SOD (250 u ml"') did not affect ACh-induced relaxation in untreated 
endothelium-containing rings (Figure 2.13).
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FIGURE 2.11 Concentration-response curves showing relaxation to acetylcholine 
(ACh, O) on phenylephrine-contracted endothelium-containing rings of rabbit aorta. 
Inhibition of endogenous Cu/Zn superoxide dismutase with diethyldithiocarbamate 
(60 min, wash) at 0.3 niM (A ), 3 mM (V ) and 10 mM (#) blocked ACh-induced 
relaxation in a concentration-dependent manner. The blockade induced by 3 mM 
diethyldithiocarbamate was sustained as was seen from a subsequent concentration- 
response curve obtained 60 min later (V).Experiments were conducted in the 
presence of catalase (1000 u mf*) to prevent accumulation of hydrogen peroxide. 
Each point is the mean ± s.e. mean of 5-10 observations. *P<0.05 and ***P<0.001 
indicate a significant difference from the relaxation induced by the maximal 
concentration of ACh in untreated rings.
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FIGURE 2.12 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ ) on phenylephrine-contracted endothelium-containing rings of rabbit aoita 
and the blockade of this relaxation following treatment with diethyldithiocarbamate 
(3mM; 60 min; washout; O). Treatment with exogenously applied superoxide 
dismutase for 20 min at 250 (A) or 750 u ml"' (▼) did not restore impaired ACh- 
induced relaxation. Experiments were conducted in the presence of catalase (1000 u 
ml"') to prevent accumulation of hydrogen peroxide. Each point is the mean ± s.e. 
mean of 6-13 observations. ***P<0.001 indicates a significant difference from the 
relaxation induced by the maximal concentration of ACh in untreated rings.
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FIGURE 2.13 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ ) on phenylephrine-contracted endothelium-containing rings of rabbit aorta. 
Treatment with exogenously applied superoxide dismutase (250 u ml"'; A) had no 
effect on relaxation. Each point is the mean ± s.e. mean of 8 observations.
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2.3.7 Effects of superoxide anion generation on acetylcholine-induced activity 
of nitric oxide
Following induction of submaximal PE (30 - 300 nM)-induced tone, the addition of 
the superoxide anion generating systems, xanthine oxidase (XO; 4.8 mu ml" 
')/hypoxanthine (HX; 0.1 mM) and LY 83583 (0.3 pM), resulted in substantial 
impairment of the ability of ACh (10 nM - 3 pM) to induced relaxation (Figures 2.14 
and 2.15, and 2.16a, respectively). It was important to establish if the blockade 
induced by XO/HX and LY 83583 was due to superoxide anion-mediated destruction 
of nitric oxide. To test this the tissues were pretreated with exogenous SOD (250 u 
ml"') for 20 min before addition of XO/HX or LY 83583. Treatment with SOD 
offered complete protection against the blockade induced by both superoxide 
generators (Figures 2.14 and 2.15, and 2.16a, respectively). Pyrogallol, another 
superoxide anion generator, did not impair ACh-induced relaxation to any degree 
when tested at the concentration of 0.1 mM (Figure 2.16b). Perhaps this 
concentration of pyrogallol generated insufficient superoxide to impair ACh-induced 
relaxation. Concentrations of pyrogallol of 0.3 mM or greater, however, caused such 
powerful falls in tone that relaxation to ACh could not be examined.
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FIGURE 2.14 Sequential experimental traces from a single phenylephrine (PE)- 
contracted endothelium-containing ring of rabbit aorta showing that control (a) 
concentration-dependent relaxations to acetylcholine (ACh) were impaired by 
treatment with xanthine oxidase (XO; 4.8 mu ml"' )/hypoxanthine (HX; 0.1 mM) (h). 
Treatment with superoxide dismutase (SOD; 250 u ml"') prevented this inhibition (c). 
Experiments were conducted in the presence of catalase (CAT; 1000 u ml"') to 
prevent accumulation of hydrogen peroxide. Drug concentrations are expressed in 
log molar units.
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FIGURE 2.15 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ ) on phenylephrine-contracted endothelium-containing rings of rabbit aorta, 
and the ability of the superoxide anion generating system, xanthine oxidase (4.8 mu 
mf')/hypoxanthine (0.1 mM) (A), to inhibit this relaxation. This inhibition was 
prevented by pretreatment for 20 min with exogenously applied superoxide 
dismutase (250 u m f \  ▼). Experiments were conducted in the presence of catalase 
(1000 u mb') to prevent accumulation of hydrogen peroxide. Each point is the mean 
± s.e. mean of 6 observations. =^ '"T<0.01 indicates a significant difference from the 
relaxation induced by the maximal concentration of ACh in untreated rings.
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FIGURE 2,16 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ ) on phenylephrine-contracted endothelium-containing rings of rabbit aorta 
and (a) the ability of LY 83583 (0.3 pM; A) to block this relaxation. Prevention of 
this blockade by pretreatment with superoxide dismutase (250 u m f'; V) is also 
shown. Treatment with pyrogallol (0.1 mM; A) did not affect ACh-induced 
relaxation (b). Experiments were conducted in the presence of catalase (1000 u mf*) 
to prevent accumulation of hydrogen peroxide. Each point is the mean ± s.e. mean of 
6-12 observations. '*'**P<0.001 indicates a significant difference from the relaxation 
induced by the maximal concentration of ACh in untreated rings.
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2.3.8 Effects of the combination of diethyldithiocarbamate and superoxide 
anion generation on acetylcholine-induced activity of nitric oxide
If endogenous Cu/Zn SOD is important in protecting nitric oxide against destruction 
by superoxide anion then its inactivation by DETCA would be expected to potentiate 
the inliibitory effects of the superoxide generating systems. This possibility was 
investigated.
The ability of XO (4.8 mu ml'^yHX (0.1 mM) or LY 83583 (0.3 pM) to impair ACh- 
induced relaxation was powerfully potentiated in tissues that were pretreated with a 
concentration of DETCA (0.3 mM; 60 min; washout) which itself caused little 
impairment of relaxation (Figures 2.17 and 2.18a, respectively). The enhanced 
blockade induced following the combined treatment of DETCA with XO/HX or LY 
83583 was abolished following treatment for 20 min with exogenous SOD (250 u ml" 
)^ (Figures 2.17 and 2.18a, respectively). Although pyrogallol (0.1 mM) had no effect 
by itself, it produced powerful blockade of ACh-induced relaxation in tissues 
pretreated with DETCA (0.3 mM; Figure 2.18b). This enhanced blockade was also 
completely prevented by pretreatment with exogenous SOD (250 u ml"'; Figure 
2.18b).
These findings suggest that endogenous Cu/Zn SOD plays a vital role in protecting 
nitric oxide from destruction by superoxide anion following its release by ACh.
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FIGURE 2.17 Concentration-response curves showing relaxation to acetylcholine 
(ACh, O) on phenylephrine-contracted endothelium-containing rings of rabbit aorta, 
and the ability of xanthine oxidase (XO; 4.8 mu ml"*)/hypoxanthine (HX; 0.1 mM) 
(A), to block this relaxation. Following treatment with diethyldithiocarbamate (0.3 
mM; 60 min; washout; T) ACh-induced relaxation was partially inliibited and 
subsequent treatment with XO/HX now produced profound blockade (O). This 
enhanced blockade was prevented by pretreatment for 20 min with exogenously 
applied superoxide dismutase (250 u ml'*; ■). Experiments were conducted in the 
presence of catalase (1000 u ml'*) to prevent accumulation of hydrogen peroxide. 
Each point is the mean ± s.e. mean of 5-10 observations. **P<0.01 and *=(=*P<0.001 
indicate a significant difference from the relaxation induced by the maximal 
concentration of ACh in untreated rings.
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FIGURE 2.18 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ ) on phenylephrine-contracted endothelium-containing rings of rabbit aorta, 
and the ability of (a ) LY 83583 (0.3 pM; A) and inability of (b ) pyrogallol (0.1 mM; 
A) to block this relaxation. Following treatment with diethyldithiocarbamate (0.3 
mM; T ) ACh-induced relaxation was partially inhibited and subsequent treatment 
with LY 83583 or pyrogallol (O ; a and b, respectively) now produced profound 
blockade. This enhanced blockade was prevented by pretreatment with exogenously 
applied superoxide dismutase (250 u ml'* ; ■). Experiments were conducted in the 
presence of catalase (1000 u ml'*) to prevent accumulation of hydrogen peroxide. 
Each point is the mean ± s.e. mean of 6-14 observations. *P<0.05, **P<0.01 and 
***P<0.001 indicates a significant difference from the relaxation induced by the 
maximal concentration of ACh in untreated rings.
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2.4 DISCUSSION
Acetylcholine (ACh) is a potent vasodilator in vivo but does not always produce 
relaxation in isolated blood vessel preparations. Furchgott & Zawadzki (1980) 
reconciled this anomaly by their discovery that endothelial cells play an obligatory 
role in the relaxation to ACh. The simple explanation was that the previously ignored 
layer of endothelial cells was almost always inadvertently rubbed off during isolation 
of blood vessel preparations. Since then the importance of the endothelium and 
release of the ‘endothelium-derived relaxing factor’ (EDRF) has revolutionised our 
understanding of how vascular tone is regulated locally. Some seven years later, 
Palmer et al. (1987) demonstrated that the lipophilic free radical gas, nitric oxide, 
accounts for the biological actions of EDRF.
The discovery that superoxide anion causes a reduction of the vasodilator effects of 
endothelium-derived nitric oxide in cascade bioassay systems, while superoxide 
dismutase (SOD) enhances it, has stimulated interest in the interaction between 
superoxide anion and nitric oxide and the potential protective role of SOD 
(Gryglewski et al., 1986; Rubanyi & Vanhoutte, 1986b). Three isoforms of SOD are 
present in eukaryotic cells: an intracellular Cu/Zn-containing form, an extracellular 
Cu/Zn-containing form, and a Mn-containing form found in the mitochondria (see 
Fridovich, 1989). Endogenous levels of Cu/Zn SOD have been shown to be critically 
important in protecting nitric oxide from destruction by superoxide in a number of 
isolated blood vessels (Cherry et al, 1990; Mügge et al, 1991a; Omar et al, 1991; 
Mian & Martin, 1995a). An enhanced superoxide-mediated destruction of nitric
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oxide is thought to underlie the vascular pathology associated with many 
cardiovascular diseases (see Marin & Rodriguez-Martlnez, 1997).
The aim of this section of the study was to develop models of oxidant stress in f
isolated rabbit aorta in which nitric oxide is destroyed by superoxide anion. It was 7
hoped that these might provide an insight into the loss of nitric oxide associated with 
cardiovascular pathology. Essentially two strategies were employed to create oxidant 
stress: 1) inactivation of endogenous Cu/Zn SOD; and 2) generation of superoxide 
anion.
2.4.1 Basal release of endothelium-derived nitric oxide relaxes rabbit aortic
rings
Basal (non-stimulated) production of nitric oxide exerts a tonic vasodilator influence 
in precontracted endothelium-containing aortic rings (Eglème et al., 1984; Martin et 
al., 1986a). This influence can be assessed indirectly when considering that the 
endothelium-dependent depression of vasoconstriction would be expected to be 
blocked or enhanced by agents which block or enhance the activity of nitric oxide, 
respectively. This vasodepressor influence of nitric oxide can be removed by 
endothelial denudation or the use of pharmacological inhibitors such N^-nitro-L- 
arginine methyl ester (L-NAME; Rees et al., 1990). The influence of basal nitric 
oxide was observed in this study where a set concentration of PE (0.1 pM) was 
shown to generate almost double the tension in endothelium-denuded compared with 
endothelium-containing rings. Also, L-NAME (100 pM) induced a rise of tone in
■fc
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precontracted endothelium-containing but not endothelium-denuded rings of aorta. 
This rise in tone almost doubled the tension in aortic rings. Both of these procedur es 
uncover the extent of the vasodepressor influence of basal nitric oxide. The influence 
of basal nitric oxide, however, is reportedly greater in rat aorta than in rabbit (Martin 
et al., 1986a); where endothelium-denuded rings are 4- to 6- fold more sensitive to 
PE at the EC30 level. Although, not as substantial as in rat, this study confirmed that 
rabbit aorta does exhibit a measurable basal nitric oxide activity.
Having characterised basal nitric oxide activity in rabbit aortic rings, the effects of 
exogenous application of Cu/Zn SOD, inhibition of endogenous Cu/Zn SOD and 
superoxide anion generation were then investigated.
2.4,2 Exogenous application of superoxide dismutase has no effect on basal 
nitric oxide activity
SOD scavenges superoxide anion by converting it to hydrogen peroxide (Halliwell & 
Gutteridge, 1989), and it is well established that exogenous SOD potentiates the 
activity of nitric oxide in cascade bioassay systems (Gryglewski et a i, 1986; 
Rubanyi & Vanhoutte, 1986b).
Exogenously applied SOD (250 u ml'*) produced a small relaxation of PE (30 -  300 
nM)-induced tone in endothelium-containing aortic rings. There was a tendency for 
this relaxation to be reduced by treatment with L-NAME (100 pM) or endothelial 
removal but this remained statistically insignificant. This SOD-induced relaxation
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was, therefore, independent of the endothelium and nitric oxide. In contrast to its 
action in rabbit aorta, exogenously applied SOD (at the same concentration; 250 u 
mb') results in substantial relaxation (approximately 70 %) of precontracted rings of 
rat aorta (Ohlstein & Nichols, 1989; Mian and Martin, 1995a and see Chapter 5). 
This relaxation is likely to be due to removal of superoxide generated in the tissue or 
oxygenated Krebs solution, which was destroying basally produced nitric oxide. The 
different effects of exogenous SOD in these two animal preparations is likely to be 
due to the greater basal production of superoxide (and therefore depression of 
vasoconstriction) in rat with respect to rabbit.
Exogenous application of SOD had no effect on the L-NAME (100 pM)-induced 
enliancement of tone in rabbit aortic rings and, by inference, no effect on basal 
activity of nitric oxide. This provides independent confirmation that background 
levels of superoxide anion must be too low to inactivate nitric oxide, otherwise, 
addition of SOD would have been expected to potentiate the effects of nitric oxide, 
leading to greater L-NAME-induced enhancement of tone.
2.4.3 Diethyldithiocarbamate has no effect on basal nitric oxide activity
One strategy employed to create oxidant stress was to inactivate the endogenous 
scavenger of superoxide, SOD. This was achieved by use of diethyldithiocai'bamate 
(DETCA). This compound irreversibly inactivates Cu/Zn SOD, but not Mn SOD, 
both in the intracellular and extracellular space by chelating the copper from the 
enzyme (Heilddla et a l, 1976; Cocco et a l, 1981; Halliwell & Gutteridge, 1989).
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Inactivation of endogenous SOD leads to increased levels of superoxide in the 
vasculature as determined by chemiluminesesce (Cherry et ah, 1990; Omar et al., 
1991; Pagano et al., 1993).
A 60 min treatment with DETCA (0.3 - 3 mM; washout) had no effect on the L- 
NAME (100 pM)“induced enhancement of tone. This suggests that basal nitric oxide 
activity remained intact when endogenous Cu/Zn SOD was inactivated. This finding 
suggests that either endogenous Cu/Zn SOD provides no protection to basal nitric 
oxide or the background levels of superoxide anion must be too low to inactivate 
nitric oxide. An alternative explanation, however, is that basally released 
endothelium-derived relaxing faetor (EDRF) may not be nitric oxide per se but a 
different, superoxide anion-resistant, compound. The later possibility was 
investigated directly by assessing whether basal nitric oxide activity was impaired in 
conditions of exogenous superoxide anion generation.
2.4.4 Superoxide anion generators impairs basal nitric oxide activity
The effects of superoxide anion generation by the well characterised systems of 
xanthine oxidase (XO)/hypoxanthine (FIX), LY 83583 and pyrogallol were 
investigated on basal activity of nitric oxide in rabbit aorta.
Oxidation of HX by XO forms superoxide and xanthine. Xanthine is then further 
oxidised by XO to produce uric acid and another superoxide. The quinones, LY 
83583 and pyrogallol, generate superoxide by undergoing redox cycling, i.e. the
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quinone autoxidises to it semiquinone which then reacts reversibly with oxygen to 
form quinone and superoxide anion (Halliwell & Gutteridge, 1989).
Following induction of submaximal PE-induced tone, XO (4.8 mu ml'*) induced a 
transient relaxation which was mediated by endothelium-derived nitric oxide since it 
was impaired by treatment with L-NAME or endothelium removal. This relaxation 
was largely limited to the first addition of XO to the aortic ring, since subsequent 
additions to the same ring after washout gave much smaller or no relaxations. Similar 
finding have been reported in rabbit aorta by Furchgott (1994) and in dog coronary 
artery by Rubanyi & Vanhoutte (1986a). A possible explanation for this relaxation is 
that commercially available XO has been reported to be contaminated by trypsin, 
phoshoplipases and chelating agents such as EDTA (Halliwell & Gutteridge, 1989). 
Furthermore, Thomas & Ramwell (1987) report that endothelium-dependent 
relaxation elicited by XO is blocked by trypsin inhibitors and mimicked by authentic 
trypsin, suggesting that this action of XO is probably due to contaminating trypsin.
Following induction of PE-tone in endothelium-containing XO-treated rings of rabbit 
aorta, addition of HX (0.1 mM) produced a substantial but transient augmentation of 
tone. This effect was absent following treatment with L-NAME or in endothelium- 
denuded tissues. The absolute dependence of the endothelium for this XO/FIX- 
mediated enhancement of PE-tone suggests that it is due to destruction of basal nitric 
oxide. Furthermore, exogenously applied SOD completely prevents this 
enhancement in tone. This suggests that the XO/HX-induced rise in tone indeed 
resulted from a superoxide-mediated destruction of basal nitric oxide. Furthermore,
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since exogenously applied SOD is active only in the extracellular space, it follows 
that generation of superoxide anion by XO/HX, and subsequent destruction of nitric 
oxide occurs solely in the extracellular space. Logically, this would seem to be the 
case since the exogenously applied enzyme, XO, would also be too large to diffuse 
into cells. As with XO/HX, the enhancement of tone induced by LY 83583 (0.3 pM) 
and pyrogallol (0.1 mM) was also impaired by treatment with exogenously applied /
SOD, suggesting that the destruction of basal nitric oxide activity in each case was 
due to the generation of superoxide in the extracellular space. These experiments Iindicate clearly, that basal activity is destroyed by superoxide, thus precluding the 
need to suggest that the mediator is anything other than nitric oxide per se.
\As reported in section 2.4.3, endogenous Cu/Zn SOD appears to be unimportant for 
the normal integrity of basal nitric oxide in rabbit aorta. This was therefore likely to I
indicate that levels of endogenous superoxide are too low to inactivate nitric oxide. If 
exogenous Cu/Zn SOD is, however, important in protecting basal activity of nitric 
oxide against destruction by superoxide anion then its inactivation by DETCA would 
be expected to potentiate the inhibitory effects of the superoxide generating systems. 
Consequently, experiments were conducted to investigate the effects of DETCA on 
the ability of XO/HX, LY 83583 and pyrogallol to inhibit basal nitric oxide activity.
It was found that following pretreatment with a low concentration of DETCA (0.3 
mM; 60 min; washout), which by itself had no effect on basal nitric oxide activity, 
the ability of XO (4.8 mu m f‘)/HX (0.1 mM), LY 83583 (0.3 pM) or pyrogallol (0.1 
mM) to enhance PE-tone was now powerfully potentiated. It was likely that this 
enlianced augmentation of tone occurred as a consequence of elevated levels of
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superoxide anion since it was blocked following pretreatment with exogenous SOD 
(250 u ml"*). These augmentations of tone were also equivalent in magnitude to the 
rise observed upon the addition of L-NAME (100 pM; approximately 1 g tension), 
suggesting that basal nitric oxide activity was virtually abolished by the superoxide 
anion generators in DETCA-treated tissues. These experiments not only demonstrate 
that endogenous Cu/Zn SOD does indeed play a vital role in protecting basal nitric 
oxide from destmction by superoxide anion, but also provide a convenient model in 
which basal nitric oxide is destroyed by an extracellular oxidant stress.
2.4.5 Acetylcholine induces endothelium -dependent relaxation in rab b it aortic 
rings
Production and release of nitric oxide from the vascular endothelium is stimulated by 
a large number of mediators such as ACh (Furchgott & Zawadzki, 1980) and by the 
physical shearing force the flowing blood (Rubanyi et al., 1986).
Although in normal physiology ACh is unlikely to stimulate production of 
endothelium-derived nitric oxide, in vitro it provides a convenient tool for assessing 
stimulated (non-basal) activity of nitric oxide. It was found that ACh (10 nM - 3 pM) 
produced a concentration-dependent and virtually complete relaxation of 
submaximal ly contracted endothelium-containing rings. This relaxation was 
impaired by inhibition of nitric oxide synthase following treatment with L-NAME 
(100 pM), and was abolished by endothelial removal. This ability of ACh to induce 
relaxation in rabbit aorta is consistent with the first report of EDRF described by
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Furchgott & Zawadzki (1980) and indicate that the endothelium-dependent mediator 
released is nitric oxide.
Having characterised agonist-stimulated activity of nitric oxide in rabbit aortic rings,
ithe effects of inhibition of endogenous Cu/Zn SOD and superoxide anion generation 
were then investigated.
2.4.6 Exogenous application of superoxide dismutase has no effect on 
acetylcholine-induced nitric oxide activity
Exogenous application of SOD (250 u ml" ) had no effect on ACh-induced relaxation
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of rings of rabbit aorta. A similar lack of effect was reported in rabbit aorta by
■■'■rOhlstein et al. (1989) and Abrahamsson et al. (1991). This suggests that background
levels of superoxide anion must be too low as to not significantly inactivate nitric f
Ioxide, otherwise, addition of SOD would have been expected to potentiate the effects 
of nitric oxide and so enhance ACh-induced relaxation. As with ACh-induced 
relaxation, basal nitric oxide activity was also unaffected by exogenous SOD 
(Section 2.4.1). Exogenously applied SOD has also been shown to be without effect 
on ACh-induced relaxation of rat aorta (Mian & Martin, 1995a).
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2.4.7 Diethyldithiocarbamate impairs acetylcholine-induced nitric oxide 
activity
In a number of blood vessels the inhibitor of Cu/Zn SOD, DETCA, leads to severe 
impairment of agonist-stimulated nitric oxide-dependent relaxation (Cherry et al, 
1990; Mügge et al, 1991a; Omar et al, 1991; Mian & Martin, 1995a). This loss of 
nitric oxide activity was unlikely to have resulted from reduced synthesis of nitric 
oxide since the release of total nitrogen oxides, as measured by chemiiuminesence, 
was unaffected (Mügge et al., 1991a). These authors concluded that the impairment 
of relaxation was due to the destruction of nitric oxide by superoxide anion as a 
consequence of inactivation of the protective Cu/Zn SOD enzyme. As with these 
previous reports, we found that treatment with DETCA (0.3 — 10 mM) alone 
produced a concentration-dependent blockade of ACh-induced relaxation. None of 
the above investigators, however, attempted to restore nitric-oxide dependent 
relaxation by replenishing SOD in the tissues. This was attempted in our study but 
we found that the blockade of ACh-induced relaxation produced by treatment with a 
submaximal concentration of DETCA (3 mM) was not reversed at all by treatment 
with exogenously applied Cu/Zn SOD (250 or 750 u ml"*). This suggests that the 
impaired relaxation does not result from inliibition of endogenous extracellular SOD 
since reapplication would be expected to restore relaxation. The blockade may, 
therefore, result from impairment of the intracellular isoform of Cu/Zn SOD which 
might allow background levels of superoxide inside cells to rise and destroy nitric 
oxide intracellularly, i.e. an intracellular oxidant stress may have been generated. 
Consistent with this proposed intracellular action of high concentrations of DETCA 
is its ability to impair the actions of nitrovasodilators, such as glyceryl trinitrate.
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which promote relaxation by the generation of nitric oxide inside smooth muscle 
cells (Omar et al., 1991). Alternatively, the effects of DETCA may have resulted 
from non-selective, i.e. SOD-independent, effects in the tissue. Kelner et al. (1989) 
have already shown that DETCA can deplete intracellular glutathione and inactivate 
key enzymes by forming alkylates with important thiol group. In addition, elevated 
levels of superoxide anion, and consequently peroxynitrite, associated with treatment 
with DETCA have been reported to inactivate nitric oxide synthase (Mitchell et al., 
1991b, Rengasamy & Johns, 1993, Pasquet et al., 1996).
Proof that the blocking action of DETCA indeed resulted from the inhibition of 
intracellular SOD would be obtained, however, if ACh-induced relaxation could be 
restored by a strategy which led to elevation of intracellular SOD or SOD-like 
activity. This will be addressed in Chapter 4 by investigating if a number of putative 
membrane-permeant SOD mimetics can restore nitric oxide-dependent relaxation 
following inactivation by DETCA.
2.4.8 Superoxide anion generators impair acetylcholine-induced nitric oxide
activity
Treatment with the superoxide anion generators, XO (4.8 mu ml"')/HX (0.1 mM) and 
LY 83583 (0.3 pM), each led to a substantial blockade of ACh-induced relaxation in 
PE-contracted endothelium-containing aortic rings. As in previous studies (Rubanyi 
& Vanhoutte, 1986a, Abrahamsson et al., 1991; Mian & Martin, 1995a), the 
inhibition of relaxation is likely to have been due to superoxide anion-mediated 
destruction of nitric oxide. This was confirmed by the ability of exogenously applied
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SOD to completely prevent the inhibitory effects of XO/HX or LY 83583. It should 
be noted also that the inhibitory effect of superoxide anion is not due to breakdown 
of ACh (Rubanyi & Vanhoutte, 1986a). The superoxide generator, pyrogallol at 0.1 
mM, did not impair ACh-induced relaxation to any degree. Concentrations of 
pyrogallol of 0.3 mM or greater, however, caused such a dramatic fall in tone that it 
prevented examination of the relaxant effects of ACh.
If exogenous Cu/Zn SOD is important in protecting agonist-induced activity of nitric 
oxide against destruction by superoxide anion then its inactivation by DETCA would 
be expected to potentiate the inhibitory effects of the superoxide generating systems. 
Consequently, experiments were conducted to investigate the effects of DETCA on 
the ability of XO/HX, LY 83583 and pyrogallol to inhibit ACh-induced relaxation. It 
was found that following pretreatment with a low concentration o f DETCA (0.3 mM; 
60 min; washout), which by itself caused little inhibition of ACh-induced relaxation, 
then the ability of XO (4.8 mu mi"*)/HX (0.1 mM) and LY 83583 (0.3 pM) to impair 
relaxation was now powerfully potentiated. Also, treatment with pyrogallol (0.1 
mM), which by itself had no effect on relaxation, now resulted in substantial 
impairment of ACh-induced relaxation. It was likely that these inliibitions had 
occurred as a consequence of elevated levels of superoxide anion since they were 
blocked following pretreatment with exogenous SOD. Since exogenous SOD, which 
cannot penetrate cells, completely restores ACh-induced relaxation, it is likely that 
this enhanced blocking ability of XO/HX, LY 83583 and pyrogallol in DETCA (0.3 
mM)"treated tissues resulted from inhibition of extracellular SOD. This confirms 
previous findings that endogenous Cu/Zn SOD is vital in protecting agonist-induced 
nitric oxide from destruction by superoxide anion (Cherry et al, 1990; Mügge et al.
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1991a; Omar et a l, 1991; Mian & Martin, 1995a). Furthermore, these experimental 
conditions provide convenient models in which ACh-induced activity of nitric oxide 
is destroyed by an extracellular oxidant stress.
Another important point to consider is the concentration dependence of the effects of 
DETCA. Specifically, high concentrations of DETCA (> 3 mM) produced blockade 
of ACh-induced relaxation which was not reversed by exogenous membrane- 
impermeant SOD, probably reflecting inhibition of intracellular Cu/Zn SOD (see 
section 2.4.3). In contrast, a low concentration (0.3 mM) facilitated blockade by the 
extracellular superoxide anion generators, and the augmented blockade was entirely 
reversed by exogenous membrane-impermeant SOD. It is likely therefore that a low 
concentration of DETCA can preferentially inhibit Cu/Zn SOD extracelluiarly 
whereas higher concentrations will inhibit both extracelluiarly and intracellularly.
2.4,9 D ifferential effect of d iethyld ith iocarbam ate on basal and  acetylcholine- 
induced activity of n itric  oxide
The results from this chapter have clearly demonstrated that both basal and ACh- 
induced activity of nitric oxide are impaired by superoxide anion and both are 
protected against destruction by endogenous Cu/Zn SOD. Surprisingly, however, 
inactivation of endogenous Cu/Zn SOD, by treatment with DETCA (3 mM) alone, 
powerfully inactivates ACh-induced activity but not basal activity of nitric oxide. 
This apparent discrepancy could be explained if endogenous levels of superoxide 
anion were different in the two experimental conditions i.e. if higher levels of 
superoxide anion were present during stimulation with ACh than during unstimulated
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conditions where basal activity of nitric oxide was measured. This could potentially 
occur if ACh-induced stimulation of endothelial cells lead to activation of cellular 
processes which stimulated superoxide production. One potential source of 
superoxide is cyclooxygenase, the enzyme that leads to production of prostaglandins, 
prostacyclin, and thromboxane (Berne & Levy, 1998). Generation of prostaglandin H 
(PGH) via PGH synthase forms free radical intermediates that react with NADH^ to 
form the radical NAD*. This radical is known to react in turn with oxygen to produce 
superoxide anion (Cosentino et al., 1994). This finding is consistent with the 
demonstrated ability of the endothelial cyclooxygenase pathway in cerebral arteries 
to produce superoxide anion (Kukreja et al., 1986). Furthermore, activated protein 
kinase C can lead to generation of superoxide anion in endothelial cells (Matsubara 
& Ziff, 1986). Thus, if ACh does lead to the generation of superoxide anion as well 
as of nitric oxide then this could explain why ACh-induced relaxation but not basal 
relaxation is impaired when endogenous Cu/Zn SOD has been compromised by 
treatment with DETCA.
To conclude, in addition to the characterisation of the effects of endothelium-derived 
nitric oxide in rabbit aorta, this chapter also describes the development of two 
distinct models of oxidant stress: an extracellular model (involving a low 
concentration of DETCA 0.3 mM in combination with superoxide generation) in 
which agonist-induced and basal activity of nitric oxide is inactivated; and an 
intracellular model (involving a high concentration of DETCA 3 mM alone) in which 
agonist-induced activity but not basal activity of nitric oxide is impaired. These 
models can be used to assay the efficacy of the ability of the putative SOD mimetics 
to protect nitric oxide from destruction by oxidant stress in vitro.
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I
3.1 INTRODUCTION
Chapter 2 confirms previous findings that superoxide anion impairs nitric oxide- 
dependent relaxation (Gryglewski et al., 1986; Rubanyi & Vanhoutte, 1986b;
Katusic & Vanhoutte, 1989; Ohlstein & Nichols, 1989; Mian & Martin, 1995a) and 
that endogenous Cu/Zn superoxide dismutase (SOD) plays a vital role in protecting 
endothelium-derived nitric oxide from destruction (Cherry et al, 1990; Mügge et al,
1991a; Omar et a l, 1991; Mian & Martin, 1995a). This process of oxidant stress- 
mediated destruction of nitric oxide is thought to be involved in the vascular 
dysfunction associated with many diseases. For example, hypertension (Nakazono et 
al, 1991; Grunfeld et al, 1995; Bouloumie et al, 1997), atherosclerosis (Sharma et 
al, 1992; Ohara et al, 1993), ischaemia-reperfusion injury (Downey, 1990), diabetes /
(Hattori et al, 1991 ; Kamata & Kobayashi, 1996) and heart failure (McMurray et al,
1990; Katz et al, 1993) are ail associated with increased free radical production and 
reduced nitric oxide-dependent relaxation. A case therefore exists for augmenting 
SOD activity in the hope of restoring nitric oxide-dependent relaxation in pathologies 
associated with oxidant stress. SOD itself is unlikely to be of therapeutic benefit 
under such circumstances because its large size prevents it from entering cells to 
protect nitric oxide from intracellular oxidant stress. However, interest is growing in 
the development of membrane permeant SOD mimetics as therapeutic agents. A 
number of different classes of SOD mimetic have been described, including the 
nitroxide spin traps PTIYO (4-phenyl-2,2,5,5-tetramethyl imidazolin-1 -yloxy-5- 
oxide) and tempol (4-hydroxy 2,2,6,6-tetramethylpiperidine-1 -oxyl) (Mitchell et al,
1990; Ewing & Janero, 1995), the superoxide scavenger tiron (4,5-dihydroxy-1,3-
i
il l
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benzene-disulfonic acid; Ledenev et al, 1986), the metal-based compounds CuDÏPS 
(Cu [II]-[diisopropylsalicylate]2 ; Huber et al., 1987; Sorenson, 1995) and MnTMPyP 
(Mn [III] tetrakis [l-methyl-4-pyridyl] porphyrin; Faulkner et a l, 1994; Gardner et 
al, 1996), and the metal salts CUSO4 and MnCl2 (Huber et a l, 1987; Beyer & 
Fridovich, 1990). The copper and manganese based compounds mimic the catalytic 
site of Cu/Zn SOD and Mn SOD, respectively.
The previous chapter was concerned with the development of models of oxidant 
stress in which nitric oxide-dependent relaxation was impaired by superoxide anion. 
These models were to be used to investigate the ability of putative SOD mimetics to 
restore impaired nitric oxide activity under conditions of oxidant stress. Before this 
was attempted, it was regarded as advantageous to ranlt the activity of each of the 
putative SOD mimetics in a biochemical assay.
Direct determination of SOD activity can be assessed only by highly specialised 
equipment such as is used in pulse radiolysis or nuclear magnetic resonance 
(Halliwell & Gutteridge, 1989). It is far simpler, however, to use indirect assays to 
detect SOD activity. In these, superoxide anion is generated by a system which then 
reacts with a detector molecule. The presence of SOD, or SOD-like compounds, 
removes the superoxide and therefore inhibits the reaction with the detector. Two 
well established distinct assays based on this system were employed. The first was 
based on the ability of the superoxide-generating system NADH and phenazine 
methosiilphate to reduce nitro blue tétrazolium (Halliwell & Gutteridge, 1989; Ewing 
& Janero, 1995). The second was based on the xanthine oxidase/hypoxanthine
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superoxide generating system to reduce cytochrome c (McCord & Fridovich, 1968; 
Halliwell & Gutteridge, 1989; Laight et al., 1997).
The aim of this section was to assess the rank order of potency of the SOD mimetics 
in these biochemical assays. The information gained would subsequently be 
compared with their ability to restore nitric oxide-dependent relaxation in conditions 
of oxidant stress.
3.2 METHODS
Superoxide dismutase (SOD)-like activity was assessed by the use of two separate 
assays which measure the ability of agents to inhibit superoxide anion-mediated 
reactions. The agents assessed were authentic SOD and the putative SOD mimetics, 
PTIYO, tempol, tiron, C11SO4, CuDIPS, M nCf and MnTMPyP. Both assays are 
based on the principle that generation of superoxide anion, a reducing agent, 
promotes reduction of a detector molecule. This causes the detector molecule to 
change colour which can be detected spectrophotometrically. If authentic SOD or a 
SOD-like agent is present in the assay it will scavenge the superoxide anion 
produced and thereby inhibit the change in colour. SOD activity, therefore, can be 
expressed as a function of its ability to inhibit the reduction of the detector agent, i.e. 
0 % inhibition corresponds to zero SOD activity while 100 % inhibition corresponds 
to maximum SOD activity (i.e. all of the generated superoxide anion was scavenged).
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The assays employed were based on the ability of superoxide anion to reduce either 
nitro blue tétrazolium or cytochrome c. Both assays were conducted in final volumes 
of 300 pi in 96 well plates, incubated at room temperature on an orbital shaker. 
Following incubation, changes in absorbance were measured with a microplate 
reader (Dynex Ltd.).
In preliminary experiments, a time course was constructed for the reduction of nitro 
blue tétrazolium and cytochrome c (Figure 3.1). This was done to establish suitable 
incubation times for assays involving SOD and the SOD mimetics.
3.2.1 Reduction of nitro blue tétrazolium
This assay was based on the ability of superoxide anion, generated by NADH and 
phenazine methosulphate, to reduce yellow nitro blue tétrazolium to blue formazan 
dye (Halliwell & Gutteridge, 1989; Ewing and Janero, 1995).
NBT^^ (yellow) + O2 -> formazan (blue)
The complete assay system consisted of (final concentrations in parenthesis): 10 pi 
of 1.5 mM nitro blue tétrazolium (50 pM), 10 pi of 2.34 mM NADH (78 pM), 100 
pi of 9.9 pM phenazine methosulphate (3.3 pM), taken to a total volume of 300 pi 
with phosphate buffer (50 mM, pH 7.4), containing ethylenediaminetetraacetic acid 
(EDTA, 0.1 mM) in order to chelate contaminating heavy metals which interfere 
with the reduction of nitro blue tétrazolium. For the assay of SOD activity, 10 pi of a 
range of concentrations of SOD or a SOD mimetic was added to the assay system at
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the expense of 10 pi of phosphate buffer. Each plate included two separate blanks to 
correct for the intrinsic absorbance of the reagents used: the first, consisted of all the 
reagents with the exception of the phenazine methosulphate and the test agent (i.e. 
SOD or the SOD mimetic). The second, consisted of all the reagents together with 
the highest concentration used of the test chemical (i.e. SOD or the SOD mimetic) 
but with the exception of the phenazine methosulphate. Zero standards (containing 
no SOD or SOD mimetic) were also included in each plate to assess the maximum 
reduction of the detector agent during the incubation period, i.e. no mimetic present. 
This control was then used to calculate SOD activity, which was expressed as a 
percentage inhibition of the reduction of nitro blue tétrazolium. Each protocol had n 
= 8 replicates on each plate. The reaction was initiated with the addition of freshly 
prepared phenazine methosulphate. Following incubation for 5 min the absorbance of 
the solution was measured at 550 mn.
3.2.2 Reduction of cytochrome c
This assay was based on the ability of superoxide anion, generated by xanthine 
oxidase/hypoxanthine (XO/FIX), to reduce cytochrome c. Commercially available 
cytoclii'ome c is supplied largely in the oxidised form, ferricytochrome c, and 
superoxide anion causes its reduction to form ferrocytochrome c. The reduced form 
of cytochrome c has a greater absorbance at 550 mn than the oxidised form (McCord 
& Fridovich, 1968; Flalliwell & Gutteridge, 1989; Laight et a l, 1997).
ferricytochrome c (Fe^^) + 0 2  -> O2 + ferrocytochrome c (Fe^^)
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The complete assay system consisted of (final concentrations in parenthesis): 10 pi 
of 90 mu mf^ XO (3 mu ml'*), 10 pi of 3 mM HX (0.1 mM), 10 pi of 900 pM 
cytochrome c (30 pM), 10 pi of 3000 u ml * catalase (100 u ml"*) and was taken to a 
total volume of 300 pi with Tris buffer (tris[hydroxymethy 1]-aminomethane 
hydrochloride; 50 mM, pH 7.6). Catalase was present to prevent the re-oxidation of 
cytoclu’ome c resulting from the build up of hydrogen peroxide, formed from the 
dismutation of superoxide anion. SOD activity was assessed by the addition of 10 pi 
of a range of concentrations of SOD or a SOD mimetic to the assay system at the 
cost of 10 pi of Tris buffer. As with the nitro blue tétrazolium assay, each plate 
included two separate blanks to correct for the intrinsic absorbance of the reagents 
used. The first consisted of all the reagents except XO and SOD or SOD mimetic. 
The second, consisted of all the reagents along with the highest concentration of 
SOD or SOD mimetic without XO. Each protocol had n = 8 replicates on each plate. 
The reaction was initiated with the addition of XO. Following incubation for 30 min 
the absorbance of the solution was measured at 550 mn.
For both assays, concentration-effect curves, calculation of pECgo values and 
statistical analyses were calculated using a computer-based programme (Graph Pad, 
Prism).
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3.2.3 Drugs, reagents and solvents
Drugs and reagents used in these experiments, but not referred to in Chapter 2, were:
Cytociu'ome c, 4,5-dihydroxy-l,3"benzene-disulfonic acid (tiron), 4-hydroxy 2,2,6,6- 
tetramethylpiperidine-1-oxyl (tempol), p-nicotinamide adenine dinucleotide (reduced 
form; NADH), nitro blue tétrazolium (NET) and phenazine metho sulfate (PMS) 
were obtained from Sigma (Poole, UK). Cu (II)-[diisopropylsalicylate]2 (CuDIPS) 
and 4-phenyl-2,2,5,5-tetramethyl imidazolin-l-yloxy-5-oxide (PTIYO) were 
obtained from Aldrich (Dorset, UK). Mn (III) tetrakis [l-methyi-4-pyridyl] porphyrin 
(MnTMPyP) was obtained from Alexis (Nottingham, UK), whilst CUSO4 and MnCl] 
were obtained from Hopkin & Williams (Essex, UK).
All drugs were dissolved in normal saline (0.9 %), except CuDIPS (3 mM stock) 
which was dissolved in 50% ethanol/ 50% Tris buffer (50 mM, pH 7.4). Control 
experiments demonstrated that the solvent ethanol/Tris buffer did not account for the 
effects observed with CuDIPS. All dilutions were made in the buffer appropriate to 
the particular assay. Concentrations of drugs are expressed as the final molar 
concentration in the plate well.
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3.3 RESULTS
3.3.1 Time-dependent reduction of nitro blue tétrazolium and cytochrome c
The reduction of nitro blue tétrazolium to formazan by NADIi/phenazine 
methosulphate proceeds rapidly, before reaching completion within 10 min or so 
(Figure 3.1a). Reduction of ferricytochi'ome c to ferrocytochrome c by the xanthine 
oxidase/hypoxanthine (XO/HX) superoxide generating system proceeds at a slower 
rate, reaching completion after around 60 min (Figure 3.1b).
Incubation periods corresponding approximately to the time to half maximum 
reduction, i.e. 5 and 30 min for nitro blue tétrazolium and cytochrome c, 
respectively, were used in all subsequent experiments.
3.3.2 Inhibition of reduction of nitro blue tétrazolium and cytochrome c by 
superoxide dismutase
When present during the incubations, authentic Cu/Zn SOD (0.03 - 300 u ml"*) 
produced concentration-dependent inhibition of the reduction both of nitro blue 
tétrazolium by the NADH/phenazine methosulphate system and of cytochrome c by 
the XO/HX system (Figure 3.2): the inhibition of reduction was virtually complete in 
each case (Table 3.1). The ability of authentic SOD to produce powerful inhibition of 
reduction of both nitro blue tétrazolium and cytochrome c provides validation of 
these methods for the assessment of SOD-like activity.
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FIGURE 3.1 Time-dependent reduction of (a) nitro blue tétrazolium and (b) 
cytochrome c by the NADH/phenazine methosulphate and the xanthine 
oxidase/hypoxanthine superoxide anion generating systems, respectively, measured 
as changes in absorbance at 550 nm (A A 5 5 0 ) .  Each point is the mean ± s.e. mean of 
8-15 observations.
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FIGURE 3.2 The ability of authentic Cu/Zn superoxide dismutase (SOD) to inliibit 
in a concentration-dependent manner the reduction both of nitro blue tétrazolium (■) 
by NADH/phenazine methosulphate and of cytochrome c (A) by xanthine 
oxidase/hypoxanthine. Each point is the mean ± s.e. mean of 8-16 observations.
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Table 3.1 The ability of authentic Cu/Zn SOD and SOD mimetics to inhibit the 
reduction of nitro blue tétrazolium and cytochrome c. Data are the mean ± s.e. mean 
of 8-16 observations. *P<0.05, **P<0.01 and ***P<0.001 indicate a significant 
difference from maximal inhibition by Cu/Zn SOD. pECso values are expressed in 
molar units except for Cu/Zn SOD which are in u m l'\
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iIIIn itro  b lu e tétrazo liu m cytoch ro m e c 1
red uction red u ction i-.'S. :
compound pECso maximum inhibition (%)
maximum 
inhibition (%>) 1
Cu/Zn SOD -0.02 ± 0.02 88.2 ± 1.3 -0.41 ±0.09 99.1 ±3.5 1
PTIYO 3.38 ±0.07 95.6 ± 1.1 2.59 ±0.23 88.2 ± 5.2
tem pol 3.88 ±0.08 98.9 ±2.1 3.36 ±0.13 94.5 ± 4.6 ■,K
tiron 4.57 ±0.16 62.5 ±0.7*+ 3.11 ±0.10 51.3 ±5.1***
CUSO4 4.04 ±0.01 81.4 ± 10.7 6.70 ± 0.04 75.7 ±4.8 a1
CuDIPS 5.72 ± 1.04 6.7 ±3.1*** 6.27 ±0.11 69.7 ± 1.6* .1
MnCb 4.28 ± 0.04 74.7 ± 2.4 6.46 ±0.21 93.3 ±4.0
MnTMPyP 7.08 ±0.30 95.9 ± 2.2 6.05 ±0.17 40.0 ± 13.9**+ '1
Î
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3.3.2 Inhibition of reduction of nitro blue tétrazolium and cytochrome c by 
superoxide dismutase mimetics
All of the putative SOD mimetics investigated exhibited some degree of SOD-like 
activity by inhibiting the reduction of either nitro blue tétrazolium or cytoclirome c, 
although the range of effective concentrations and maximum inhibitions varied 
widely (Figures 3.3 and 3.4, and Table 3.1).
The metal-based agent, MnTMPyP, was clearly the most potent compound at 
inhibiting the reduction of nitro blue tétrazolium, and the inhibition it produced was 
nearly complete (Figure 3.3 and Table 3.1). The other metal-hased agents, CUSO4, 
CuDIPS and MnCh, the nitroxide spin traps, PTIYO and tempol, and the superoxide 
scavenger, tiron, were all considerably less potent. Nevertheless, of all the agents 
tested, only tiron and CuDIPS failed to reach near complete inhibition of reduction. 
In fact CuDIPS had viitually no inhibitory activity even at the highest concentration 
tested (30 pM; Figure 3.3 and Table 3.1).
All of the SOD mimetics tested produced a concentration-dependent inlubition of 
reduction of cytochi’ome c (Figure 3.4). The metal-based agents, CUSO4, CuDIPS, 
MnCh and MnTMPyP, were clearly more potent than the spin traps, PTIYO, tempol 
and tiron, in inhibiting the reduction of cytoclirome c: of these, only MnCh, PTIYO 
and tempol produced near complete inhibition of reduction. MnTMPyP was 
considerably (greater than 10-fold) less potent in inhibiting the reduction of 
cytochrome c than of nitro blue tétrazolium but PTIYO and tiron also displayed a 
lower potency.
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FIGURE 3.3 The ability of (a) PTIYO (□ ), tempol (A) and tiron (V) and (b) CuSO^
(A), CuDIPS (V), MnCl] (■) and MnTMPyP (#) to inhibit the reduction of nitro blue 
tétrazolium (NBT) by the NADH/phenazine methosulphate superoxide anion 
generating system. Each point is the mean ± s.e. mean of 8-16 observations.
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FIGURE 3.4. The ability of (a) PTIYO (□ ), tempol (A) and tiron (V) and (b)
CUSO4 (A), CuDIPS (▼), M11CI2 (■) and MnTMPyP (•) to inhibit the reduction of 
cytoclu'ome c (cyt c) by the xanthine oxidase/hypoxanthine superoxide anion 
generating system. Each point is the mean ± s.e. mean of 8-16 observations.
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3.4 DISCUSSION
A number of biochemical assays can be employed to detect superoxide dismutase 
(SOD)-like activity. The majority of these are based on the ability of SOD to inlhbit 
superoxide anion-mediated reactions. These assays, therefore, do not measure 
dismutation of superoxide directly. As a consequence, caution must be observed 
since the ability of a compound to interfere with the generation of superoxide anion 
could be interpreted incorrectly as SOD-like activity. Consequently, the use of two 
quite independent assays was regarded as a prudent step to insure against an agent 
being falsely identified as having SOD-like activity. The first assay was based on the 
ability of superoxide anion, generated using NADH and phenazine methosulphate, to 
reduce nitro blue tétrazolium (Halliwell & Gutteridge, 1989; Ewing and Janero,
1995), and the second on the ability of xanthine oxidase/hypoxanthine to reduce 
cytoclirome c (McCord & Fridovich, 1968; Halliwell & Gutteridge, 1989; Laight et 
al., 1997). The use of these assays was fully validated by the ability of authentic 
Cu/Zn SOD to inhibit virtually completely the reduction both of nitro blue 
tétrazolium and cytochrome c.
The presence of EDTA is necessary component in the nitro blue tétrazolium assay in 
order to chelate contaminating metals such as free copper of iron ions which could 
otherwise cause the dismutation of superoxide anion and therefore interfere with the 
assay of SOD activity. Consequently, assessment of the SOD-like activity of the 
metal-based agents that exist in an ionic state (CUSO4 and MnCE) or as a weak co­
ordination complex (CuDIPS; Huber et al., 1987), was compromised in this assay. 
When the concentration of CUSO4 or MnCE was increased beyond the chelating
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capacity of EDTA, i.e. above 0.1 mM, then both these agents exhibited substantial 
SOD-like activity. The insolubility of CuDIPS, however, limited the highest Ï
concentration of this agent to 30 pM, and this was well within the chelation capacity 
of EDTA. Consequently, CuDIPS demonstrated virtually no SOD-like activity in this 
assay. In contrast, the manganese centre of MnTMPyP is firmly located within the 
porphyrin ring (Faulkner et al., 1994), and is not chelated by EDTA. Consequently, 
MnTMPyP demonstrated considerable SOD-like activity in this assay. For those 
agents which could easily be assessed in the nitro blue tétrazolium assay, the ranlc 
order of potency was MnTMPyP > tiron > tempol > PTIYO.
In contrast to the nitro blue tétrazolium assay, the cytochrome c assay does not utilise 
EDTA and, therefore, proved more versatile, permitting the activity of all of the SOD 
mimetics to be assessed. In this assay, the rank order of potency was CuSO# > MnCE |
> CuDIPS > MnTMPyP > tiron > tempol > PTIYO. Encouragingly, this rank order 
of potency was essentially similar to that of the nitro blue tétrazolium assay 
(excluding the metal-based agents inhibited by EDTA). Of the metal-based agents, 
only MnCb produced near maximal inhibition of the reduction of cytochrome c. The 
remaining metal based agents, CUSO4, CuDIPS and MnTMPyP, produced 
substantially lower inhibition. Amongst the metal-based agents, only MnCE has its 
metal in its lower valence state, i.e. Mn(II)Cl2, while the others all have the metal in 
their higher valence state, i.e. Cu(II)S0 4 , Cu(II)DIPS and Mn(III)TMPyP. The lower 
maximal inhibition by CUSO4, CuDIPS and MnTMPyP may result from an 
additional superoxide-independent component of reduction of cytochrome c. 
Specifically, during the dismutation of superoxide anion, the metal centres Cu(II) and
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Mn(III) are reduced to Cu(I) and Mn(II), respectively (Step 1; de Alvare et al., 1976; 
Huber et a l, 1987; Halliwell & Gutteridge, 1989; Faulkner et a l,  1994) and during
subsequent normal redox cycling with superoxide anion (O2 ), the Cu(I) and Mn(II) 
are re-oxidised, with hydrogen peroxide (H2O2) being produced (Step 2 ; Halliwell & 
Gutteridge, 1989):
Step 1: Cu(II) or Mn(III) + O2 -> Cu(I) or Mn(II) + O2
Step 2: Cu(I) or Mn(II) + O2 + 2H’*’ Cu(II) or Mn(III) + H2O2
From the electrochemical series, however, it is likely that the Cu(I) or Mn(II) formed 
in Step 1 will have the additional opportunity to participate in a redox reaction with 
the Fe^^ iron of cytochrome c, resulting in its reduction. Thus, the inhibition of 
superoxide-catalysed reduction of cytoclirome c achieved by these compounds will 
be offset by the ability of their respective lower valency states to directly produce 
reduction. In contrast, the metal-free agents, PTIYO and tempol, produce near 
complete inhibition of reduction of cytochrome c. The metal-free agent, tiron, on the 
other hand produced only about half maximal inhibition of reduction of cytochrome 
c. This is likely to be due to the ability of tiron to cause direct reduction of 
cytochrome c by itself (Mok et al., 1998).
Most of the compounds, including SOD itself, were more potent in the nitro blue 
tétrazolium assay than in the cytoclirome c assay. This could suggest that less 
superoxide is being produced in the former assay than in the latter. The difference in 
potency is particularly striking for MnTMPyP (greater than 10-fold). As explained
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above, MnTMPyP will dismutate superoxide anion by undergoing redox cycling 
from Mn(III) to Mn(II). The reaction rates for superoxide dismutation by 
Mn(lI)TMPyP and Mn(III)TMPyP are, however, strikingly different, i.e. 4 x1 0^  M"‘ 
s‘‘ and 3.9 x 10  ^ M"^  s'*, respectively (Faulkner et a l, 1994). Clearly, the optimum 
valency state of MnTMPyP for superoxide scavenging is the Mn(II) form. Reduction 
of the native state of Mn(III)TMPyP to the more active Mn(II)TMPyP form by the 
superoxide dismutation process is relatively slow, but can proceed faster, at least in 
E. coli, by reduction at the hand of cellulai* elements such as NADPH and glutathione 
(Faulkner et at., 1994). This is likely to explain the reportedly greater superoxide 
removing potency of MnTMPyP in E. coli than in in vitro biochemical assays of 
SOD-like activity where these additional means of reduction are absent (Faulkner et 
al., 1994; Gardner et al., 1996). The nitro blue tétrazolium assay uses the 
NADH/phenazine methosulphate reducing system as the means of generating 
superoxide anion (Halliwell & Gutteridge, 1989; Ewing and Janero, 1995) and this is 
likely to reduce at least some of the Mn(III)TMPyP to the more active 
Mn(II)TMPyP. HX/XO has no such reducing ability, however, and this probably 
explains the lower potency of MnTMPyP in the cytochrome c assay.
Having assessed the rank-order of SOD-like activity of the different SOD mimetics 
in two independent biochemical assays, the path was clear to investigate how this 
compared with the ability of these agents to protect nitric oxide from destruction by 
superoxide anion in the models of oxidant stress developed in rabbit aorta (Chapter 
2).
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Protection o f nitric oxide... Chapter 4
4.1 INTRODUCTION
The loss of vasodilator function following the interaction of nitric oxide with 
superoxide (Gryglewski et al., 1986; Rubanyi & Vanhoutte, 1986b; Kaustic & 
Yanlioutte, 1989; Ohlstein & Nichols, 1989, Mian & Martin, 1995a) has led to the 
suggestion that this process is involved in a number of cardiovascular pathologies. 
Therapeutic intervention with the scavenger of superoxide anion, superoxide 
dismutase (SOD), would seem to be a logical approach to redress the 
superoxide/nitric oxide imbalance. The large size of this enzyme, however, prevents 
its entry into cells to protect nitric oxide from an intracellular oxidant stress (Gardner 
et al., 1996). There is considerable interest, therefore, in the therapeutic potential of 
membrane permeant superoxide dismutase (SOD) mimetics in the treatment of 
pathologies associated with oxidant stress. A diverse range of these has been 
described, including the metal-based compounds CuDIPS (Cu [II]- 
[diisopropyisalicylate]2 ; Huber et al, 1987; Sorenson, 1995) and MnTMPyP (Mn 
[III] tetrakis [l-methyl-4-pyridyl] porphyrin; Faulkner et a i, 1994; Gardner et al,
1996) which dismutate superoxide in a manner similar to that of authentic Cu/Zn 
SOD and Mn SOD, respectively. Simple metal salts of Cu and Mn also possess 
SOD-like activity (Huber et a l, 1987; Beyer & Fridovich, 1990). Other compoimds, 
such as the nitroxide spin traps PTIYO (4-phenyl-2,2,5,5-tetramethyl imidazolin-1- 
yloxy-5-oxide) and tempol (4-hydroxy 2,2,6,6-tetramethylpiperidine-1-oxyl) 
(Mitchell et al, 1990; Ewing & Janero, 1995), and the superoxide scavenger tiron 
(4,5-dihydroxy-1,3-benzene-disulfonic acid; Ledenev et al, 1986) are also laiown to 
relieve oxidant stress in isolated cell studies.
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In the previous chapter, the ranlc order of potency of the above SOD mimetics to 
scavenging superoxide anion was assessed using two independent biochemical 
assays. The central aim of this chapter was to investigate the potential ability of these 
SOD mimetics to restore nitric oxide-dependent vasodilator function following its 
inhibition by oxidant stress. As described in Chapter 2, two distinct models of 
oxidant stress were created in isolated rings of rabbit aorta in an attempt to mimic the 
impaired endothelial-dependent relaxation associated with vascular disease. One 
model involved treatment with a low concentration of the inactivator of endogenous 
Cu/Zn SOD, diethyldithiocarbamate (DETCA; 0.3 mM). This powerfully potentiated 
the ability of xanthine oxidase/hypoxanthine, which generates superoxide only in the 
extracellular space, to impair both basal and acetylcholine (ACh)-stimulated activity 
of nitric oxide. These impairments were reversed following treatment with 
exogenous SOD suggesting that in this form of oxidant stress, nitric oxide was 
destroyed by superoxide in the extracellular space. The other model of oxidant stress 
involved treatment with a high concentration of DETCA (3 mM) alone to inliibit 
extracellular and intracellular isoforms of Cu/Zn SOD. Although this had no effect 
on basal nitric oxide activity, it resulted in blockade of ACh-induced relaxation in a 
manner which was not reversed by membrane-impermeant, exogenously applied 
SOD. The destruction of ACh-induced nitric oxide activity under these conditions is 
therefore likely to have resulted from inhibition of intracellular Cu/Zn SOD leading 
to intracellular destruction of nitric oxide by superoxide anion
In this chapter, these models of oxidant stress were used to assess the ability of the 
SOD mimetics to protect nitric oxide from destruction in vitro.
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4.2 METHODS
4.2.1 Preparation of tissues and assessment of nitric oxide activity
Methods for preparation of rabbit aortic rings for tension recording are detailed in 
Chapter 2. Basal activity of nitric oxide was assessed indirectly by measuring the 
endothelium-dependent depression of phenylephrine (PE)-induced contraction in 
aortic rings. This endothelium-dependent depression of vasoconstriction would be 
expected to be blocked by agents which inhibit the activity of nitric oxide. 
Specifically, submaximal tone was generated in aortic rings using PE (0.1 pM) and 
basal nitric oxide activity was assessed by the augmentation of tone seen following 
addition of the inhibitor of nitric oxide synthase, N^-nitro-L-arginine methyl ester 
(L-NAME, 100 pM), or the superoxide-generating system, xanthine oxidase (4.8 mu 
ml’’)/ hypoxanthine (0.1 mM). Agonist-stimulated activity of nitric oxide was 
determined by assessing acetylcholine (ACh)-induced relaxation. Specifically, 
cumulative concentration response curves to ACh (10 nM - 3 pM) were constructed 
on endothelium containing rings following induction and stabilisation of submaximal 
PE (30 - 300 nM)-induced tone.
4.2.2 Effect of superoxide dismutase mimetics
The effects of superoxide dismutase (SOD) mimetics were assessed on basal and 
ACh-stimulated activity of nitric oxide. Specifically, following PE (30 -  300 nM)- 
induced contraction and a 20 min treatment with PTIYO (100 pM), tempol (3 mM), 
tiron (10 mM), CUSO4 (3 pM), CuDIPS (3 pM), MnCb (100 pM) or MnTMPyP
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(100 pM), basal nitric oxide activity was assessed from the augmentation of tone 
observed following the addition of L-NAME (100 pM). The effects of the mimetics 
on agonist-induced activity of nitric oxide was assessed by construction of 
concentration-response curves to ACh (10 iiM -  3 pM) on PE (30 -  300 nM)- 
contracted rings pretreated for 20 min with PTIYO (10 - 300 pM), tempol (0.1 - 3 
mM), tiron ( 1 - 10  mM), CUSO4 (1 - 100 pM), CuDIPS (1 - 100 pM), MnCla (1 - 100 
pM) or MnTMPyP (10 pM - 1 mM).
4.23 Generation of oxidant stress by inactivation of endogenous Cu/Zn 
superoxide dismutase together with superoxide anion production
Oxidant stress was generated by inactivating endogenous Cu/Zn SOD with a low 
concentration of the copper chelator, diethyldithiocarbamate (DETCA) in 
combination with superoxide anion generation using the xanthine oxidase 
(XO)/hypoxanthine (HX) system. In these experiments, following a 60 min 
incubation period with DETCA (0.3 mM; followed by washout), aortic rings were 
submaximally contracted with PE (30 -  300 iiM). XO (4.8 mu mf^) was then added 
at least 20 min before the addition of its substrate, HX (0.1 mM). As indicated in 
Chapter 2, this treatment resulted in an inhibition of both basal and ACh-stimulated 
activity of nitric oxide.
An examination was made of the ability of exogenously applied authentic Cu/Zn 
SOD and of the SOD mimetics to prevent this inhibition of nitric oxide activity. In 
these experiments, SOD (250 u m f’), PTIYO (10 - 300 pM), tempol (30 pM - 1 
mM), tiron (0.3 - 10 mM), CUSO4 (0.3 - 3 pM), CuDIPS (1 - 100 pM), M nCf (1 -
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100 |iM) or MnTMPyP (100 - 600 fiM) were added to the XO (4.8 mu mP^)-treated 
tissue 20 mill before addition of HX (0.1 mM). The ability of SOD and the SOD 
mimetics to protect basal activity of nitric oxide was assessed indirectly from the 
depression of the increase in tone observed upon the addition of HX. Furthermore, 
their ability to protect agonist-stimulated activity of nitric oxide was assessed from 
cumulative concentration-response curves to ACh (10 nM -  3 pM).
4.2.4 Generation of oxidant stress by inactivation of endogenous Cu/Zn 
superoxide dismutase
The other condition of oxidant stress described in Chapter 2 involved a 60 min 
incubation with a high concentration of DETCA (3 mM; followed by washout). This 
had no effect on basal nitric oxide activity but resulted in blockade of ACh-induced 
relaxation which was likely to be due to intracellular destruction of nitric oxide by 
superoxide anion. An examination was made of the ability of the SOD mimetics to 
reverse this inhibition of ACh-induced relaxation. In these experiments, after 
incubation and washout of DETCA (3 mM; 60 min) and induction of submaximal PE 
(30 -  300 nM) tone, PTIYO (10 pM), tempol (0.1 mM), tiron (1 mM), CUSO4 (1 p 
M), CuDIPS (1 pM), MnCE (100 pM) or MnTMPyP (600 pM and 1 mM) were 
added 20 min before the generation of concentration response curves to ACh (10 iiM 
-  3 pM),
All experiments involving DETCA or XO/HX were conducted in the presence of 
catalase (1000 u ml'*) to prevent the accumulation of hydrogen peroxide.
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4.3 RESULTS
4.3.1 Effects of superoxide dismutase mimetics on acetylclioline-iuduced 
relaxation
Before examining the ability o f the SOD mimetics to protect nitric oxide under 
conditions of oxidant stress, experiments were conducted to determine if they had 
any effects by themselves on acetylcholine (ACh)-induced relaxation.
Following induction of phenylephrine (PE; 30 - 300 nM)-induced tone in 
endothelium-containing rings of rabbit aorta, exogenously applied Cu/Zn superoxide 
dismutase (SOD; 250 u ml"*) had no effect on ACh-induced relaxation (Chapter 2; 
Figure 2.12). As with SOD, treatment for 20 min with the superoxide dismutase 
(SOD) mimetics, tiron (1 - 30 mM), MnTMPyP (10 pM -  1 mM), or M11CI2 (1 - 100 
pM) failed to affect ACh (10 nM - 3 pM)-induced relaxation (Figures 4.2 and 4.4). 
Relaxation was, however, impaired slightly following treatment with tempol at 3 mM 
but not at 0.1 or 1 mM (Figure 4.2) and to a greater extent by PTIYO at 300 pM but 
not at 10 or 100 pM (Figure 4.1). Both CuDIPS and CuSO^ caused a significant 
impairment of relaxation at 10 and 100 pM but not at 1 pM (Figure 4.3). Thus, 
although some SOD mimetics have no detrimental action on ACh-induced 
relaxation, the ability of others to produce impairment of relaxation by themselves 
will clearly compromise their ability to protect nitric oxide in conditions of oxidant 
stress.
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FIGURE 4.1 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ ) on phenylephrine-contracted endothelium-containing rings of rabbit aorta 
and the effects of PTIYO at 10 (A ), 100 (T ) and 300 pM (#) on this relaxation. Each 
point is the mean ± s.e. mean of 5-11 observations. **=^P<0.001 indicates a 
significant difference from the relaxation induced by the maximal concentration of 
ACh in untreated rings.
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FIGURE 4.2 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ ) on phenylephrine-contracted endothelium-containing rings of rabbit aorta 
and the effects of (a) tempol 0.1 (A), 1 (▼) and 3 mM (®) and (b) tiron at 1 (A), 10 
(▼) and 30 niM (®) on this relaxation. Each point is the mean ± s.e. mean of 5-11 
observations. **"^P<0.001 indicates a significant difference from the relaxation 
induced by the maximal concentration of ACh in untreated rings.
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FIGURE 4.3 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ ) on phenylephrine-contracted endothelium-containing rings of rabbit aorta 
and the effects of (a) CUSO4 at 1 (A), 10 (T) and 100 pM (•) and (b) CuDIPS at 1 
(A), 10 (T) and 100 pM (•) on this relaxation. Each point is the mean ± s.e. mean of 
7-10 observations. ’*'**P<0.001 indicates a significant difference from the relaxation 
induced by the maximal concentration of ACh in untreated rings.
#
ÿj
-ïi
%
■Ï
1':
■.Î
:
Page 118
i
Protection o f nitric oxide.,. Chapter 4
20.
log [ACh] M
100m
80-
szo 60.
Ë
20.
•b'^ o ZÔ ^.5
log [ACh] M
FIGURE 4.4 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ )  on phenylephrine-contracted endothelium-containing rings of rabbit aorta 
and the effects of (a) MnCh at 1 (A), 10 (V) and 100 pM (®) and (b) MnTMPyP at 
10 (A) and 100 pM (▼) and 1 mM (®) on this relaxation. Each point is the mean ± 
s.e. mean of 5-12 observations.
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4.3.2 Ability of superoxide dismutase mimetics to inhibit the endothelium- 
dependent rise in tone induced by xanthine oxidase/hypoxanthine in 
diethyldithiocarbamate (0.3 mM)-treated tissues
In Chapter 2, evidence was provided that the augmentation of tone seen in 
endothelium-containing tissues upon addition of xanthine oxidase/hypoxanthine 
(XO/HX) was due to destruction of basal nitric oxide by superoxide anion. 
Exogenously applied authentic membrane-impermeant SOD prevented this 
augmentation (Chapter 2; Figures 2.6 and 2.7). This suggests that the destruction of 
nitric oxide occurred in the extracellular space. The ability of SOD mimetics to 
inhibit this augmentation was therefore examined as an additional means of assessing 
their SOD-like action.
As expected, the endothelium-dependent rise in PE (30 -  300 nM)-induced tone 
produced by XO (4.8 mu mE')/HX (0.1 hiM) in DETCA (0.3 mM, 60 min, washout)- 
treated tissues was inhibited by a 20 min pretreatment with SOD (250 u mf^; Figure 
4.5 - 4.8). It was also inhibited in a concentration-dependent manner by a 20 min 
pretreatment with PTIYO (10 - 300 pM), tempol (0.1 - 3mM), tiron (1 - 30 mM), 
CuDIPS ( 0 .1 -3  pM), CuS04 ( 0 .1 -3  pM), MnTMPyP (100 - 600 pM) and MnCh 
(1 - 100 pM) (Figures 4.5 - 4.8).
Thus, all of the SOD-mimetics were able to prevent the XO/HX-mediated 
augmentation of PE-induced tone. However, based upon these results alone it would 
be unwise to conclude that all of the SOD mimetics had indeed protected basal nitric 
oxide from destruction by superoxide anion. An alternative explanation needed to be
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FIGURE 4.5 The enhancement of phenylephrine (0.1 pM)-induced tone resulting 
from treatment with xanthine oxidase (4.8 mu m l'' )/hypoxanthine (0.1 mM) in 
endothelium-containing rings of rabbit incubated with diethyldithiocarbamate (0.3 
mM) (control) was abolished by pretreatment with superoxide dismutase (SOD; 250 
u ml'*), and inliibited in a concentration-dependent manner by PTIYO (10, 100 and 
300 pM) (filled columns). Experiments were conducted in the presence of catalase 
(1000 u ml'*) to prevent accumulation of hydrogen peroxide. Each column is the 
mean ± s.e. mean of 6 observations. =^*P<0.01 and *^*P<0.001 indicate significant 
differences from the change in tone of control tissues, respectively.
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FIGURE 4.6 The enhancement of phenylephrine (0.1 pM)-induced tone resulting 
from treatment with xanthine oxidase (4.8 mu ml"' )/hypoxanthine (0.1 mM) in 
endothelium-containing rings of rabbit incubated with diethyldithiocarbamate (0.3 
mM) (control) was abolished by pretreatment with superoxide dismutase (SOD; 250 
u ml"*), and inliibited in a concentration-dependent manner by (a) tempol (0 .1, 1 and 
3 mM) and (b) tiron (1, 10 and 30 mM) (filled columns). Experiments were 
conducted in the presence of catalase (1000 u inl'^) to prevent accumulation of 
hydrogen peroxide. Each column is the mean ± s.e. mean of 5-10 observations. 
***P<0.001 indicates a significant differences from the change in tone of control 
tissues.
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FIGURE 4.7 The enhancement of phenylephrine (0.1 pM)-induced tone resulting 
from treatment with xanthine oxidase (4.8 mu ml"^)/hypoxanthine (0.1 mM) in 
endothelium-containing rings of rabbit incubated with diethyldithiocarbamate (0.3 
mM) (control) was abolished by pretreatment with superoxide dismutase (SOD; 250 
u ml"^), and inhibited in a concentration-dependent mamier by (a) CUSO4 (0.3, 1 and 
3 pM) and (b) CuDIPS (0.3, 1 and 3 pM) (filled columns). Experiments were 
conducted in the presence of catalase (1000 u ml"*) to prevent accumulation of 
hydrogen peroxide. Each column is the mean ± s.e. mean of 5-10 observations. 
*P<0.05, ="'*P<0.01 and ***P<0.001 indicate significant differences from the change 
in tone of control tissues, respectively.
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FIGURE 4.8 The enhancement of phenyleplirine (0.1 pM)-induced tone resulting 
from treatment with xanthine oxidase (4.8 mu ml'*)/hypoxanthine (0.1 mM) in 
endothelium-containing rings of rabbit incubated with diethyldithiocarbamate (0.3 
mM) (control) was abolished by pretreatment with superoxide dismutase (SOD; 250 
u ml"*), and inhibited in a concentration-dependent manner by (a) MnCE (1 , 10  and 
100 pM) and (b) MnTMPyP (100, 300 and 600 pM) (filled columns). Experiments 
were conducted in the presence of catalase (1000 u ml"*) to prevent accumulation of 
hydrogen peroxide. Each column is the mean ± s.e. mean of 5-11 obsei'vations. 
=^*P<0.01 and ***P<0.001 indicate significant differences from the change in tone of 
control tissues, respectively.
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considered first, i.e. that the SOD mimetics had inactivated basal nitric oxide 
themselves and this action, and not removal of superoxide had led to blockade of the 
XO/HX-induced augmentation of tone. To test this possibility, each of the SOD 
mimetics was added to rings of rabbit aorta to determine if they affected the 
endothelium-dependent augmentation of PE-induced tone seen upon the addition of 
the inhibitor of nitric oxide synthase, L-NAME (100 pM). The augmentation of tone 
by L-NAME does not involve superoxide anion and would therefore be unaffected 
by an agent possessing SOD-like activity only. A single high concentration of each 
SOD mimetic was used in this section of the study.
The L-NAME (100 pM)-induced rise in tone of PE (0.1 pM)-contracted 
endothelium-containing rings was unaffected following treatment with exogenously 
applied authentic Cu/Zn SOD (Chapter 2; Figure 2.5a). As with SOD, the L-NAME- 
induced rise in tone was unaffected following a 20 min pretreatment with tiron (10 
mM), CuDIPS (3 pM), CuSO^ (3 pM) or MnCl2 (100 pM) (Figure 4.9). In contrast, 
the rise in tone was impaired by around 50 % following treatment with PTIYO (100 
pM) and tempol (3 mM), and by around 25 % by MnTMPyP (100 pM).
Thus, CuDIPS, CUSO4 and MnCE do not appear to impair basal nitric oxide activity 
and their ability to inhibit the augmentation of PE-induced tone produced by XO/HX 
probably reflects their activity in removing superoxide anion. For PTIYO, tempol 
and to a lesser extent MnTMPyP, a major component of their ability to impair the 
augmentation of PE-induced tone will have resulted from inhibition of the action of 
basal nitric oxide, with the remainder occurring from the scavenging of superoxide.
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FIGURE 4.9 The enhancement of phenylephrine (0.1 pM)-induced tone resulting 
from treatment with L-NAME (100 pM; control) in endothelium-containing rings of 
rabbit aorta was impaired by treatment with (a) PTIYO (100 pM) and tempol (3 
mM) but not tiron (3 mM) and (b) MnTMPyP (100 pM) but not CUSO4 (3 pM), 
CuDIPS (3 pM) or MnCb (100 pM). Each column is the mean ± s.e. mean of 6-12 
observations. *P<0.05, **P<0.01 and **P<0.001 indicate significant differences 
from the change in tone of control tissues, respectively.
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4.3.3 Ability of superoxide dismutase mimetics to protect acetylcholine- 
induced relaxation from blockade by xanthine oxidase/hypoxanthine in 
diethyldithiocarbamate (0.3 mM)-treated tissues
The blockade of ACh-induced relaxation seen with by xanthine oxidase (XO; 4.8 mu 
ml"^)/hypoxanthine (HX; 0.1 mM) in DETCA (0.3 mM, 60 min, washout)-treated 
tissues was completely prevented by pretreatment with authentic SOD (250 u ml"*)
(Chapter 2; Figure 2.17). The blockade was also prevented, in a concentration- 
dependent manner, by a 20 min pretreatment with MnTMPyP (100 - 600 pM) and 
MnCl] (1 “ 100 pM) (Figure 4.13). Substantial prevention of blockade was also 
observed following pretreatment with CuDIPS at 1 and 3 pM, but not at 0.1 mM, and 
with C11SO4 (0.3 - 3 pM) (Figure 4.12). There was, however, a tendency for both of 
these, at the highest concentration used (3 pM), to be less effective at concentrations 
of ACh of 1 pM and above. Weak prevention of blockade of ACh-induced relaxation 
was observed following pretreatment with tiron at 1 mM but none was seen at 0.3 or 
10 mM (Figure 4.11). Tempol produced weak prevention of blockade at 0.1 mM but 
none was seen at 30 pM or 1 mM (Figure 4.11). No reversal of blockade was 
observed, however, following pretreatment with PTIYO at 10 and 100 pM, and at 
300 pM the blockade was intensified (Figure 4.10).
Thus, the metal-based SOD mimetics seem more effective than the spin traps in 
protecting nitric oxide from destruction by this extracellular oxidant stress.
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FIGURE 4.10 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ ) on phenylephrine-contracted endothelium-containing rings of rabbit aorta 
and the blockade of this relaxation following combined treatment with 
diethyldithiocarbamate (0.3 mM, 60 min, washout) and xanthine oxidase (4.8 mu ml' 
^)/hypoxanthine (0.1 mM) (O). The effects of 20 min pretreatment with PTIYO at 
10 (A), 100 (T) and 300 pM (#) on this blockade are also shown. Experiments were 
conducted in the presence of catalase (1000 u ml'*) to prevent accumulation of 
hydrogen peroxide. Each point is the mean ± s.e. mean of 6-12 observations. 
###P<0.001 indicates that the SOD mimetic had a significant effect on the relaxation 
induced by the maximal concentration of ACh in rings treated with 
diethyldithiocarbamate and xanthine oxidase/ hypoxanthine.
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FIGURE 4.11 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ )  on phenylephrine-contracted endothelium-containing rings of rabbit aorta 
and the blockade of this relaxation following combined treatment with 
diethyldithioearbamate (0.3 mM, 60 min, washout) and xanthine oxidase (4.8 mu ml' 
^hypoxanthine (0.1 mM) (O ). The effects of a 20 min pretreatment with (a) tempol 
at 30 pM (A), 0.1 (▼) and 1 mM (#) and (b) tiron at 0.3 (A), 1 (T) and 10 niM (#) on 
this blockade are also shown. Experiments were conducted in the presence of 
catalase (1000 u ml"^) to prevent accumulation of hydrogen peroxide. Each point is 
the mean ± s.e. mean of 5-15 observations. #P<0.05 and ##P<0.01 indicate that the 
SOD mimetic had a significant effect on the relaxation induced by the maximal 
concentration of ACh in rings treated with diethyldithiocarbamate and xanthine 
oxidase/ hypoxanthine.
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FIGURE 4.12 Concentration-response curves showing relaxation to acetylcholine 
(ACh, O) on phenylephrine-contracted endothelium-containing rings of rabbit aorta 
and the blockade of this relaxation following combined treatment with 
diethyldithiocarbamate (0.3 mM, 60 min, washout) and xanthine oxidase (4.8 mu ml" 
^)/hypoxanthine (0.1 mM) (O ). The effects of a 20 min pretreatment with (a) CUSO4 
at 0.3 (A ), 1 (V) and 3 pM (#) and (b ) CuDIPS at 0.1 (A ), 1 (V ) and 3 pM (») on this 
blockade are also shown. Experiments were conducted in the presence of catalase 
(1000 u ml"') to prevent accumulation of hydrogen peroxide. Each point is the mean 
± s.e. mean of 5-15 observations. #?<0.05 and ###P<0.001 indicate that the SOD 
mimetic had a significant effect on the relaxation induced by the maximal 
concentration of ACh in rings treated with diethyldithiocarbamate and xanthine 
oxidase/ hypoxanthine.
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FIGURE 4.13 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ )  on phenylephrine-contracted endothelium-containing rings of rabbit aorta 
and the blockade of this relaxation following combined treatment with 
diethyldithiocarbamate (0.3 mM, 60 min, washout) and xanthine oxidase (4.8 mu m f 
^)/hypoxanthine (0.1 mM) (O ). The effects of a 20 min pretreatment with (a) MnCb 
at 1 (A), 10 (T) and 100 pM (#) and (b) MnTMPyP at 100 (A), 300 (▼) and 600 pM 
(•) on this blockade are also shown. Experiments were conducted in the presence of 
catalase (1000 u ml'^) to prevent accumulation of hydrogen peroxide. Each point is 
the mean ± s.e. mean of 5-15 observations. #P<0.05, ##P<0.01 and ###P<0.001 
indicate that the SOD mimetic had a significant effect on the relaxation induced by 
the maximal concentration of ACh in rings treated with diethyldithiocarbamate and 
xanthine oxidase/ hypoxanthine.
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4.3.4 Effects of superoxide dismutase mimetics on acetylcholine-induced 
relaxation in diethyldithiocarbamate (3 mM)-treated tissues
The blockade of ACh-induced relaxation resulting from treatment with a high 
concentration of DETCA (3 mM) alone is unaffected by treatment with membrane- 
impermeant exogenous SOD (250 u mf ' )  (Chapter 2; Figure 2.12). This blockade 
may therefore result from the inactivation of endogenous intracellular Cu/Zn SOD 
leading to an increase in the background levels of superoxide which in turn would 
destroy nitric oxide inside cells, i.e. it is likely therefore that DETCA exerts an 
intracellular oxidant stress. If this is indeed the case, then, in contrast to the 
ineffectiveness of SOD itself, the membrane-permeant SOD mimetics would be 
expected to reverse this blockade. Consequently, experiments were designed to test 
this possibility. The concentrations of the SOD mimetics used in this section of the 
study were those which proved most effective at reversing the blockade induced by 
the extracellular oxidant stress (or for PTIYO, the highest concentration that did not 
enhance the blockade induced by the extracellular oxidant stress).
The blockade of ACh (10 nM -  3 pM)-induced relaxation resulting from treatment 
with DETCA (3 mM; 60 min; washout) was not reversed to any degree by treatment 
for 20 min with PTIYO (10 pM), tempol (0.1 mM) or tiron (1 mM) (Figuie 4.14) or 
with CuDIPS or CuSO^ (both at 1 pM; Figure 4.15). In fact, treatment with PTIYO 
and CuDIPS actually enhanced the blockade seen. In contrast, significant, although 
incomplete reversal of blockade was observed following treatment with MnTMPyP 
(600 pM and 1 mM) and with MnCl2 (100 pM) (Figure 4.16).
Thus, a major component of the actions of DETCA is likely to result from inhibition 
of intracellular Cu/Zn SOD, with the remainder perhaps reflecting non-selective 
effects of DETCA.
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FIGURE 4.14 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ ) on phenylephrine-contracted endothelium-containing rings of rabbit aorta 
and the blockade of this relaxation following treatment with diethyldithiocarbamate 
(3 niM; 60 min; washout; O ). The effects of PTIYO (10 pM; A), tempol (0.1 mM; 
T) and tiron (1 mM; e) on this blockade are also shown. Experiments were 
conducted in the presence of catalase (1000 u ml“‘) to prevent accumulation of 
hydrogen peroxide. Each point is the mean ± s.e. mean of 5-15 observations. 
###P<0.001 indicates that the SOD mimetic had a significant effect on the relaxation 
induced by the maximal concentration of ACh in diethyldithiocai'bamate-treated 
rings.
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FIGURE 4.15 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ ) on phenylephrine-contracted endothelium-containing rings of rabbit aorta 
and the blockade of this relaxation following treatment with diethyldithiocarbamate 
(3 mM; 60 min; washout; O ). The effects of CUSO4 (1 pM; A) and CuDIPS (1 pM; 
V ) on this blockade are also shown. Experiments were conducted in the presence of 
catalase (1000 u mf^) to prevent accumulation of hydrogen peroxide. Each point is 
the mean ± s.e. mean of 5-11 observations. ##P<0.01 indicates that the SOD mimetic 
had a significant effect on the relaxation induced by the maximal concentration of 
ACh in diethyldithiocarbamate-treated rings.
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FIGURE 4.16 Concentration-response cui'ves showing relaxation to acetylcholine 
(ACh, □ )  on phenylephrine-contracted endothelium-containing rings of rabbit aorta 
and the blockade of this relaxation following treatment with diethyldithiocaibamate 
(3 mM; 60 min; washout; O ). The effects of MnTMPyP at 100 pM (A), 600 pM (T) 
and ImM (•) and MnCC at 100 pM (a) on this blockade are also shown. 
Experiments were conducted in the presence of catalase (1000 u mf^) to prevent 
accumulation of hydrogen peroxide. Each point is the mean ± s.e. mean of 5-15 
observations. ##P<0.01 and ###P<0.001 indicate that the SOD mimetic had a 
significant effect on the relaxation induced by the maximal concentration of ACh in 
diethyldithiocarbamate-treated rings, respectively.
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4.4 DISCUSSION
The vital vasodepressor role played by endothelium-derived nitric oxide is impaired 
following its destruction by superoxide anion (Gryglewski et n/., 1986; Rubanyi &
Vanhoutte, 1986b; Kaustic & Vanhoutte, 1989; Ohlstein & Nichols, 1989, Mian &
Martin, 1995a). The enhanced destruction of nitric oxide by superoxide anion forms 
a common defect in a number of pathological conditions including diabetes (Hattori 
et al, 1991; Kamata & Kobayashi, 1996), hypertension (Nakazono et al, 1991;
Grunfeld et al, 1995; Bouloumie et al, 1997), ischaemia-reperfusion injury 
(Downey, 1990), heart failure (McMurray et al, 1990; Katz et al., 1993) and 
atherosclerosis (Sharma et al., 1992; Ohara et al, 1993). Nitric oxide is protected 
from destruction, however, by the endogenous scavenger of superoxide anion, 
superoxide dismutase (SOD). Three isoform of SOD are expressed in eukaryotic 
cells: an Cu/Zn containing form found both in the intracellular and extracellular 
space; and a Mn containing form found in the mitochondria (see Fridovich, 1989).
Results from Chapter 2 confirmed the findings of others by showing that inliibition 
of both the intracellular' and extracellular isoforms of Cu/Zn SOD, using the copper 
chelator diethyldithiocarbamate (DETCA), leads to loss of nitric oxide activity in the 
vasculature (Cherry et al, 1990; Mügge et al, 1991a; Omar et a l, 1991; Mian &
Martin, 1995a). Such findings demonstrate that Cu/Zn SOD provides a vital role in 
protecting endothelium-derived nitric oxide from destruction by superoxide anion. In 
view of this vital protective role of Cu/Zn SOD, it seems, logical in pathologies 
associated with oxidant stress to attempt to restore impaired nitric oxide function by /
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augmenting superoxide anion scavenging activity. SOD itself, however, is likely to 
be of limited therapeutic potential because it cannot enter cells to protect nitric oxide 
intracellularly. Greater therapeutic potential lies therefore in the development of low 
molecular weight, membrane-permeant SOD mimetics. A number of structurally 
distinct classes of SOD mimetic have been described including the spin traps PTIYO, 
tempol, and tiron, and the metal-based agents CUSO4, CuDIPS, MnCfi and 
MnTMPyP.
As described in Chapter 2, two distinct models of oxidant stress were generated in 
isolated rings of rabbit aorta in an attempt to mimic the impaired endothelium- 
dependent relaxation associated with many vascular diseases. One model, involving 
treatment with a low concentration of the inhibitor of endogenous SOD, DETCA (0.3 
mM), together with the extracellular generation of superoxide by xanthine 
oxidase/hypoxanthine (XO/HX), resulted in impairment both of basal and 
acetylcholine (ACh)-induced activity of nitric oxide. This impairment could be 
prevented by exogenous application of authentic membrane-impermeant SOD and is, 
therefore, likely to be due to extracellular destruction of nitric oxide by superoxide 
anion. The second model, involving treatment with a high concentration of DETCA 
(3 mM) alone, resulted in an impairment of ACh-induced nitric oxide activity which 
was not reversed by application of SOD and, therefore, is likely to involve 
intracellular destruction of nitric oxide by superoxide anion.
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The aim of this section of the study was to assay the efficacy of the putative SOD 
mimetics to restore nitric oxide dependent relaxation in isolated rings of rabbit aorta 
following inhibition by extracellular and intracellular oxidant stress.
4.4.1 Actions of non metal-based superoxide dismutase mimetics
Despite possessing SOD-like activity in biochemical assays (Chapter 3), the spin 
trap, PTIYO failed to restore convincingly ACh-induced relaxation following its 
inhibition by either the extracellular (DETCA 0.3 mM and XO/HX) or the 
intracellular (DETCA 3mM) oxidant stress. In fact, PTIYO actually intensified the 
blockade in both conditions. Tempol (0.1 mM), however, produced a weak reversal 
of ACh-induced relaxation following its inactivation by the extracellular oxidant 
stress. Nevertheless, both agents did prevent the superoxide-mediated enhancement 
of tone in endothelium-containing tissues consistent with protection of basal nitric 
oxide activity. This action, however, was found to be due in part to the inactivation 
of basal nitric oxide activity since the augmentation of tone induced by the inhibitor 
of nitric oxide synthase, N'^-nitro-L-arginine methyl ester (L-NAME), was impaired. 
Furthermore, both agents impaired ACh-induced relaxation by themselves.
The inability of these stable nitroxides to restore relaxation in conditions of oxidant 
stress is presumably related to the demonstrated ability of this class of agent to 
inliibit the activity of nitric oxide by a direct chemical reaction (Akaike et al, 1993). 
Considering that spin traps bind free radicals and that nitric oxide itself is a free 
radical then this is perhaps not too surprising. The reaction, as described by Akaike
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et al (1993), is that stable nitroxides (R-N-O; where R symbolises the rest of 
molecule) can react with nitric oxide (NO) to produce nitrogen dioxide (NO2) (Step
1) which can then form, via a reaction with water (H2O), nitrite (NO2 ) and nitrate
(NO3 ) and the hydrogen ion (H^) (Step 2).
Step 1; R-N-O + NO —> R-N + NO2
H2O
Step 2: 2NO2 <-> N2O4 —> NO2 + NO] + 2H
Stable nitroxides are known to scavenge nitric oxide with different degrees of 
potency (Akaike et al, 1993). Indeed, in our study PTIYO was considerably more 
potent than tempo! in its ability to impair both basal and ACh-induced nitric oxide 
activity. PTIYO thus appears to have a stronger affinity for nitric oxide than tempo!. 
On the other hand, tempo!, appears to have a greater affinity than PTIYO for 
superoxide anion since it produced a partial recovery of ACh-induced relaxation. It 
would appear, therefore, to have a greater affinity with superoxide anion than nitric 
oxide. In fact, tempo! proved to be a more effective scavenger of superoxide than 
PTIYO in the two independent biochemical assays (Chapter 3).
Overall, in addition to their ability to scavenge superoxide, stable nitroxides also 
react with nitric oxide and impair the ability of the endothelium to cause relaxation. 
It is therefore unlikely that this class of SOD mimetic could be developed as 
therapeutic agents with which to restore nitric oxide-dependent relaxation in 
pathologies associated with oxidant stress.
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The superoxide anion scavenger, tiron, provided only weak protection to ACh- 
induced relaxation against the blockade induced by an extracellular oxidant stress, 
and was ineffective against the intracellular stress. Tiron did, however, fully protect 
basal nitric oxide against the extracellular oxidant stress. Despite tiron demonstrating 
poor SOD-like action against oxidant stress, it had no inhibitory effect on basal or 
ACh-induced nitric oxide activity in control preparations even when used at 
concentrations up to 30 mM. Therefore, unlike the stable nitroxides which inactivate 
nitric oxide, spin traps like tiron have potential to be developed into an effective 
therapeutic agent.
4.4.2 Actions of copper-based superoxide dism utase m imetics
The copper-based agents, CUSO4 and CuDIPS, both powerfully protected basal and 
ACh-induced nitric oxide activity, in a concentration-dependent manner, against 
inhibition by the extracellular (DETCA 0.3 mM and XO/HX) oxidant stress. Neither 
agent, however, restored nitric oxide-dependent relaxation following its inactivation 
by the intracellular (DETCA 3mM) oxidant stress. In light of their effective SOD- 
like actions against the extracellular oxidant stress, the inability to restore relaxation 
in the intracellular oxidant stress probably reflects the inability of these agents to 
penetrate cell membranes in this tissue. CUSO4 has, however, previously been 
reported to restore endothelium-dependent and nitrovasodilator-mediated relaxation 
following inliibition by DETCA in rat aorta (Plane et al., 1997). We found no such
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restoration in rabbit aorta, however, perhaps reflecting a reduced ability of copper 
ions to enter cells in this tissue.
Neither CUSO4 or CuDIPS impaired ACh-induced or basal activity of nitric oxide 
when used at low concentrations ( 1 - 3  pM). However, at higher concentrations (10 - 
100 pM) both agents powerfully impaired ACh-induced relaxation; the effect of the 
higher concentrations was not investigated on basal nitric oxide activity. Inliibition of 
relaxation by these copper-based agents may occur by at least two pathways. One 
pathway derives from the finding that CuDIPS directly inactivates nitric oxide 
synthase and therefore inhibits nitric oxide production (Baquial & Sorenson; 1995). 
Specifically, according to these authors, CuDIPS acts as an electron acceptor and 
disrupts the five-electron oxidation of the guanidino nitrogen atom of L-arginine 
during the formation nitric oxide. The second pathway derives from the basis that 
both CUSO4 and CuDIPS can form a highly reactive oxidant, hydroxyl radical, which 
could potentially impair relaxation (Halliwell & Gutteridge, 1989). Both CUSO4 
(existing in an ionic complex) and CuDIPS (existing in weak co-ordination complex; 
Huber et al., 1987) will generate free copper ions in solution. Free copper can lead to 
the generation of hydroxyl radical by a process known as the superoxide-assisted 
Fenton reaction or the copper-catalysed Haber-Weiss reaction. Here, free native
copper (Cu^^) is reduced by superoxide anion (O2 ) to Cu^ (Step 1). The reduced 
copper is then oxidised by hydrogen peroxide (H2O2) to form hydroxyl radical (OH*) 
and hydroxide anion (OH ) (Step 2). (Halliwell & Gutteridge, 1989).
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Step 1: + O2 -> Cu'’ + O2
Step 2: CW + H2O2 —> + 0H° + OH
Net: O2 + H2O2 -> OH* + OH' + O2
Hydroxyl radical can react with virtually all biological molecules and may initiate a 
propagating chain of reactions that can lead to lipid peroxidation, DNA alteration and 
damage to vital proteins (Marin & Rodriguez-Martinez, 1997 and see Chapter 1 
Section 1.2.4). The potential production of such a highly reactive agent by CUSO4 or 
CuDIPS may contribute to the impaired relaxant ability of ACh. Indeed, this could 
have been investigated using hydroxyl radical scavengers such as mannitoi or 
dimethyl sulfoxide. The greater potency of CuDIPS than CUSO4 to impair ACh- 
induced relaxation, perhaps reflects the ability of the former agent to be involved in 
both of the above described pathways.
The concentration-dependent SOD-like effects of CUSO4 and CuDIPS described in 
this chapter are almost identical. Since both complexes will generate free copper ions 
in solution, it is possible that it is the free copper, rather than the CUSO4 and CuDIPS 
complexes per se, that accounts for the SOD-like actions. Compounds that lead to 
elevation of free copper ions in vivo are likely to be too toxic to be considered as 
therapeutic agents.
Page 142
Page 143
■!y
Protection of nitric oxide... Chapter 4
4.4.3 Actions of manganese-based superoxide dismutase mimetics
The manganese-based agents, MnCh and MnTMPyP, both fully protected ACh- 
induced activity of nitric oxide from destruction by the extracellular oxidant stress 
(DETCA 0.3 mM and XO/HX). A major finding of this study, however, is that, in 
sharp contrast to the effects of authentic SOD or the other SOD mimetics 
investigated, both MnCE and MnTMPyP reversed the inhibition of ACh-induced 
relaxation generated by the intracellular oxidant stress i.e. treatment with a high 
concentration of DETCA (3 mM) alone. Neither agent, however, fully reversed this 
DETCA-induced inhibition; MnTMPyP produced no greater restoration when used at 
1 mM than at 600 pM, while MnCl] precipitation in Krebs solution limited its use to 
concentrations of 100 pM or less. Thus, a major component of the actions of DETCA 
(3 mM) is likely to result from inhibition of intracellular Cu/Zn SOD, with a lesser 
component reflecting non-selective effects of DETCA, such as depletion of 
intracellular glutathione and generation of lipid peroxides (Kelner et al, 1989), In 
view of the membrane permeance of MnTMPyP (Faullcner et al, 1994; Gardner el 
al, 1996) it may not be surprising that this agent can reverse the effects of inhibition 
of intracellular Cu/Zn SOD. In contrast, manganese ions resulting from addition of 
MnCl] would not be expected to cross cell membranes readily to relieve an 
intracellular oxidant stress. It is possible, however, that this ion gained entry to cells 
through non-selective divalent cation channels (Fasolato et a i,  1993; Somasundaram 
& Mahaut-Smith, 1994).
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The potency of MnCb in protecting nitric oxide-dependent relaxation against both an 
extracellular and intracellular oxidant stress was considerably greater than for 
MnTMPyP. This may be related to the valency state of native MnCl] with respect to 
MnTMPyP, i.e. Mn(II)Cl2 and Mn(III)TMPyP. As was demonstrated by Faullmer et 
al. (1994), the rate constant for removal of superoxide anion by MnTMPyP was 
substantially different depending on the valency state of the metal i.e. the Mn(II) 
form was 100 fold more active than the native Mn(III) form (rate constants of 4 x 10  ^
M"' S"‘ and 3.9 x 10  ^ M'* S'*, respectively). Reduction of the native state of 
Mn(III)TMPyP to the more active Mn(II)TMPyP form by the superoxide dismutation 
process is relatively slow but can proceed faster, at least in E. coli, by reduction at 
the hand of cellular elements such as NADPH and glutathione (Faulkner et al,
1994). This is likely to explain the reportedly greater superoxide removing potency 
of MnTMPyP in E. coli than in in vitro biochemical studies (Faulkner et ai, 1994). 
The higher affinity of Mn(II) over Mn(III) for superoxide anion may therefore 
explain the greater potency of Mn(II)Cl2 than of Mn(III)TMPyP in restoring ACh- 
induced relaxation following its inhibition by both extracellular and intracellular 
oxidant stress. SOD mimetics based on a Mn(II) metal centre may therefore have 
greater therapeutic potential than those based on the Mn(III) form. The simple metal 
salt, MnCl], is, however, too toxic to be considered as a potential therapeutic agent. 
High levels of free manganese have been linked to decreases in brain dopamine 
levels leading to Parkinson’s disease-like symptoms (Halliwell & Gutteridge, 1989).
As expected for SOD mimetics, both MnCk and MnTMPyP prevented the 
superoxide-mediated enhancement of tone in endothelium-containing rings induced
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by the extracellular oxidant stress. For MnTMPyP, this action, however, was found 
to be due in part to the inactivation of basal nitric oxide activity rather than to the 
scavenging of superoxide anion. Surprisingly, the concentration of MnTMPyP (100 
qM) that impaired basal nitric oxide activity had no effect on ACh-induced 
relaxation. An explanation for this is not instinctively obvious and a more detailed 
examination of the actions of MnTMPyP on basal activity of nitric oxide is detailed 
in the next chapter.
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5.1 INTRODUCTION
In Chapter 4, a series of structurally distinct superoxide dismutase (SOD) mimetics 
was assayed for the ability to protect endothelium-derived nitric oxide from 
destruction by superoxide anion. Amongst these compounds, we found that two, i.e. 
Mn [III] tetrakis [l-methyl-4-pyridyl] porphyrin (MnTMPyP; Faullmer et al., 1994; 
Gardner et al., 1996) and the metal salt, M nCf (Huber et al., 1987; Beyer & 
Fridovich, 1990), were unique in that they were able to restore acetylcholine (ACh)- 
induced relaxation in rings of rabbit aorta following inhibition with an extracellular 
(treatment with the inactivator o f Cu/Zn SOD diethyldithiocarbamate, DETCA 0.3 
mM, together with the superoxide generating system xanthine oxidase/hypoxanthine) 
and an intracellular (DETCA 3mM alone) oxidant stress. Moreover, the ability of 
these compounds to restore ACh-induced relaxation by an intracellular oxidant stress 
was not shared with authentic, membrane-impermeant SOD. These compounds 
could, therefore, provide a lead in the development of agents with greater therapeutic 
potential than SOD itself in the treatment of pathologies associated with oxidant 
stress. Surprisingly, one of these, i.e. MnTMPyP appeared to inhibit basal but not 
ACh-induced, activity of nitric oxide in rabbit aorta. This ability to inhibit basal 
nitric oxide activity was completely unexpected since previous work in rat aorta 
showed that authentic SOD (Ohlstein & Nichols, 1989; Mian & Martin, 1995a) and 
certain Mn-based SOD mimetics, i.e. the porphyrinic compound SC50268 (Kasten et 
al., 1995) and MnCE (Kasten et al., 1994) actually produced endothelium-dependent
Page 146
Manganese based,.. Chapter 5
relaxation by protecting basal nitric oxide from destruction by superoxide anion. 
These relaxant actions are believed to result from protection of basal nitric oxide 
from destruction by endogenous superoxide.
The aim of this section of the study was to explore further the effects of MnTMPyP 
on basal activity of nitric oxide. These experiments were conducted on rat aorta since 
it exhibits much greater basal activity of nitric oxide that rabbit aorta (Martin et al., 
1986a and see Chapter 2). The effects of authentic SOD and MnCl] on basal activity 
of nitric oxide were also studied for comparison with MnTMPyP on this tissue.
5.2 METHODS
5.2.1 P repara tio n  of tissues
Methods for preparation of aortic rings from female Wistar rat (200 -  250 g) for 
tension recording are identical to those detailed for rabbit aorta in Chapter 2 with the 
exceptions that: rats were killed by stumiing and exanguation; all tissues were used 
fresh on the day of preparation; when removing the endothelium, the aortic ring was 
weighted with a 1 g rather than 2 g weight; and aortic rings were mounted under 1 g 
rather than 2 g resting tension within tissue baths.
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5.2.2 Assessment of effects of superoxide dismutase, MnCIa and MnTMPyP on 
basal nitric oxide activity
The effects of authentic superoxide dismutase (SOD) and the SOD mimetics, 
MnTMPyP and MnCl], on basal nitric oxide activity were examined in rat aortic 
rings. This was achieved by constructing cumulative concentration-response curves 
to SOD (0.1 - 300 u ml"'), MnTMPyP (10 nM - 300 nM) or M nClj (10 nM - 100 
fj.M) on endothelium-containing rings following induction of submaximal (40 -  50 % 
of maximal) PE (0.1 - 0.3 pM)-induced tone: enhancement of basal activity was 
assessed as a fall in tone and inhibition as an augmentation of tone. The effects of 
prior inhibition of nitric oxide synthase with N^-nitro-L-arginine methyl ester (L- 
NAME, 100 pM) or of endothelial removal were examined on responses to SOD,
MnTMPyP and MnCl]. In addition, the effects of pretreatment with SOD (250 u ml"
*) and the scavenger of hydrogen peroxide, catalase (1000 u ml'*), were also 
examined on MnTMPyP-induced changes in tone.
5.2.3 Assessment of effects of M nTM PyP on acetyleholine-mdnced relaxation
The effects of MnTMPyP were also examined on acetylcholine (ACh)-induced 
relaxation. In order to achieve this, cumulative concentration-response curves to ACh 
(10 nM - 3 pM) were constructed on endothelium-containing rings of rat aorta 
following a 20 min pretreatment with MnTMPyP (3 and 300 pM). The relaxation 
obtained was compared with that of control rings. As will be seen from the Results, 
MnTMPyP produced an endothelium-dependent rise in PE-induced tone in rat aortic
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rings. Therefore when MnTMPyP was employed, the concentration of PE was 
reduced such that the level of tone obtained was similar to that of control rings.
5.2.4 Presentation of data
The ability of authentic SOD, MnCE and MnTMPyP to affect basal activity of nitric 
oxide on rat aortic rings was expressed as a percentage (%) change in the pre­
existing level of PE-induced tone. Results are expressed as the mean ± s.e. mean of n 
separate experiments. Statistical comparisons were made by one-way analysis of 
variance followed by the Bonferroni post-test. A value of P<0.05 was considered 
significant. Concentration-response curves and statistical analyse were performed 
using a computer-based programme (Graph Pad, Prism).
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5.3 RESULTS
5.3.1 Effects of superoxide dismutase, MnCI] and MnTMPyP on 
phenylephrine-induced tone on rat aorta
Following induction of submaximal tone with phenyleplu'ine (PE, 0.1 - 0.3 pM) in 
endothelium-containing rings of rat aorta, authentic Cu/Zn superoxide dismutase 
(SOD, 0.1 - 300 u ml’*) and MnCl2 (10 nM - 100 pM) each produced concentration- 
dependent relaxation (Figures 5.1 and 5.2). If relaxation was mediated by nitric oxide 
then it would be expected to be blocked by inliibition of nitric oxide synthase or 
endothelial denudation. Indeed, pretreatment of endothelium-containing rings with 
N^^-nitro-L-arginine methyl ester (L-NAME, 100 pM) and endothelial denudation 
almost completely blocked SOD- and M nCf-induced relaxation. The relaxant 
effects of SOD and MnCb are, therefore, likely to have arisen from the scavenging 
of superoxide anion leading to enhanced activity of basal nitric oxide activity.
In contrast to the action of SOD and M nCf, the change in tone observed following 
treatment of endothelium-containing rings with MnTMPyP (10 iiM - 300 pM) 
comprised two components: an initial enhancement of PE-induced tone (from 10 nM 
- 30 pM, to a maximum of 156.6 ± 9.2 % of initial tone), followed by a relaxant 
component (from 100 - 300 pM, to a maximum relaxation of 28.8 ± 7.6 % of initial 
tone; Figure 5.3). Pretreatment with the L-NAME (100 pM) or endothelial removal 
abolished the enhancement of PE-induced tone seen with MnTMPyP (Figure 5.3; 
maximum levels attained were 113.7 ± 4.5 and 106.2 ± 4.7 % of initial tone.
Page 150
Manganese based... Chapter 5
(DCO 80.T3<DOZ5Y GO. 
‘ T  LU CL
c
'o 20-
T Tr T T T I
log [SOD] u ml
FIGURE 5.1 Concentration-response curves showing relaxation to authentic Cu/Zn 
superoxide dismutase (SOD, □ )  on phenylephrine (PE)-contracted endothelium- 
containing rings of rat aorta and the impairment of this relaxation following 
treatment with L-NAME (100 pM; A) or endothelial removal (V). Each point is the 
mean + s.e. mean of 8 observations. ***P<0.001 indicates a significant difference 
from the relaxation induced by the maximal concentration of SOD in untreated rings.
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FIGURE 5.2 Concentration-response curves showing relaxation to MnCl2 (□ ) on 
phenylephrine (PE)-contracted endothelium-containing rings of rat aorta and the 
impairment of this relaxation following treatment with L-NAME (100 pM; A) or 
endothelial removal (T). Each point is the mean ± s.e. mean of 5-14 observations. 
***P<0.001 indicates a significant difference from the relaxation induced by the 
maximal concentration of M nCf in untreated rings.
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respectively). Pretreatment for 20 min with SOD (250 u ml'*; Figure 5.3) also 
resulted in blockade of the MnTMPyP-induced enhancement of PE-induced tone: it 
produced a greater than 10-fold rightward shift in the concentration response curve 
but did not depress the maximum enhancement observed (137.6 ± 9.9 % of initial 
tone).
5.3.2 Effects of MnTM PyP on acetylcholine-induced relaxation In ra t aorta
From the section 5.3.1, MnTMPyP appears to inactivate basal nitric oxide by a 
superoxide-mediated action. MnTMPyP also impaired basal but not ACh-induced 
activity of nitric oxide in rabbit aorta (Chapter 4). The effects of MnTMPyP on ACh- 
induced relaxation in rat aorta were, therefore, assessed.
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The inhibition of the MnTMPyP-induced augmentation of the following endothelial 
denudation or treatment with L-NAME or SOD, suggests that it may be due to a 
superoxide-mediated destruction of basal nitric oxide.
The relaxant action of high concentrations of MnTMPyP (100 -  300 pM) was 
unaffected by endothelial removal or treatment with L-NAME (100 pM; Figure 5.3), 
suggesting that this relaxation does not involve nitric oxide. Furthermore, the 
relaxant actions of MnTMPyP in endothelium-containing or endothelium-denuded 
tissues was unaffected by pretreatment for 20 min with either SOD (250 u ml"') or, 
the scavenger of hydrogen peroxide, catalase (1000 u ml"'; Figure 5.4). The fail in 
tone is unlikely, therefore to be mediated by superoxide anion or hydrogen peroxide.
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ACh (10 nM - 3 pM) induced a concentration-dependent relaxation of rat 
endothelium-containing aortic rings following induction of submaximal PE-induced 
tone. Pretreatment for 20 min with MnTMPyP at 3 and 300 pM (concentrations of 
MnTMPyP that had maximal contractile and relaxant effects, respectively) had no 
effect on this relaxation (Figure 5.5).
Thus, in rat aorta, as with rabbit aorta, MnTMPyP inactivates basal but not ACh- 
induced activity of nitric oxide.
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FIGURE 5.3 Concentration-response curves showing changes in tone induced by 
MnTMPyP (□ ) on phenylephrine (PE)-contracted endothelium-containing rings of 
rat aorta and the effects of superoxide dismutase (250 u ml"'; • ) ,  L-NAME (100 pM; 
A) or endothelial removal (T) on these changes. Each point in the mean ± s.e. mean 
of 5 - 15 observations.
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FIGURE 5.4 Concentration-response curves showing changes in tone induced by 
MnTMPyP (□ ) on phenylephrine (PE)-contracted, endothelium-denuded rings of rat 
aorta and the effects of superoxide dismutase (250 u ml '; A) or catalase (1000 u ml"'; 
V) on these changes. Each point in the mean ± s.e. mean of 5 observations.
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FIGURE 5.5 Concentration-response curves showing relaxation to acetylcholine 
(ACh, □ ) on phenylephrine (PE)-eontraeted, endothelium-containing rings of rat 
aorta and the effects of MnTMPyP at 3 (A ) and 300 pM (T ) on this relaxation. Each 
point is the mean ± s.e. mean of 6-11 observations.
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5.4 DISCUSSION
The Mn-based SOD mimetics, MnTMPyP and MnCh, were able to restore agonist- 
stimulated nitric oxide-dependent vasodilator function following inhibition by 
oxidant stress in rabbit aorta and, therefore, may have therapeutic potential in 
pathologies associated with oxidant stress (Chapter 4). Surprisingly, MnTMPyP 
appeared to inhibit basal nitric oxide in rings of rabbit aorta. In an attempt to 
investigate this action further, the effects of MnTMPyP were compared with those of 
SOD and MnCU in rings of rat aorta where basal nitric oxide is much more 
developed (Martin ei al., 1986a and see Chapter 2), and therefore easier to study.
5.4.1 Superoxide dismutase and MiiCU potentiate basal nitric oxide activity on
ra t  ao rta
Exogenously applied authentic Cu/Zn SOD produced powerful concentration- 
dependent relaxations of endothelium-containing rings of rat aorta in confirmation of 
previous reports (Ohlstein & Nichols, 1989; Mian & Martin, 1995a). The relaxation 
was abolished by endothelial removal or treatment with L-NAME, an inhibitor of 
nitric oxide synthesis. It is therefore likely to have arisen from removal of superoxide 
anion, generated either within the tissue or in the oxygenated Krebs solution, which 
was continuously destroying some of the basally produced nitric oxide. MnCh, like 
authentic SOD, produced concentration-dependent relaxation of rat aortic rings and 
this too was abolished by treatment with the nitric oxide synthase inhibitor, L- 
NAME, or endothelial removal.
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Similar findings were reported by Kasten et al (1994) who showed additionally that 
MnCf-induced relaxation was associated with a rise in cyclic guanosine 
monophosphate levels in the tissue. They too concluded that this relaxation was 
likely to have oceurred as a consequence of protection of basal nitric oxide from 
destruction by superoxide anion.
Studies by Rubanyi & Vanhoutte (1986a) and Laight et al. (1998) reported that 
SOD-induced relaxation of endothelium-containing preparations of dog coronary 
artery and rat aorta, respectively, was impaired by pretreatment with catalase. This 
would suggest that the relaxation obtained is not completely due to potentiation of 
basal nitric oxide activity but also due to the SOD-mediated elevation of the end 
product of superoxide dismutation, i.e. hydrogen peroxide. Hydrogen peroxide has 
been reported to cause vasorelaxation by endothelium-dependent and -independent 
mechanisms (Furchgott, 1991; Zembowicz et al., 1993; Mian & Martin, 1995a; Mian 
& Martin, 1995b). Unpublished data from our laboratory has demonstrated, however, 
that catalase has no effect on SOD-induced relaxation in rat aorta and therefore rules 
out the involvement of hydrogen peroxide.
5.4.2 MnTM PyP inhibits basai but not agonist-stimulated nitric oxide activity 
on ra t aorta
In contrast to the actions of SOD and MnCl2, the SOD mimetic, MnTMPyP, induced 
a biphasic effect on PE-precontracted rings of rat aorta. This comprised an initial
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enhancement of PE-induced tone followed by a secondary relaxant component. The 
abolition of the initial enhancement of tone by treatment with L-NAME or by 
endothelial removal suggests that this results from destruction of the action of basal 
nitric oxide. Furthermore, as determined by its ability to impair the L-NAME- 
induced rise in PE-induced tone, MnTMPyP was also shown to impair the action of 
basal nitric oxide in rabbit aorta (Chapter 4; Figure 4.9).
Pretreatment with SOD also produced blockade of the MnTMPyP-induced 
enhancement of tone in rat aorta, although the characteristics of this were different 
from the simple inhibition by L-NAME and endothelium-denudation. In this case, 
the MnTMPyP concentration-response curve was shifted to the right by greater than 
10-fold, although SOD did not depress the maximum enhancement of tone obtained. 
Quite paradoxically, therefore, the destruction of basal nitric oxide induced by 
MnTMPyP, a putative SOD mimetic, would appear to be due to generation of 
superoxide anion. The parallel shift suggests that in the presence of SOD, higher 
concentrations of MnTMPyP can still produce sufficient superoxide to destroy basal 
nitric oxide. On the basis that the high molecular weight of SOD prevents its entry 
into cells it is likely that the superoxide-mediated destruction of basal nitric oxide 
produced by MnTMPyP occurs largely in the extracellular space. An alternative 
explanation, however, is that higher concentrations of MnTMPyP may penetrate cells 
to generate superoxide and thereby inactivate basal nitric oxide intracellularly, where 
exogenously applied SOD is not active.
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If, indeed, MnTMPyP destroys basal nitric oxide by producing superoxide anion then 
it would be expected that this compound would similarly impair agonist-induced 
nitric oxide-dependent relaxation. This, however, was not the case. When used at 
concentrations that impaired the action of basal nitric oxide both in rabbit and rat 
aorta, MnTMPyP had no effect on ACh-induced relaxation in either tissue (Chapter 4 
and this chapter). There is, therefore, a clear difference in the susceptibly of basal 
and agonist-stimulated activity of nitric oxide to destruction by MnTMPyP-generated 
superoxide anion. This could suggest that the agonist-stimulated endothelium- 
derived relaxing factor (EDRF) is not nitric oxide per se but a different, superoxide 
anion resistant compound. Indeed, some workers have proposed that basal EDRF is 
free nitric oxide, while that released in response to agonists comes from a pre-formed 
store (Ignarro, 1991; Cocks & Angus, 1991) of a stable nitric oxide-releasing 
molecule such as an S-nitrosothiol (Myres et al., 1990). However, this explanation 
seems unlikely since there is overwhelming evidence that agonist-stimulated 
EDRF/nitric oxide is indeed susceptible to destruction by superoxide anion 
(Gryglewski et al., 1986; Rubanyi & Vanhoutte, 1986b; Moncada et al., 1986; 
Ohlstein & Nichols, 1989; Lawson et al., 1990; Furchgott et al., 1994; Mian & 
Martin, 1995a; this study).
Thus, in contrast to its ability to protect ACh-induced relaxation from inactivation by 
an applied oxidant stress (Chapter 4), MnTMPyP paradoxically destroys basal nitric 
oxide tlu'ough the generation of superoxide anion. MnTMPyP, therefore, can be either 
a net scavenger or generator of superoxide anion. These dual effects maybe explained 
on the basis of differences in the prevailing redox environment (Gardner et al., 1996).
, Page 161
Manganese based... Chapter 5
Specifically, these authors found that MnTMPyP blocked the superoxide-dependent 
inhibition of growth of human lung carcinoma cells and murine fibrosarcoma cells 
seen following addition of the superoxide-generator phenezine pyocyanine. In 
contrast, MnTMPyP enlianced the ability of the naphthoquinone menadione to inliibit 
cell growth by a superoxide-dependent mechanism. They suggest that redox cycling of 
MnTMPyP occurs during dismutation of superoxide, in a manner similar to that of Mn 
SOD, and that both valency states i.e. Mn(III)TMPyP and Mn(II)TMPyP can remove 
the free radical (see below). They provide evidence, however, of an alternative 
pathway for reduction of native Mn(III)TMPyP to Mn(II)TMPyP by cellular 
reductants (AH2) which produces radical intermediates (AH') that then may react with
moleculai- oxygen (O2) to produced superoxide (O2 ). Furthermore, although, the 
oxidation of Mn(II)TMPyP back to Mn(III)TMPyP can be catalysed by superoxide, 
leading to its dismutation to hydrogen peroxide (H2O2), it may, alternatively, be 
catalysed by other cellular eieetron acceptors (B), forming partially reduced 
intermediates (B'), which may then also produce superoxide anion. Although both 
Mn(III)TMPyP and Mn(II)TMPyP can scavenge superoxide anion, Faullcner et al. 
(1994) provided evidence that the reaction rates are quite different 3.9 x lO’ M'^ s'* 
and 4 x 1 0 ^  M"’ s~\ respectively. Therefore, superoxide dismutation is more likely to 
occur during the oxidation of Mn(II)TMPyP than the reduction of Mn(III)TMPyP. 
This suggests that the AH2 AH' pathway is more likely to produce superoxide than 
the B —> B' pathway.
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From the above scheme, MnTMPyP is likely to be a net scavenger of superoxide if 
background levels of this free radical are high, i.e. with high levels of superoxide it 
will be less likely that cellular reductants and electron acceptors will participate in 
redox reactions with MnTMPyP thereby reducing superoxide generation. For 
example, in conditions of oxidant stress, where levels of superoxide anion are high, 
MnTMPyP has been shown to be an effective scavenger of this free radical (Chapter 
4). A possible explanation, therefore, of why MnTMPyP inactivates basal but not 
agonist-stimulated activity of nitric oxide may perhaps be related to background 
levels of superoxide anion in the different experimental conditions. In Chapter 2 it 
was suggested that treatment of endothelium-containing rings of rabbit aorta with 
ACh might enhance production of superoxide anion via stimulation of 
cyclooxygenase (Kurki'eja et al., 1986; Consentino et al., 1994) or protein kinase C
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(Matsubara & Ziff, 1986). Therefore levels of superoxide may be lower in conditions 
where basal nitric oxide is investigated than when ACh is used to elicit relaxation. 
Consequently, MnTMPyP may have a tendency to be a net scavenger of superoxide 
during experimental conditions where ACh-induced relaxation is assessed but a net 
generator of superoxide in its absence, hence the destruction of basal nitric oxide.
Another possible explanation, however, is that low levels of nitric oxide produced 
under basal conditions are destroyed to a greater extent by superoxide anion than the 
higher levels produced following agonist stimulation (Mian & Martin, 1995a).
The origin of the relaxation induced by higher concentrations of MnTMPyP is 
unclear- but does not involve nitric oxide since it is unaffected by treatment with L- 
NAME or endothelial removal. Whether acting as a scavenger or generator of 
superoxide, high concentrations of MnTMPyP may promote the build up the 
dismutation product, hydrogen peroxide. Hydrogen peroxide is a well known 
vasorelaxant (Furchgott, 1991; Zembowicz et al., 1993; Mian & Martin, 1995a; Mian 
& Martin, 1995b) and this may account for the MnTMPyP-induced relaxation. 
Pretreatment with the scavenger of hydrogen peroxide, catalase, however did not 
affect the this relaxation. Such experiments camiot fully rule out the involvement of 
hydrogen peroxide, since exogenously applied catalase, like SOD, is only active in 
the extracellular space. The possibility therefore remains that the relaxation produced 
by high concentrations of MnTMPyP results from the intracellular accumulation of 
hydrogen peroxide.
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Endothelial cells possess the antioxidant capability to protect themselves from the 
oxidative stress induced by reactive oxygen species. In normal physiology, a fragile 
equilibrium exists between free radical production and antioxidant activity. Many 
pathologies, however, are associated with increased free radical production and/or 
reduced anti oxidant capacity which then shifts this balance towards oxidative stress. 
Oxidant stress not only damages tissues (Halliwell & Gutteridge, 1989; Berman & 
Martin, 1993) but can impair many cellular processes, including endothelium-derived 
nitric oxide-dependent relaxation (Katusic & Vanhoutte, 1989; Ohlstein & Nichols, 
1989, Mian & Martin, 1995a). Diseases such as hypertension (Nakazono et al, 1991; 
Grunfeld et al, 1995; Bouloumie et al, 1997), atherosclerosis (Sharma et al., 1992; 
Ohara et al, 1993), ischaemia-reperfusion injury (Downey, 1990), diabetes (Hattori 
et al, 1991; Kamata & Kobayashi, 1996) and heart failure (McMurray et al, 1990; 
Katz et a l, 1993) are ail associated with nitric oxide/superoxide anion imbalance.
Therapeutic treatment with authentic superoxide dismutase (SOD) does not usually 
restore impaired endothelium-dependent relaxation since this enzyme cannot 
penetrate cell membranes to protect nitric oxide from destruction by superoxide 
anion intracellularly. Attempts have been made to overcome this problem, however, 
with the use of modified membrane-permeant forms of SOD. Authentic SOD has 
been attached to the membrane permeant carrier molecule, polyethylene glycol 
(PEG; Zalipsky, 1995). This modification also extends the plasma half-life of SOD 
from minutes to hours. In in vitro studies, PEG-SOD has been shown to partially 
restore endothelium-dependent relaxations that had been impaired in cholesterol fed 
rabbits (Mügge et a l, 1991b). Also, liposome-encapsulated SOD has been shown to
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partially restore endothelium-dependent relaxation in angiotensin 11-mediated 
hypertension in rats (Rajagopalan et al., 1996; Laursen et al., 1997). Despite 
providing greater antioxidant protection than with authentic SOD, these modified 
forms of SOD did not fully protect endothelium-derived nitric oxide from destruction 
by superoxide anion in any of these studies. Greater therapeutic potential may lie, 
however, with membrane permeant compounds that exhibit SOD-like activity. A 
number of different classes of such SOD mimetic have been described, including the 
metal-based agents, CuDIPS (Cu [II]-[diisopropyIsalicylate]2) and MnTMPyP (Mn 
[III] tetrakis [l-methyl-4-pyridyl] porphyrin), which dismutate superoxide in a 
manner similar to authentic Cu/Zn SOD and Mn SOD, respectively. Simple metal 
salts of Cu and Mn also possess SOD-like activity. Other compounds, such as the 
nitroxide spin traps, PTIYO (4-phenyl-2,2,5,5-tetramethy 1 imidazolin-1 -yloxy-5- 
oxide) and tempol (4-hydroxy 2,2,6,6-tetramethylpiperidine-1 -oxyl), and the 
superoxide scavenger tiron (4,5-dihydroxy-1,3-benzene-disulfonic acid) are also 
known to relieve oxidant stress in a number of test systems.
All of the above agents possess SOD-like activity in biochemical and/or isolated cell 
and tissue studies. Their ability to protect nitric oxide from destruction by an oxidant 
stress was, however, unlcnown prior to the start of this project. The aim of this study, 
therefore, was to investigate the ability of the above SOD mimetics to protect nitric 
oxide-dependent relaxation in conditions of oxidant stress. To do this, two separate 
conditions of oxidant stress were generated in rabbit isolated aortic rings. The first, 
involved inhibition of endogenous Cu/Zn SOD with a low concentration of 
diethyldithiocarbamate (DETCA; 0.3 mM) in combination with the generation of
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superoxide anion by the xanthine oxidase/hypoxanthine system. This resulted in an 
inliibition of both basal and acetylcholine (ACh)-stimulated activity of nitric oxide. 
Exogenously applied membrane-impermeant SOD prevented this inhibition of 
relaxation suggesting that this oxidant stress was confined to the extracellular space. 
The second, involved treatment with a high concentration of DETCA (3 mM) alone. 
The inability of exogenous SOD to reverse the inliibition of ACh-induced relaxation 
seen with this treatment suggests that this oxidant stress was intracellulai', i.e. 
resulted from inhibition of intracellular Cu/Zn SOD. This chapter discusses the 
activity of the above SOD mimetics in this study in context with their actions 
described elsewhere. Other strategies to redress the nitric oxide/superoxide 
imbalance and speculation regarding the future of the therapeutic potential of SOD 
mimetics are also discussed.
6.1 Non metal-based superoxide dismutase mimetics
The nitroxide spin traps, PTIYO and tempol, protect mammalian cells from oxidant 
stress (Mitchell et al., 1990; Krishna et al., 1996) and successfully scavenge 
superoxide in biochemical assays (Ewing & Janero, 1995; Chapter 3). Of these, only 
tempol protected nitric oxide-dependent relaxation (albeit weakly) from destruction 
by the extracellular oxidant stress in this study. In fact, PTIYO actually enhanced the 
blockade of relaxation resulting from both the extracellular and intracellular oxidant 
stresses (Chapter 4). It seems unlikely, therefore, that PTIYO could be used as an 
effective antioxidant in pathologies involving nitric oxide. Indeed, a large number of 
nitroxide spin traps have previously been shown to oxidise rapidly nitric oxide to 
nitrite and nitrate (Akaike et al., 1993). Indeed, another member of this group
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carboxy-PTIO (2"[4"CarboX"yphenyl]-4,4,5,5,-tetramethyl imidazoline-1-oxyi 3- 
oxide) has been used as an effective scavenger of endothelium-derived nitric oxide 
(Rand & Li, 1995). Tempol has, however, been used successfully in a number of 
pathological conditions. In rat, this nitroxide diminished the free radical-induced 
pancreatic injury produced from cerulin infusion (Sledzinski et at., 1995), retinal 
degeneration generated from intense light radiation (Wang et a i,  1995) and renal 
dysfunction induced by endotoxic shock (Leach et al., 1998). In addition to its 
superoxide scavenging activity, tempol is reportedly able to exert a further protective 
action by inhibiting the catalytic actions of transition metals and, hence, attenuates 
the formation of hydroxyl radical (Monti et al., 1996). Despite its ability to scavenge 
nitric oxide (Akaike et al., 1993) and impair endothelium-dependent relaxation 
(Chapter 4), tempol has been used successfully as a SOD-mimetic in other vascular 
studies. Administration of tempol normalised blood pressure in spontaneously 
hypertensive rats (SLIR; Schnackenberg et al., 1998). This reduction of blood 
pressure was nitric oxide-dependent suggesting that tempol had scavenged the 
enhanced superoxide levels that were destroying nitric oxide in this animal model 
(Nakazono et al., 1991). Furthermore, tempol is also reported to produce a 
maintained fall in blood pressure in normotensive rats tlnoughout a sustained 
infusion (Leach et al., 1998). This suggests that even in normotensive rats superoxide 
destroys some of the nitric oxide produced. In agreement with this, Zollner et al. 
(1997) report that tempol enhanced the bioactivity of nitric oxide generated by 
cultured endothelial cells. It is likely, therefore, that in each case the investigators 
used an optimum dose of tempol which scavenged superoxide with minimal 
inactivation of nitric oxide.
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The superoxide anion scavenger, tiron, has been shown reduce superoxide levels in 
lymphocytes (Devlin et al., 1981) and neutrophils (Gyllenhammar, 1987) and in 
biochemical assays (Laight et al., 1997; Chapter 3). In addition, tiron reduced the 
enhanced superoxide levels evoked by inhibition of Cu/Zn SOD by treatment with 
DETCA in rabbit aorta (Pagano et al., 1993). In this study, however, tiron provided 
only weak protection of nitric oxide-dependent relaxation against impairment by the 
extracellular oxidant stress. The lack of use of this compound in the recent literature 
suggests that tiron has become generally unfavoured as a SOD-mimetic of choice.
6.2 Copper-based superoxide dismutase mimetics
The copper-based mimetic, CuDIPS, demonstrated SOD-like activity in biochemical 
assays (Huber et al., 1987; Chapter 3) and prevented the free radical-induced 
inhibition of growth of baby hamster cultured kidney fibroblasts (Burdon et a l,
1995). CuDIPS also protected powerfully nitric oxide-dependent relaxation from the 
extracellular oxidant stress in rabbit aorta (Chapter 4). In addition, CuDIPS 
potentiated relaxation to the nitric oxide donor, 3-morphollnosydnonimine (SIN-1) in 
rat aorta (Emsley et a l, 1998). SIN-1 is known to generate superoxide as well as 
nitric oxide and the potentiation of relaxation may, therefore, reflect the superoxide 
scavenging ability of CuDIPS. In contrast, the copper-free carrier molecule 3,5- 
diisopropylsalicylate4 (DIPS), did not alter the relaxation to SIN-1 (Emsley et al., 
1998). This suggests that the DIPS ligand has no SOD-like activity. CuDIPS itself, 
however, induces nitric oxide-dependent relaxation in rings of rat aorta (Wyatt et al., 
1998). This relaxation is, thus, similar to that produced by authentic SOD (Ohlstein
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& Nichols, 1989; Mian & Martin, 1995a; Chapter 5). It is likely that this CuDIPS- 
induced relaxation was due to removal of superoxide anion, generated either within 
the tissue or in the oxygenated Krebs solution, which was continuously destroying 
some of the basally produced nitric oxide. All of these results indicate that CuDIPS is 
a highly effective SOD mimic. In this study, however, high concentrations of 
CuDIPS (10 -  100 jiM) powerfully impaired acetylcholine (ACh)-induced relaxation 
in rabbit aorta (Chapter 4). CuDIPS also dramatically impaired ACh-induced 
relaxation in rat aorta (Emsley et al., 1998). In addition, these authors report that the 
DIPS ligand itself caused a small attenuation of relaxation to ACh (approximately 50 
% of the inhibition caused by CuDIPS). Furthermore, Harrison et al. (1986) report 
that the DIPS ligand was just as effective as CuDIPS at preventing the free radical 
mediated induction of interleukin 2 synthesis in mouse thymoma cell lines. 
Therefore, in contrast, to the findings of Emsley et al. (1998), this suggests that DIPS 
does indeed posses some SOD-like actions. In this study, however, we found that 
CUSO4 (which gives free copper in solution) gave almost identical effects to CuDIPS 
(both as a SOD mimetic and as an inhibitor of ACh-induced relaxation). Since 
CuDIPS exists in a weak co-ordination complex (Huber et al., 1987), this agent is 
also likely to give free copper in solution. This suggests that the effects of CuDIPS 
are perhaps due to free copper and not to DIPS. Since CuDIPS can directly inactivate 
nitric oxide synthase (Baquial & Sorenson, 1995) and both CUSO4 and CuDIPS give 
free copper in solution leading to hydroxyl radical formation (see section 1.2.4), and 
therefore are liable to be toxic, neither agent is likely to be used successfully in the 
treatment of vascular pathologies.
Page 170
General Discussion Chapter 6
6.3 Manganese-based superoxide dismutase mimetics
The manganese-based compound, MnTMPyP, is reported to have powerful 
superoxide scavenging activity in E.coli (Faulkner et al., 1994) and cultured 
mammalian cells (Gardner et al., 1996). In this study, MnTMPyP was shown to be a 
potent scavenger of superoxide in biochemical assays (Chapter 3) and was the only 
mimetic investigated, apait from the simple metal salt MnCl^, to protect nitric oxide 
from destruction by both an extracellular and intracellular oxidant stress (Chapter 4). 
In another study conducted in this laboratory, MnTMPyP also restored nitrergic 
neurotransmission following its inactivation by oxidant stress (induced by 
inactivation of Cu/Zn SOD with DETCA in combination with superoxide generated 
by LY 83583) in strips of bovine retractor penis muscle (Mok et al., 1998). The 
SOD-like characteristics of MnTMPyP, however, have been questioned by findings 
of Pfeiffer et al. (1998). These authors propose that MnTMPyP can inhibit directly 
nitric oxide synthase and soluble guanylate cyclase in cultured porcine endothelial 
cells. Furthermore, they report that MnTMPyP can even scavenge nitric oxide. No 
such effect of MnTMPyP was found in this study. Even at millimolar concentrations, 
MnTMPyP had no inhibitory effect on ACh-induced relaxation (Chapter 4). We did 
find, however, that MnTMPyP was capable of inactivating basal nitric oxide activity 
via the generation of superoxide. Therefore, despite its effective SOD-like action in 
conditions of oxidant stress, MnTMPyP itself is not suitable as a therapeutic agent in 
the treatment of vascular pathologies. A modified version of MnTMPyP, developed 
by Batinic-Haberle et al. (1997), however, may hold greater therapeutic potential. 
The reported superoxide scavenging ability of this compound, Mn(II)OBTMPyP'^'
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(5,10,15,20-tetrakis-[N-methylpyridinium-4-yl] porphyrin), is some 60-fold greater 
than for Mn(III)TMPyP (rate constants 2.2 x 10^  M"‘ s“‘ and 4 x 10  ^ M"^  s '\  
respectively). The ability of this compound to protect nitric oxide from destruction 
by oxidant stress is likely to be greater than for MnTMPyP, but this remains to be 
tested. It is also not known if the unwanted side effects of MnTMPyP, i.e. its ability 
to act as a generator of superoxide, apply additionally to Mn(II)OBTMPyP'^‘.
Two other potentially interesting manganese-based SOD mimetics are described in 
the literature. Despite our efforts, however, we were unable to obtain samples of 
either of these agents to investigate in our models of oxidant stress. The first of these, 
EUK-8 (salen A(# '-bis[salicylideneamino]ethane]-manganese[III]), is a combined 
SOD and catalase mimetic and is Icnown to prevent free radical-induced damage to 
hippocampal slices (Musleh et a l, 1994) and cultured neuronal cells (Bruce et al.,
1996). In addition, EUK-8 protects rat heart from the free radical-induced injury 
resulting from ischaemia/reperfusion (Pucheu et al., 1996; Tanguy et al., 1996). 
EUK-8 also protects ACh-induced relaxation from inhibition by superoxide anion 
and produces a concentration-dependent relaxation of rat aorta (Barandier et al.,
1997). This EUK-8-induced relaxation, however, was quite different from that 
observed from treatment with SOD (Ohlstein & Nichols, 1989; Mian & Martin, 
1995a; Chapter 5). Surprisingly, the relaxation was actually enhanced by endothelial 
removal or treatment with an inhibitor of nitric oxide synthase. The authors conclude 
that the relaxation was mediated through activation of adenylate cyclase, soluble 
guanylate cyclase and perhaps potassium channels and not via protection of nitric 
oxide (Barandier et al., 1997).
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The other compound, SC52608 (Mn[II]-dichloro[^rnm--2,3-cyclohexanO“l,4,7,10,13- 
pentaazacyclopentadecane]), has its metal in the more active manganese(II) form. It 
induces concentration-dependent relaxation of rat aortic rings which is abolished by 
endothelial removal or treatment with an inhibitor of nitric oxide synthase (Kasten et 
al., 1995). As with authentic SOD, it is likely that this relaxation was due to removal 
of superoxide anion, generated either within the tissue or in the oxygenated Krebs 
solution, which was continuously destroying some of the basally produced nitric 
oxide. Thus, unlike MnTMPyP which destroys basal nitric oxide through generation 
of superoxide anion, SC52608 protects basal nitric oxide. This agent also reduces 
ischaemia/reperfusion damage to rabbit isolated hearts (Kilgore et al., 1994) and 
skeletal muscle (Deune et al., 1996). There is therefore potential for compounds like 
SC5608 to be used as therapeutic agents.
6.4 Ascorbic acid as a superoxide dismutase mimetic
In addition to its widespread actions as a vitamin, ascorbate (vitamin C), is an 
important endogenous seavenger of superoxide anion (Som et al., 1983) and 
consequently has the potential to protect nitric oxide from this free radical. Indeed, 
ascorbate exhibits the same two characteristic actions on the vasculature as described 
for authentic SOD. First, it produces endothelium-dependent, nitric oxide mediated 
relaxation of rat aorta (Dudgeon et al., 1998). Secondly, ascorbate reverses the 
blockade of ACh-induced relaxation resulting from the same extracellular oxidant 
stress used in this study. In addition, reports show that administration of ascorbate
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reverses the impaired nitric oxide-mediated vasodilation seen in patients with 
coronary artery disease (Hattori et al., 1991; Levine et al., 1996), diabetes mellitus 
(Ceriello ei a l, 1991; Ting el a l,  1996), heart failure (Llorning et al., 1998) and 
hypertension (Ceriello et al., 1991). Overloading with ascorbate may, however, be 
potentially mutagenic, since amounts of 500 mg per day (compared with the 60 mg 
per day recommended by the EU) are reported to elevate levels of 8-oxo-adenine, a 
marker of DNA oxidation (Podmore et al., 1998). Nevertheless, ascorbate has 
promising potential in the treatment of pathologies associated with oxidant stress and 
warrants further investigation.
6.5 Gene tran sfe r as a therapeu tic  inteiwention
Transfer and expression of genetic material within the vascular endothelium 
represents an alternative strategy to normalise the nitric oxide/superoxide imbalance 
associated with oxidant stress. Gene transfer to blood vessels in vivo has been 
accomplished by Von Der Leyden et al. (1995). This study used a rat carotid injury 
model to overexpress the endothelial nitric oxide synthase (eNOS) gene in the 
neointima using a Sendai virus/liposome in vivo gene transfer technique. The eNOS 
gene transfection restored nitric oxide production to normal levels, increased 
vascular reactivity and reduced neointima formation significantly (Yon Der Leyden 
et al., 1995). These results show that the eNOS gene is a major modifiable factor in 
the treatment of vascular disease. Furthermore, genetic transfer of human Cu/Zn 
SOD to bovine aortic endothelial cells successfully inhibited the oxidation of low 
density lipoproteins (Rios et al., 1996). To date, however, the transfer of SOD genes
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to the vascular endothelium in vivo has not been reported. A unified study of the 
combined transfer of eNOS and SOD genes to animal models of disease remains to 
be investigated.
6.6 Future of superoxide dismutase mimetics
Ultimately, the genetic transfer of eNOS/SOD may be the most powerful tool in 
redressing the nitric oxide/superoxide imbalance of vascular disease. Therapeutic 
intervention with genetic material in human pathologies, however, is not likely to be 
available for some time. Until then, membrane-permeant SOD mimetics may be the 
most feasible method to increase antioxidant capacity of cells. Consequently, there is 
considerable interest in the development of such agents. The initial investigation of 
novel compounds in biochemical or isolated cell or tissue studies has a role. 
However, the discovery of harmful side effects of some of these mimetics, as 
uncovered in this investigation, suggests that more work will be required before an 
agent can be given safely to patients. The recent literature would suggest that the 
main focus of activity is with the metal-based SOD mimetics. This is in accord with 
the findings of this study which show that the metal-based agents were considerably 
more effective than the spin traps in protecting nitric oxide. In addition to the classes 
of compound described in this chapter, there are literally hundreds of other 
antioxidant compounds that could potentially possess SOD-like activity. Many of 
these, such as poly-phenols and fiavanoids, are found in abundance in fruit and wine 
(Catapano et al., 1997). Screening all of these agents for their ability to protect nitric 
oxide from oxidant stress would be costly and time consuming. However, a
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iaïowledge of the process of nitric oxide production and of its physiological actions, 
and of the chemistry involved in superoxide dismutation, could reduce the number of 
compounds investigated to only those with the pharmacological potential to be 
effective SOD mimetics.
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